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INTRODUCTION 
 
1. General anatomy of the intestine and functions of the intestinal epithelium 
The mammalian intestine is organized into two anatomical portions sharing the same basic 
structure but accounting for different functions: the small and the large intestine (or colon). 
Both of these portions are organized in multiple layers of tissues consisting in an external 
smooth muscle layer (muscularis externa) responsible for peristaltism, a dense irregular 
connective tissue (submucosa), a thin lamina of muscle outside the lamina propria and a an 
internal mucosa constituted by a lose cell-rich connective tissue accounting for myofibroblast, 
lymphocites, plasma cells, mast cells and macrophages and rich in capillaries (Slomianka and 
Lutz, 2009). The inner mucosal surface of the intestine is covered by a monolayer of different 
epithelial cells representing the largest surface of interaction of the organism with the external 
world (about 250m2 in humans) and which is constantly renewed by the stem and proliferative 
compartment. Newborn cells are incessantly generated by cell division in the proliferative 
compartment and migrate upward to differentiate and eventually die by anoikis before they 
are shed into the intestinal lumen. The homeostatic self-renewal is accomplished within 3 to 5 
days. The intestinal epithelia exert at least 4 main functions:  
• Absorption:  after the initial degradation in the stomach, the chow enters the luminal 
flow through the pyloric valve and is forced in its progression toward the distal 
intestine by the peristaltic contractions. All along the small intestine the content is 
continuously degraded by the populations of commensal bacteria hosted in the 
lumen (microflora or microbiota), and is then absorbed by the epithelial cells. The 
molecules that are absorbed are then distributed to the whole body by the blood 
supply. 
• Endocrine function: the epithelial layer accounts for a specialized cell type 
(enteroendocrine cells) responsible for the secretion of hormones in the blood such 
as the serotonine, the glucagon-like peptide (GLP), the gastric-inhibitory peptide 
(GIP), that regulate the secretion of insulin and the digestion. 
• The barrier function: the intestinal epithelium constitutes a physical barrier allowing 
the selective entry of small molecules in the blood. The epithelial cells are 
connected by different type of junctions: tight junctions, adherent junctions, GAP 
junctions and desmosomes allowing cell-to-cell adhesion, communication and 
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selective permeability (figure 1). This selective filter can be modulated by signaling 
molecules that can alter the organization of the junctions (Tsukita, Furuse, and Itoh 
2001). A supplemental physical layer is represented by the mucus secreted by 
specialized cells (goblet cells) and is constituted by mucines, polysaccharides and 
antimicrobial peptides having the role of embedding trillions of bacteria and 
pathogens impeding their contact with epithelial cells. The mucus also contains 
secreted antimicrobial molecules such as the resistin-like molecules (RELM) and 
antibodies like the Immunoglobulin-A. The density, composition and bacterial load 
of the mucus varies along the intestinal portions and its elimination and renewal is 
permitted by the peristaltic contractions of the intestine.    
  
 
Figure 1: A) Schematic illustration of epithelial cell-cell junctions. B) Electon micrograph of the junctional 
complex of mouse intestinal epithelia (Mv: microvilli; TJ: tight junction; AJ: adherens junction; DS: 
desmosomes).  Adapted from Tsukita, Furuse, and Itoh 2001. 
 
• Immune function: as mentioned, the intestine represents the largest surface of 
contact with the external world represented by the luminal content. The intestinal 
mucosa constantly interacts with trillions of commensal microorganisms and is 
periodically challenged by the presence of different pathogens. Several immune 
mechanisms participate to protect the host from the infection with enteric bacteria 
and shape the composition of the commensal microbiota(figure 2) (Perez-Lopez et 
al. 2016). The sensing of pathogens associated molecular patterns (PAMPs) occur 
via different classes of pattern recognition receptors (PRRs) expressed at the 
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membrane or in the intracellular compartments of epithelial cells (Akira et al., 
2006). Toll like receptors (TLRs) and NOD-like receptors (NLRs) can sense the 
microorganisms and trigger downstream signaling pathways leading to the 
activation of mechanisms of innate and adaptive immune response (Zheng et al. 
2008; Behnsen et al. 2014). Pathogen recognition leads to the production of pro-
inflammatory cytokines that can induce activation of the IL23-Th17 immune cell 
axis and the secretion of antimicrobial proteins and defensins (Zheng et al. 2008; 
Behnsen et al. 2014). In addition, activation of the mucosal adaptive immunity 
involves the production of specific antibodies like immunoglobulin A (IgA), which 
is an antibody class unique to the mucosa and produced by the plasma B-cells 
residing in the lamina propria (Cerutti and Rescigno 2008; McPherson et al. 2008). 
These mechanisms also control the normal composition of the intestinal commensal 
microbiota which, in turn, participates to the protection to infection with pathogens, 
both directly through the competition for nutrients and indirectly through the 
modulation of mucosal immunity. 
 
 
Figure 2: schematic illustration of the major mechanisms involved in the sensing of pathogen and 
microbiota and immune response. Dendritic cells (DC) sample the intestinal content and induce the 
activation of regulatory T (Treg) cells to produce IL10 and stimulate the activity of several other cell types 
like Th17, ILC3, NK and γδ cells. Plasma cells contribute in controlling the intestinal flora by producing 
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secretory IgA. IL17 and IL22 induce the production of antimicrobial peptides (AMP) secreted by Paneth 
cells. (IL23-R: IL23 receptor; NLRs: NOD-like receptors; PMSs: polymorphonuclear cells; ROS: reactive 
oxygen species; TLR: toll-like receptors; TNF: tumor necrosis factor). Figure adapted from Perez-Lopez 
et al., 2016. 
 
1.1. The small intestine 
The epithelium in the portion of the intestine located between the stomach and the cecum (i.e. 
the small intestine) is organized in two different compartments that constitute the crypt-villus 
unit (figure 3). Villi are finger-like protrusions that project into the lumen to increase the 
surface of absorption and are covered by a monolayer of post-mitotic epithelial cells. The 
apical (luminal) surface of each epithelial cell is covered by protrusions, the microvilli, which 
serve to further increase the luminal epithelial surface. Lymph vessels and capillaries located 
in the lamina propria of each villus mediate the transport of absorbed nutrients to the whole 
body. Each villus is surrounded at its base by multiple epithelial invaginations, the crypts of 
Lieberkühn that constitute the proliferative compartment of intestinal epithelia. Multiple 
intestinal stem cells are located at the very bottom of each crypt where they are intermingled 
between terminally differentiated Paneth cells. The intestinal epithelium accounts for 6 
differentiated cell types with absorptive or secretory functions: enterocytes, goblet cells, 
enteroendocrine cells, Paneth cells, tuft cells and M-cells (figure 4) (van der Flier and Clevers 
2009). The genetic interactions driving the specification and the functions of these lineages 
are further described later in the text.    
Follicular structures named Peyer’s patches are found in the small intestine, which are found 
at higher density in the distal small intestine. These structures are rich in B and T-
lymphocytes and are lined by a simple monolayer of epithelial cells containing specialized M-
cells.   
The absorption of nutrients, vitamins and ions occurs in the small intestine that can be 
anatomically divided in 3 portions: the duodenum, the jejunum and the ileum. The duodenum 
represents the most proximal and the shortest portion of the small intestine starting at the exit 
of the pyloric valve of the stomach, and in anatomical contact with the pancreas. In this 
portion the lenght of villi is maximal, providing the largest surface of absorption. Absorptive 
cells in this portion express the proteins forming the channels for the absorption of iron. The 
jejunum represent the medial portion of the intestine, followed by the ileum which is 
characterized by shorter villi and smaller proliferative compartment in which, however, the 
Paneth cells are more abundant.     
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Figure 3: illustration of the human small intestinal regions and architecture. (Encyclopaedia Britannica, 
2003) 
 
 
 
Figure 4 : intestinal epithelial cells types. A) crypt-villus axis visualized via hematoxylin-eosin staining. B) 
Goblet cells by PAS staining. C) Paneth cells revealed by lyzozyme immunostaining. D) Enteroendocrine 
cells revealed by Chromogranin A immunostaining. G) Enterocytes revealed by F) Tuft cells expressing 
the DCLK1 marker. G) M-cells expressing Spi-B.  Picture from H. Clevers, 2013. 
 
1.2.  The large intestine 
The large intestine, or colon, represents the portion of the intestine located between the cecum 
and the rectum (figure 5). The human colon accounts for different anatomical portions. The 
epithelium is organized in crypts, resembling to those found in the small intestine and 
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accounting for the proliferative cells but they lack Paneth cells. Villi are replaced by a flat 
epithelial layer, mainly constituted by colonocytes. The flow of the intestinal content is 
accompanied by the absorption of water and sodium. 
 
 
Figure 5: illustration of the architecture of the human large intestine (colon). (Encyclopaedia Britannica, 
2003) 
 
1.3.  Epithelial lineages:  specification and functions 
The intestinal epithelium accounts for six differentiated lineages whose functional identity is 
either absorptive (enterocytes) or secretory (goblets cells, Paneth cells, enteroendocrine cells, 
tuft cells and M-cells) (figure 6).  The intestinal stem cell compartment lying at the bottom of 
the crypt represents the common origin of all these lineages (H. Clevers 2013). Epithelial cell 
fates are commonly believed to be set just above the stem cell compartment at the position +5 
in the crypt, which is considered as the origin of differentiation of the progenitors representing 
the immediate progeny of intestinal stem cells. The molecular circuit governing the choice 
between absorptive and secretory fate consists in the relatively simple genetic interaction 
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between two helix-loop-helix transcription factors: Math1 and Hes1. Math1 represents the 
master gene responsible for the secretory fate decision. Its deletion results in the complete loss 
of all secretory cell types, whereas its overexpression can force progenitors into a secretory 
fate (Yang et al. 2001; Shroyer et al. 2007; VanDussen and Samuelson 2010). The expression 
of Math1 is negatively regulated by Hes1, a transcriptional target of the Notch signaling 
pathway in epithelial cells. The deletion of Hes1 leads to the depletion of enterocytes and 
increased number of secretory cells (Jensen et al. 2000). Downstream to this genetic 
interaction, specific transcription factors (or combinations of these) are responsible for the 
differentiation of each specialized cell type.  
 
 
Figure 6: epithelial specification and function. Left: schematic representation of the different epithelial 
cell types according to their position in the crypt-villus axis. Right: Molecular program driving the 
specification of the different mature cell types. 
 
1.3.1. The Intestinal stem cell compartment 
The intestinal epithelium is completely renewed every 3-5 days throughout the entire lifetime. 
This outstanding capacity is conferred by the proliferating crypts representing the real engine 
of the epithelial self-renewal process, as Stevens and Leblond showed in the landmark study 
they published in 1947 (Leblond and Stevens 1948). This work showed for the first time that 
the life span of most cells in the intestinal epithelium is in the order of days, and the high rate 
of production of newborn cells is continuously balanced by the elimination of cells that 
migrate upward from the crypt, before they are ejected as soon as they reach the tip of the 
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villus. Such a dynamic turnover implies the existence of one or multiple populations of cells 
capable to give rise to the different cell types populating the intestinal epithelium 
(multipotency) and maintain their own pool throughout the entire life (self-renewal), a dual 
ability that correspond to the definition of adult stem cell. More than a century back, 
Bizzozero showed that, in homeostatic conditions, cell divisions only occur in the intestinal 
crypts in which cells with stem properties were already suspected to reside (Bizzozero, 1893 
(M. Bjerknes and Cheng 1981). The following decades of work have lead to the formulation 
of the stem cell zone model according to which intestinal stem cells reside, together with 
Paneth cells, in a permissive environment at the very bottom of the crypts allowing self-
renewal capacities. These cells are identified as crypt base columnar cells (CBC). As soon as 
newborn cells exit this location and pass through the position +5 (above the uppermost Paneth 
cell) they start their maturation toward precise differentiated cell lineages.  
 
1.3.1.1. Lgr5, a robust marker of intestinal stem cells 
One of the key challenges in the field of stem cell biology consists in the capacity of 
investigators to identify exquisite reliable markers that can serve to discriminate cells with 
self-renewal ability from their non-stem progeny. Such markers have long remained elusive in 
the case of intestinal stem cells, making the quantification and the characterization of these 
cells only speculative. By analyzing a list of genes that are part of a common genetic program 
shared by colon cancer cells and intestinal crypts Barker and collaborators were able to 
identify the first robust maker of intestinal stem cells, the leucine-reach repeat containing G-
protein coupled receptor 5 (Lgr5)(Barker et al. 2007). This gene encodes a serpentine receptor 
which is a facultative component of the Wnt complex. The generation of a knock-in mouse 
model in which the expression of the recombinase Cre is driven by the Lgr5 promoter 
(Lgr5EGFP-Ires-CreERT2) crossed with the Rosa26R-LacZ reporter allowed the formal 
demonstration of the capacity of Lgr5-positive cells to permanently replenish the entire 
epithelial compartment giving rise to all differentiated cell types within 5 days. All Lgr5GFP+ 
cells were invariably found to divide each day and to be in physical contact with Paneth cells. 
Apart from the intestine, Lgr5 was found to represent a bona fide marker for stem cells of 
other organs including the stomach, the hair follicle, the prostate and the kidney. 
 The opportunity to isolate GFP positive cells in the Lgr5EGFP-Ires-CreERT2 model by fluorescent 
activated cell sorting allowed the further identification and the functional analysis of 
additional stem cell markers with different cellular localization and functions (figure 7), such 
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as the transcription factor Ascl2 representing a master regulator of the intestinal stem cells 
genetic program, Olfm4 and Smoc2 (van der Flier, Haegebarth, et al. 2009; van der Flier, van 
Gijn, et al. 2009; Muñoz et al. 2012). Other markers were identified although their expression 
is shared with cells in the non-stem transit amplifying compartment, such as CD133, 
Musashi1 and Hunk among the others (Zhu et al., 2009; Munoz et al., 2012). These non-
specific markers are often used in combination as an alternative to the few mentioned bona 
fide intestinal stem cells markers in order to evaluate the stem genetic program exhibited by 
cells in different experimental conditions. 
 
 
Figure 7: Functional classification of genes up-regulated in Lgr5
high
 intestinal stem cells. Genes are 
assigned to different functional classes according to their gene ontology molecular function with 
PANTHER. The figure presents 279 genes for some of the most relevant functional categories, selected in 
a list of 510 genes found to be enriched in Lgr5
high 
cells. Muñoz et al. 2012. 
!
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1.3.1.2. The +4  stem cells model 
During the recent years some studies have revealed the existence of a multipotent Lgr5-
negative population located at the position +4, just above the uppermost Paneth cells. These 
cells express the Bmi1 proto-oncogen marker (Sangiorgi and Capecchi 2008). Tian and 
colleagues elegantly showed that Lgr5+ cells are dispensable to the maintenance of the 
intestinal homeostasis during a couple of days (Tian et al. 2011). The authors made use of a 
genetic model in which the expression of the diphteria toxin receptor is driven by the Lgr5 
promoter resulting in the ablation of Lgr5-positive cells after the administration of diphtheria 
toxin to the mice. They also performed a genetic tracing model in which the expression of the 
recombinase Cre under the control of the Bmi1 promoter is combined with the R26R-LacZ 
reporter locus to demonstrate that the ablation of the Lgr5+ cells can be obviated by the 
capacity of crypt Lgr5--Bmi+ cells to repopulate the intestine. These observations led the 
authors to speculate that Lgr5+ compartment may represent the unique or prevalent source of 
stem cells in normal homeostasis and that the Bmi1+ population deriving from Lgr5+ cells 
might be recruited to take on the role of their in the case of injury and depletion of the Lgr5+ 
compartment.  
 
1.3.1.3. Crypt plasticity and self-renewal 
The possibility that population of cells capable of self-renewal might be organized in a 
hierarchical fashion prompted the investigators in the field of stem cell biology to further 
focus the attention on the plasticity of non-stem intestinal precursors and their capacity to 
regain stemness.  
The first lineage tracing study to report the potential reversion of progenitor cells to stemness 
during tissue regeneration concerned the Lgr5-;Dll1+ population, which normally represent a 
subset of goblet and Paneth progenitors (van Es et al. 2012). In 2013 Buczacki and colleagues 
showed that non dividing short-lived Lgr5+ Paneth/enteroendocrine precursors disappear over 
time as a result of terminal differentiation in healthy mice whereas they are able to 
dedifferentiate and repopulate the other epithelial lineages upon damage (Buczacki et al. 
2013). Another very recent work from Tetteh and colleagues has shown that upon Lgr5-
expressing stem cells depletion, short-lived Alpi+ enterocyte precursors may serve as a 
reservoir of potential stem cells by dedifferentiating to replenish the damaged Lgr5+ 
compartment (Tetteh et al., 2016).  
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These studies showing an unexpected degree of plasticity of committed progenitors has 
prompted the scientific community to reconsider the role of cellular reprogramming in the 
intestinal homeostasis. The molecular program driving such plasticity has not been 
extensively investigated yet, but one recent study based on an innovative algorithm for the 
analysis of transcriptional heterogeneity in a given cell population provided clues for an 
attempting some speculations. By making use of this methodology the authors were able to 
detect previously unidentified sub-types of enteroendocrine cell types (Grün et al. 2015). The 
application of such a tool to investigate the heterogeneity existing within the Lgr5+-GFPhigh 
compartment showed that these bona fide stem cells represent a heterogeneous population 
mixed with rare Lgr5-positive early secretory cell types. One possible interpretation of these 
evidences may be that Lgr5+ cells undergo commitment toward defined secretory fates very 
early in the crypt and then they gradually lose their self-renewal ability later during migration.  
 
1.3.2. Enterocytes 
Enterocytes (or colonocytes in the colon) are the most abundant cell types in the small and 
large intestines. Their primary function consists in the absorption of nutrients and vitamins at 
the apical surface and in the export of these nutrients to the blood supply.  Enterocytes were 
recently showed to be capable of secreting mucines that serve to protect the epithelium from 
the contact with pathogens. Their differentiation depends on the expression of Hes1 and on 
the inhibition of the secretory fate played by the Notch signaling through the repression of 
Math1 (see above) (Kazanjian et al. 2010; T.-H. Kim and Shivdasani 2011). Ptk6 deficient 
mice display delayed maturation of enterocytes (Haegebarth et al. 2006). 
 
1.3.3. Paneth cells 
Paneth cells are located within the crypt where they complete their maturation by escaping the 
flow of migration toward the villus, and instead migrate downward to settle at the crypt 
bottom where they can persist for 2 months or more, with the oldest Paneth cells residing at 
the very base of the crypt (Ireland et al. 2005). Paneth cells are normally present only in the 
small intestine, but in some pathological conditions, characterized by intestinal metaplasia, 
these cells can also be found in the esophagus, in the stomach or in the colon. The necessity 
for the Math1 activity for their formation implies their secretory identity, and their 
differentiation depends on active Wnt signaling and on the Wnt target transcription factor 
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Sox9 as demonstrated by the depletion of this cell type in the Sox9 knock-out mouse model 
(van Es et al. 2005; Bastide et al. 2007; Mori-Akiyama et al. 2007; Durand et al. 2012).  
These cells possess extensive ER and Golgi network necessary to the production of their 
typical secretory granules. Granules are released via exocytosis in response to a variety of 
stimuli including bacterial surface components, acetylcholinergic and toll-like receptors 
agonists. The vast number of molecules belonging to the secretive granules makes Paneth 
cells a major player in the control of the homeostatic balance of the intestine via different 
functions (H. C. Clevers and Bevins 2013). Antimicrobial peptides such as lyzozyme and 
defensins are among the most abundant components of these granules and their 
characterization have elucidated the role exerted by Paneth cells in the innate immunity 
against enteric pathogens and in the modulation of the composition of the intestinal 
microbiota.  
However the close association of Paneth cells with intestinal stem cells prompted researchers 
to investigate the functional relationship within these two populations. A number of recent 
findings demonstrate that Paneth cells constitute the prominent source of niche factors for the 
self-renewal compartment. This notion is supported by the fact that that the ablation of Paneth 
cells in 3 genetic models results in the progressive loss of Lgr5+ intestinal stem cells in the in 
vitro organotypic culture system (Sato et al. 2011). However, the ablation of Paneth cells in 
vivo does not produce obvious changes in the stem compartment, indicating that, in vivo, these 
factors are redundantly produced by other sources (Garabedian et al. 1997; Durand et al. 
2012). The development of primary ex vivo cultures of intestinal stem cells that can be grown 
into intestinal organotypic structures (further detailed later in the text) provided additional 
evidences for the role of Paneth cells in the maintenance of the stem compartment. Indeed, 
single sorted Lgr5-positive cells grown in matrigel rarely survive and give rise to mature 
intestinal organoids, whereas Paneth/stem cell doublets show a higher clonogenic efficiency, 
supporting the idea that these cells may provide intestinal stem cells with niche factors 
necessary to their identity (Sato et al. 2011; Geiser et al. 2012).  Molecular arrays have shown 
that the gene expression profiles of these cells include the massive production of components 
redundant with the factors that are essential for the maintenance of intestinal organoids such 
as Wnt3, EGF, and the Dll1 and Dll4 Notch ligands (Sato et al. 2011).  
 
1.3.4. Goblet cells 
! "+!
Goblet cells represent the most abundant secretory type in the small intestine, where they are 
equally distributed all along the crypt-villus axis. These cells are in charge of producing the 
mucins that constitute the physical barrier preventing the chemical and physical interaction 
between epithelial cells and the microorganism in the lumen (R. Goll and van Beelen 
Granlund 2015). They also produce factors involved in the organization of such a barrier, 
such as the trefoil factor 3 (TFF3) and they are implicated in the process of the immune Th2 
response by the production of the resistin-like molecule β (RELM-β) (Y. S. Kim and Ho 
2010). The SPDEF and KLF4 transcription factors are required for their terminal 
differentiation (Katz et al. 2002; Gregorieff et al. 2009; Noah et al. 2010; Ghaleb et al. 2011).  
This cell type share the expression of some markers with Paneth cells, like Spdef and Agr2, 
although no common precursors have been identified so far for these 2 populations. 
 
1.3.5. Enteroendocrine cells 
Enteroendocrine cells represent a rarer secretory lineage responsible for the production of 
hormones and peptides found in the secretory granules that are typically observed in this cell 
type. These molecules are released trough the basal membrane to the blood or function as 
signaling molecules modulating the activity of basal neurons, in order to the regulate 
metabolism and digestion. Enteroendocrine cells account for at least 16 different sub-types 
defined by distinctive molecular signatures, although a comprehensive functional 
classification is still lacking (May and Kaestner 2010). The commitment of all these sub-types 
depends on the function of the Neurogenin-3 transcription factor (Ngn3) (Jenny et al. 2002; 
Lee et al. 2002). The K and L subtypes are responsible for the production of peptides 
regulating the secretion of insulin by the β pancreatic cells, such as the gastric inhibitory 
peptides (GIP) and the glucagon like peptides (GLP). The enterocromaffin subtype is 
responsible for the massive production of serotonin hormone regulating the peristaltic 
intestinal movements. Ngn3 deficient mouse models display a severe impairment in the 
absorption of lipids absorption and regulation of glucose homeostasis (Mellitzer et al. 2010). 
 
1.3.6. Tuft cells 
Tuft cells constitute a very rare population (representing 0,3-0,4% of the epithelial cells) of 
cells that are homogenously distributed along the intestinal length and crypt-villus axis. These 
cells have also been identified in lung and pancreatic epithelia (Gerbe, Legraverend, and Jay 
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2012). Their typical morphology is characterized by the presence of long microvilli at the 
apical surface, suggesting that these cells might be involved in the sensing of the luminal 
content. Gerbe and collaborators identified these cells as an independent secretory lineage, 
since their terminal differentiation depend on the Atoh1 transcription factor but not on the 
activity of Ngn3, Spdef, Sox9 or Gfi1 transcription factors (Gerbe et al. 2011; Matthew 
Bjerknes et al. 2012). Tuft cells express Sox9 during their differentiation, but this factor is 
required neither for their specification nor for their survival in the adult intestine. The same 
authors have also identified doublecortin-kinase 1 (Dclk1) as the first specific marker of these 
cells, previously referred to as a potential marker for quiescent intestinal stem cells (Gerbe et 
al. 2009). However recent works have raised the possibility that this gene could also represent 
a marker of intestinal tumoral stem cells (Nakanishi et al. 2013; Westphalen et al. 2014a). The 
transcription factor Pou2f3 was recently identified as the first master gene responsible for the 
specification of tuft cells, since knock-out mice completely lack this cell lineage (Gerbe et al. 
2016a). This recent work, together with two other publications has recently documented the 
first function of tuft cells that are essential to initiate the Th2 immune response against 
helmint parasites(Gerbe et al. 2016b; Howitt et al. 2016; von Moltke et al. 2016). Pou2f3 
deficient mice display an impaired capacity to eliminate these parasites, due to a defective 
production of the IL-25 alarmin cytokine (whose tuft cells represent the only epithelial 
source) resulting in the abrogation of the Th2 immune response activation.  
The molecular profile of tuft cells indicate that these cells might exert other functions 
involved in the modulation of inflammatory processes, since these cells represent a unique 
epithelial source of opiodes, cyclo-oxygenases, and also express the hematopoietic 
prostaglandin D synthetase (Bezençon, le Coutre, and Damak 2007; Gerbe et al. 2011; Gerbe, 
Legraverend, and Jay 2012).    
 
1.3.7. M-cells 
Microfold cells reside in the epithelium that overlies specialized gut-associated lymphoid 
structures, the Peyer’s patches(Owen and Jones 1974). Their function consists in the transport 
and the presentation of luminal antigens to the immune cells in the underlying stroma. Their 
maturation depends on the transcription factor SpiB belonging to the Ets family (Knoop et al., 
2009). Indeed, SpiB knockout mouse models completely lack M-cells (de Lau et al. 2012). 
The cytokine Rank-L secreted by stromal cells was shown to be essential for the maturation of 
M-cells: although its receptor RANK is expressed by all epithelial cells, the addition of the 
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ligand to the culture medium induce the commitment of intestinal primary cultures toward the 
differentiation of M-cell lineage (de Lau et al. 2012). 
 
1.4.  Homeostatic dynamics of the intestinal epithelium 
The rapid rate of turnover and its simple architectural organization make the intestinal 
epithelium a unique model to study the relationship between stem cells and their direct 
progeny as well as the influence played by genetic and environmental factors on this balance. 
Such basic biological knowledge becomes even more valuable when we consider the 
increased susceptibility to develop pathologies like cancer as the result of any failure in these 
mechanisms. The workhorse Lgr5high intestinal stem cells constantly feed the transit 
amplifying (TA) compartment located just above the Paneth cell-containing stem-permissive 
environment. This progeny undergo 4-5 rounds of rapid (12 hours) cell divisions before they 
undergo to terminal differentiation and continue migrating toward the tip of the villus. 
Alternatively, as previously mentioned these committed daughter cells can in turn revert to 
stemness and replace the injured Lgr5+ compartment.  
Each crypt contains a constant number of about 15 Lgr5+ cells, whose identity is robustly (but 
not exclusively) defined by the heterotypic contact with Paneth cells. The prevailing view on 
how adult stem cells accomplish their dual homeostatic role has long been based on an 
asymmetric cell division model in which daughter cells adopt divergent stem or TA fates. 
Short- and long-term clonal tracing results showed that equipotent stem cells rather divide 
symmetrically each day and are subjected to a neutral competition for the available surface of 
contact with surrounding Paneth cells, with none of daughter cells having a higher a priori 
chance to maintain stemness (Lopez-Garcia et al. 2010; Snippert et al. 2010). Such conclusion 
is coherent with the relatively long time needed for a newly formed crypt to become 
monoclonal (about 1 to 6 months), which means that at a given moment all the cells in the 
same crypt derive from one of those 15 stem cells. The number of stem cells is therefore 
tightly regulated by the presence of Paneth cells, which are in turn generated in finely 
controlled number and localization at the bottom of the crypt (van Es et al. 2005; Andreu et al. 
2008; Farin, Van Es, and Clevers 2012). This homing was shown to be associated to the 
presence of EphrinB1 ligand, which is expressed by differentiated cells in a reverse villus-to-
crypt gradient. Paneth cells, the prevailing epithelial source of Wnt ligands, express the Wnt 
target gene coding for the EphB3 receptor as a result of autocrine stimulation, so that the 
EphrinB1-EphB3 interaction exerts a repulsive force driving the downward migration of these 
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cells toward the bottom of the crypt (Batlle et al. 2002). All committed EphB3-negative cells 
are mechanically pushed into the crypt-to-villus flow by newly formed TA cells. Therefore 
EphB3 knock-out mice display defective homing of Paneth cells that tend to comigrate with 
the other cells. The neutral competition between stem cells to maintain the proximity to 
Paneth cells has been shown to be biased by genetic mutations that are typically associated 
with colorectal cancer initiation and progression and that confer intestinal stem cells a 
relatively slight clonal advantage, although their fate is not deterministic since many wild-
type cells are still capable to replace the mutated ones (figure 8) (Vermeulen et al. 2013; 
Vermeulen and Snippert 2014). This observation represents one of the first direct proofs that 
the intrinsic program of the tissue contributes to the maintenance of genome integrity, which 
has long represented an outstanding open question on the tissue accounting for the highest 
turnover rate in the body. As for many types of adult stem cells, the immortal strand 
hypothesis was believed to represent the mechanism responsible for genome integrity in 
intestinal stem cells. According to the original Cairns model, segregation of the old- and the 
newly synthesized DNA strands occur asymmetrically at stem cell division, with the old 
strands retained by the daughter cell maintaining the stem identity (Cairns, 1975). In 2011 two 
independent works showed that this model does not apply to intestinal stem cells, which 
segregate their chromosomes randomly at every cell division, both in normal homeostasis and 
during regeneration upon injury (Escobar et al. 2011; Schepers et al. 2011). 
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Figure 8: intestinal stem cells dynamics in intestinal homeostasis and cancer. A) Schematic representation 
of the adenoma to carcinoma sequence associated with the accumulation of genetic lesions. Oncogenic 
mutations alter the competitive fitness of intestinal stem cells. The mutation creates a bias that favor 
mutated cells over wild-type cells to colonize the entire crypt,s but is not deterministic since a proportion 
of wild-type cell can still displace mutated ones. C) Quantification of the relative competitive advantage 
associated to the main oncogenic mutation. D) The mutant clone expands throughout the epithelium via 
enhanced rate of crypt fission.  (Vermeulen and Snippert 2014) 
 
1.5.  Major signaling pathways governing the epithelial homeostasis 
As briefly mentioned in the previous sections, the precise architecture and cell composition of 
the different regions of the intestinal epithelium is orchestrated by strict gradients of soluble 
! "%!
molecules (morphogens) produced by different sources located at different areas of the 
intestine (Vanuytsel et al. 2013). The phenotypic response of each cell is therefore determined 
by its position within this concentration of different gradients. Morphogens involved in at 
least three major signaling pathways cooperate in order to establish and maintain this 
organization: the Wnt pathway, the BMP pathway and the Notch pathway. In this section we 
will illustrate the sources of the morphogens controlling the activity of these pathways, their 
intracellular effectors and the phenotypic outcomes as well as their role in the decision 
between proliferation, self-renewal and differentiation.    
 
1.5.1. The Wnt pathway 
The Wnt signaling pathway controls a myriad of biological processes throughout development 
and adult life of the entire animal kingdom. Most mammalian genomes, including the human 
genome, harbor 19 Wnt genes falling into 12 conserved subfamilies (H. Clevers and Nusse 
2012). Proteins encoded by these genes act as close-range signaling morphogens by 
interacting with their receptors consisting in a heterodimeric complex of a Frizzled and 
LRP5/6 subunits (figure 9). The ten mammalian Frizzled receptors are 7-transmembrane 
receptors having a large extracellular N-terminal cysteine-rich domain that constitutes a 
hydrophobic binding platform for lipid-modified Wnt ligands (Bhanot et al. 1996; Dann et al. 
2001; Janda et al. 2012). In the absence of binding of Wnt to the receptor complex, cytosolic 
β-Catenin is efficiently captured by the destruction complex formed the scaffold protein Axin, 
the casein kinase 1 (CK1) the Adenomatous Polyposis Coli protein (APC) and the glycogen 
synthase kinase 3β (GSK3β) (Mao et al. 2001; Zeng et al. 2005). The two kinases in the 
complex phosphorylate the N-ter of the β-Catenin allowing the binding of the E3 ubiquitin 
ligase complex followed by its degradation mediated by the proteasome (Davidson et al. 
2005). The interaction between the Wnt ligands and the receptors leads to the phosphorylation 
of the cytoplasmatic domain of LRP5/6 and a conformational change in both LRP and 
Frizzled subunits allowing the sequestration of Axin which prevents proteosomal degradation 
of the β-Catenin and allows its translocation to the nucleus. As a result, β-Catenin interacts 
with T-cell/lymphoid enhancer factor (Tcf/Lef) family members by displacing Groucho 
repressor from the complex, thus modulating the transcription of Wnt target genes (Behrens et 
al. 1996; Molenaar et al. 1996). Among the first and most important Wnt target genes were 
cMyc and Cyclin D1 (Beier et al. 1999; Herbst et al. 2014). Nuclear localization of β-Catenin 
therefore represents the most common hallmark of Wnt activation. The activity of the Wnt 
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pathway is also enhanced by the function of the secreted the R-spondin able to enhance 
proliferation of intestinal epithelial cells both in vivo and in vitro (Kazanskaya et al. 2004). 
Lgr4, -5 and -6 were later identified as the receptors of these glycoproteins (Carmon et al. 
2011; de Lau et al. 2011). Along with the cytosolic β-Catenin destruction complex the 
activation of the Wnt pathways is antagonized by extracellular proteins such as the Dickkopf 
(DKK) and secreted frizzled-related proteins (SFRP), as well as the Wnt inhibitor factor-1 
(WIF-1) (Glinka et al. 1998; Bovolenta et al. 2008).  
Several studies have shown the major implication of this signaling pathway in the regulation 
of the balance between proliferation and differentiation in the small intestine. Neonatal Tcf4 
knockout mice lack the proliferative epithelial compartment. Conditional deletion of this 
gene, as well as in the case of β-Catenin, showed that Wnt signaling is required for the 
maintenance of crypts in adult animals (Korinek et al. 1998; Pinto et al. 2003). Since Paneth 
cells represent the main source of Wnt ligands, the activity of the pathway is modulated in a 
crypt-to-villus gradient. Stem cells (and differentiated Paneth cells) residing at the bottom of 
the crypts are exposed to the highest concentration of Wnt factors allowing the self-renewal 
ability and multipotency (Sato et al. 2011). The discovery of the Wnt target gene Lgr5 
(receptor of the Wnt agonist Rspo) as a bona fide positive marker of intestinal stem cells 
provided the first direct evidence of the role played by this signaling pathway in the 
promotion of the intestinal stem phenotype (Barker et al. 2007). Several alterations 
concerning the molecular players of the Wnt pathway are associated with colorectal cancer 
susceptibility, initiation and progression. 
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Figure 9: schematic representation of the Wnt pathway before (A) and after the binding of Wnt ligand 
followed by the activation of the intracellular signaling cascade leading to the modulation of the 
expression of Wnt target genes.  
 
1.5.2. The TGF-β/BMP pathway 
Bone Morphogenetic Proteins are soluble factors belonging to the TGF-β cytokine family 
known to be involved in several developmental processes as well as in adult tissue 
homeostasis (Vanuytsel et al. 2013). Depending on the tissue and on the cellular context 
BMPs were shown to regulate cell growth, differentiation and apoptosis. BMP ligands are 
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secreted in their active form in the extracellular environment where they form homo- or 
heterodimeric complexes before binding to their cognate receptors (BMPRs) (figure 10). 
Tight regulation of the pathway is exerted at multiple levels. Soluble antagonists are secreted 
to sequester them from binding to their receptors. BMPs bind to a class of Ser/Thr receptors 
type I/II heterodimers. There are four type I (Alk1, Alk2, Alk3 (BMPR1A), Alk6 (BMPR1B)) 
and three type II (BMPR-II, ActR-IIA and ActR-IIB) receptors (Zwijsen, Verschueren, and 
Huylebroeck 2003; Schmierer and Hill 2007). BMPRs sequences contain an N-terminal 
extracellular binding domain, a transmembrane domain and a Ser/Thr kinase C-terminal 
domain. BMPs first bind to the type I receptors, and then to the BMP/BMPR1 complex bind 
with high affinity the type II receptor. The proximity of type I and type II receptors allows the 
phosphorilation of the Gly/Ser domain in the type I receptor sequence by the type II kinase 
domain, converting the complex to its active form. The activated complex signals through the 
phosphorylation of members of the family of protein homologues of Drosophila gene 
Mothers against decapentaplegic (SMADs). SMAD proteins can be divided into 3 functional 
classes: 
, Receptor associated SMADs (R-SMADs), representing the intracellular effectors of 
the BMP activation. R-SMADs 1, -5, -8 bind to the active BMPR and exclusively 
transduce BMP signaling, while R-SMADs 2, -3 belong to the TGF-β signaling 
pathway. 
, Cooperating SMADs (Co-SMADs) 2 and 4 which form active complexes with R-
SMADs. Their expression represents a supplemental layer of regulation of the signal 
transduction. 
, Inhibitory SMADs 6 and 7 which can prevent the phosphorylation and the activity of 
R-SMADs by sequestering SMAD1 in an inactive SMAD1-6 complex or by 
preventing the phosphorylation of R-SMADs mediated by the activated BMPR. 
Phosphorylated R-SMADs form heterodimeric complexes with Co-SMAD and can then 
efficiently translocate to the nucleus where, in combination with other transcription factors, 
they exert a regulation on the expression of multiple target genes. These targets include the 
family of Id1-4 factors that act as dominant negative regulators by preventing the binding of 
other bHLH transcription factors to their targets (Jen, Weintraub, and Benezra 1992; Ogata et 
al. 1993; Iavarone et al. 1994; Bhatia et al. 1999). BMP can also inhibit proliferation by 
regulating the expression or the stability of cyclin-dependent kinase inhibitors (Yamato et al. 
2001; Beck et al. 2007).  
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The expression of the BMP pathway components in the intestine is complex, with part of 
these components being expressed in both epithelial and stromal cells and others being 
restricted to the mesenchyme (Hardwick et al. 2004; Li et al. 2007; Haramis et al. 2004). 
Experimental models of reduction of the BMP signal via the knockdown of the receptor 
Bmpr1A or the overexpression of the Noggin inhibitor display hyperproliferation of the 
intestinal stem cells, formation of ectopic crypts along the villus axis and development of 
intestinal polyps, suggesting a role for the BMP signals as a quiescence marker (Hardwick et 
al. 2004). In 2004, a controversial work from He and colleagues suggested that BMPs 
signaling might prevent stem cell identity by antagonizing the Wnt pathway via the activation 
of PTEN and the suppression of nuclear β-catenin accumulation mediated by Akt (He et al. 
2004). However, a more accurate examination of the PTEN expression pattern showed that 
this marker is associated with enteroendocrine cells at the bottom of the crypt rather than 
intestinal stem cells (Matthew Bjerknes and Cheng 2005). 
The BMP extracellular inhibitors gremlin (Grem) 1 and 2 are exclusively expressed by the 
mesenchymal myofibroblasts surrounding the crypts, thus ensuring the inactivation of BMP 
ligands in the stem and proliferative compartment. Genetic duplication of a 40 kilobases 
region upstream the GREM1 gene is associated with ectopic epithelial expression of the gene, 
an automosomal dominant human condition resulting in hereditary mixed polyposis syndrome 
(HMPS) characterized by the development of mixed-morphology colorectal tumors at a 
median age of 47 (Jaeger et al. 2012). In a recent work from Davis and colleagues, the authors 
showed that the aberrant expression of Grem1 in epithelial cells leads to the formation of 
ectopic crypts in the villus axis (Davis et al. 2015). However these crypts lack bona fide 
Lgr5
+ stem cells. Markers of stem cells only appear in the tissue upon the constitutive 
activation of the Wnt pathway mediated by the loss of Apc function, thus reinforcing the idea 
that both activation of Wnt- and suppression of BMP signaling represent conditio sine qua 
non for the establishment and maintenance of stemness in the intestinal epithelium.  
However, the transcriptional outcome mediated by the BMP signaling in intestinal epithelial 
cells is still poorly characterized. Some evidences propose that Ids can promote differentiation 
instead of proliferation in the small intestine since Id2 and Id3 were found to be upregulated 
in cells at the crypt-villus junction.  
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Figure 10: schematic representation of the Notch pathway signaling upon the ligand of BMPs soluble 
factors to the BMP receptors. BMPs ligands are sequestered by the extra cellular inhibitors (example 
Noggin) produced by the microenvironment.  
 
1.5.3. The Notch pathway 
The highly conserved Notch signaling pathway is responsible for cell fate decision through 
cell-to-cell interaction mediated by the expression of Notch-ligands and –receptors in 
metazoan. Four single-pass trans-membrane Notch receptors (1-4) specifically interact with 5 
single-pass trans-membrane ligands Jagged1, 2, Delta-likke (Dll) 1, 3 and 4 (Chiba 2006). 
This interaction results in the proteolytic release of the receptor N-terminus intracellular 
domain (NICD) mediated by intracellular γ-protease (figure 11) (De Strooper et al. 1999). 
Upon release, NICD translocate to the nucleus where it binds to the transcription factor CLS 
inducing differential transcription of several Notch-target genes (Artavanis-Tsakonas, Rand, 
and Lake 1999).  
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Figure 11: schematic representation of the activation of the Notch sgnalilng via the cell-cell interaction 
leading to the proteolitic excision and the translocation of the Notch intracellular domain (NICD).   
 
Notch receptors and ligands are heterogeneously expressed across the different epithelial populations 
and loss-of-function studies have shown a certain degree of redundancy between these actors (Sander 
and Powell 2004; Pellegrinet et al. 2011; Fre et al. 2011). Specific intestinal deletion of Notch1 and 2 
does not result to an obvious intestinal phenotype. However, blocking both receptors leads to the 
conversion of proliferative cells to postmitotic goblet cells (Riccio et al. 2008). Dll1/Dll4/Rbp-J 
combined knockout animals display the loss of expression of the bona fide stem markers Olfm4, Ascl2 
and Lgr5, which correlates with the loss of Ki67+ proliferative cells in the crypts (Pellegrinet et al. 
2011; Stamataki et al. 2011). Paneth cells express Dll4 to maintain the undifferentiated state of 
adjacent intestinal stem cells (Sato et al. 2011). Importantly, lineage tracing studies have showed the 
expression of Notch receptors 1 and 2 and and active Notch signaling in the multipotent stem 
compartment. As previously mentioned, Notch activation represses the expression of Atoh1 and, to a 
smaller extent, Neurogenin-3 transcription factors both responsible for the maturation of secretory 
lineages (Fre et al. 2005). Indeed, stem cells and enterocytes progenitors express high levels of Hes1, 
while its expression is lost in all secretory cell types. Constitutive epithelial activation of the Notch 
signaling leads to the expansion of the proliferative compartment and to the depletion of goblet cells 
accompanied by a general impairment of differentiation (Fre et al., 2005). Taken together, all these 
observations support the formulation of a lateral inhibition model, according to which the expression 
of Dll1 and Dll4 in Paneth cells triggers the Notch signaling in all the surrounding stem cells, therefore 
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promoting the expression of Hes1 and the “default” enterocyte fate program (T.-H. Kim and 
Shivdasani 2011; Sancho, Cremona, and Behrens 2015). Cells that exit the Paneth cell permissive 
zone are no longer exposed to membrane-bound Notch ligands and can stochastically shut-off the 
expression of Hes1, hence inducing the expression of Atoh1 and committing to the secretory fate.  
 
1.6.  In vitro organotypic cultures in the study of epithelial biology in homeostasis 
and disease 
The identification of Lgr5 as a robust marker of intestinal stem cells has led to a dramatic 
development in the understanding of their biology. One of the most outstanding achievements 
is represented by the establishment of protocols allowing the conditions for culturing Lgr5-
positive cells ex vivo. In 2009 Sato and collaborators showed that single sorted Lgr5+;GFPhigh 
cells obtained from Lgr5-EFGP-ires-CreERT2 crypts can build structures that retain hallmarks 
of intestinal epithelium in vivo (Sato et al. 2009). When cultured in laminin-enriched matrigel 
mimicking the crypt base environment in the presence of EGF, the BMP inhibitor Noggin and 
R-spondin1, Lgr5-positive cells are able to give rise to organoids that recapitulate the 
stereotypical structure and physiology of the intestinal epithelium (figure 12). Structures 
consist in multiple crypt-like domains containing Lgr5+ proliferating cells intermingled 
between Paneth cells, and villus-like domains lining the central lumen in which apoptotic 
cells are shed. All differentiated epithelial lineages are represented and can be identified by 
the expression of their typical markers. Structures can be dissociated and replated to form new 
organoids, without any loss of replating efficiency after several passages. Organoids remain 
morphologically and karyotypically indistinguishable after several successive replatings for 
an indefinite lapse of time. After few replatings, cultures are stroma-free and their 
maintenance only depends on EGF, R-spondin1 and Noggin that are added to medium. 
However, although all epithelial cells are exposed to the same concentration of morphogens 
added to the medium, only cells within the crypt display signs of active Wnt signaling such as 
the nuclear translocation of β-catenin. Taken together, these observations demonstrate that 
epithelial stem cells possess differential responsiveness to extrinsic stimuli as part of an 
intrinsic program allowing the self-organization of the epithelial architecture which is 
therefore, at least at some extent, independent on the positional cues provided by the 
environment in vivo.  
The ability of intestinal stem cells to grow into structures that faithfully recapitulate the self-
renewal hierarchy of the intestinal epithelium offers a wide range of approaches to investigate 
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several aspects related to intestinal physiopathology, regenerative medicine and drug 
screening. First, the requirement for a minimal well-defined culturing medium may allow the 
evaluation of the role played by extrinsic factors in the regulation of the homeostatic balance 
between proliferation, differentiation and death.  Organoids can be derived from conditional 
genetic animal models in order to monitor the effect of genetic components on a real time 
basis, for instance upon the deletion of coding sequences via the activation of transgenic 
recombinases in culture. This model is also amenable to any experimental protocol used for 
cell lines, including transfection of DNA and small interfering RNA as well as retro- and 
lentiviral mediated transduction (Koo et al. 2012; Onuma et al. 2013).  
 
 
Figure 12: intestinal organotypic cultures. A) Kinetic of development from a single Lgr5+ cell  plated on 
matrigel (day 0) to fully developed structures accounting for crypt and villus domains. B) reconstruction 
of confocal imaging of an epithelial organoids (nuclei are in red, Lgr5+-GFP+ cells in green are located at 
the bottom of the crypts.) C) schematic representation of the organotypic structure. (Sato et al. 2009). 
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Recently, genome-editing technologies were successfully applied in order to model the 
genetic basis of human diseases in organotypic cultures. In 2013 the Clevers group made use 
of CRISPR/Cas9 mediated homologous recombination in order to correct the mutation of the 
CFTR locus in intestinal organoids derived from biopsies of patients affected by cystic 
fibrosis and restore the function of the transmembrane conductor receptor coded by the gene 
(Schwank et al. 2013). The same team also recently provided formal validations of the 
multistep genetic model driving colorectal cancer initiation and progression (Drost et al. 2015; 
Matano et al. 2015). Authors were able to recapitulate the phenotypic traits of the well 
described adenoma to carcinoma progression by sequentially introducing genetic mutations in 
four of the most commonly mutated colorectal cancer genes (APC, P53, KRAS and SMAD4). 
This model also allows researchers to establish primary lines from human adenomas and 
colorectal cancer. The current challenge in public health consists in the generation of 
biobanks of cultures derived from patients’ biopsies that can be suitable to bridge the gap 
between the individual molecular background data provided by deep-sequencing and the 
screening for the choice of personalized treatment. 
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2. Colorectal cancer 
Cancer represents the leading cause of death in economically developed countries and the 
second leading cause in developing countries. The global incidence of cancer continues to 
increase, which is explained by the aging and growth of the world population but also by the 
increasing adoption of cancer-causing behaviors and by the increase of cancer-causing 
environmental factors in the economically developing world (Jemal et al. 2011; Globocan 
2012).  
Colorectal cancer (CCR) represents the third most commonly diagnosed cancer in males and 
the second in females. Overall, the highest incidence rate is found in economically developed 
countries, whereas the lowest rates are found in Africa and south-central Asia (figure 13).  
Rates are substantially higher in males than in females. Notably, the incidence of colorectal 
cancer is rapidly increasing in areas historically at low risk such as countries in Eastern 
Europe and Eastern Asia. These trends are likely to be associated with economical 
development and mutating life-style in these areas (Jemal et al. 2011). These evidences 
suggest that the overall incidence is largely influenced by environmental modifiable cues. 
Nonetheless, colorectal cancer actually represents an extremely heterogeneous group of 
malignancies associated with a complicated molecular classification (Müller, Ibrahim, and 
Arends 2016). The molecular and environmental components of the related risk are therefore 
variable. Interestingly, the United States is the only country in which the incidence rate has 
shown a statistically significant decrease in the most recent period, which largely depends on 
the development of screening tools for early diagnosis and effective removal of pre-cancerous 
lesions. The results of a multicentre randomized trial performed in the United Kingdom 
published in 2010 showed that the preventive one-time screening of the population aged 
between 55 and 64 reduced the incidence by 33% and the mortality by 43% (Hilsden and 
Rostom 2010).  
Colorectal cancer related death is associated to invasiveness and acquisition of metastatic 
capacity associated to the late stages of the malignancies. Classification of patients to their 
clinical stage is therefore made according to the TNM (Tumor-Node-Metastasis) system, 
which describes the size of the primary tumor, whether the nearby lymph nodes contain 
cancer cells, and whether cancer has spread to a distant organ. Prognosis is very variable and 
correlates with the clinical stage at diagnosis. Survival rate is over 90% within the first 5 years 
for stage I patients, 50% for stage III patients and 5-10% for stage IV patients. Overall, these 
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notions indicate that the early evaluation of the individual risk and the diagnosis of the 
pathology at very early stages represent the most effective tools in public health management. 
 
 
Figure 13: heat-map representing the incidence of colorectal cancer in the world represented as the 
number of new cases per year. Legend represents new cases in thousands. (Globocan 2012) 
 
2.1. Genetic alterations driving initiation and progression of CRC 
As mentioned, colorectal cancer represents a heterogeneous group of malignancies, and many 
efforts were made to provide a molecular classification of its different subtypes (Müller, 
Ibrahim, and Arends 2016). The majority of 70-80% CRC are sporadic, whereas around 20-
30% of the cases have a hereditary component associated to genetic alterations that can be 
either uncommon, such as Lynch Syndrome (3-4%) patients and the familial adenomatous 
patients (FAP, 1-2%), or associated to low-risk rare alleles (Whiffin et al. 2014). The vast 
majority of sporadic cases were found to be associated to mutations in the Adenomatous 
polyposis coli (APC) Wnt negative regulator, while an additional 15% of patients show 
alterations in other components of the Wnt pathways that are either mutated or epigenetically 
silenced (Vogelstein et al. 1988; Morin et al. 1997; Frayling IM and Arends MJ, 2016). These 
evidences clearly suggested that alterations leading to the constitutive activation of the Wnt 
signaling play a central role in the initiation of CRC. Importantly, FAP patients carry a 
heterozygous germline mutation on the APC gene (de la Chapelle 2004). As a result of the 
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loss or inactivation of the second allele, these individuals invariably develop multiple 
adenomas by the age of 30, unless they undergo to preventive colostomy. In 1990, by 
examining the collection of genomic alterations most commonly associated to different stages 
of the malignancies, Fearon and Vogelstein proposed a schematic model summarizing the 
main genetic events associated to the adenoma to carcinoma progression ((Fearon and 
Vogelstein 1990). According to this model, the initiating loss of APC function results in the 
formation of a hyperproliferative pre-cancerous lesion. This step is typically followed by 
gain-of-function type mutations on the RAS oncogene, or other mutations resulting in the 
constitutive activation of the MAPK signaling that normally acts downstream the EGF. The 
third major event is inactivation of the p53, which is responsible for inactivation of the cell 
cycle check-points normally triggered by DNA damage in normal cells and that leads to the 
adenoma to carcinoma transition. The fourth main alteration in the sequence leads to the loss 
of TGFβ responsiveness either through the loss of the co-operating SMAD4 or the 
inactivation of the TGFBRII receptor. Although this model has represented a conceptual 
breakout in our understanding of the molecular etiology of CRC, its formal validation was 
only recently accomplished. Dow and collaborators have recently shown that Apc suppression 
is not only responsible for adenoma initiation, but it is also indispensable for tumor 
maintenance. By making use of a conditional in vivo model of doxycycline-regulated shRNA 
suppression of Apc the authors showed that restoration of Apc function leads to rapid 
regression of the tumor that eventually results in the restoration of the disrupted crypt-villus 
homeostasis (Dow et al. 2015). Importantly, such restoration is independent on the presence 
of the additional mutations (Kras, p53) that are responsible for the progression to carcinoma, 
proving that the constitutive activation of the Wnt pathway represents a conditio sine qua non 
for tumor maintenance at any stage of its progression. Two independent works showed that 
the sequential introduction of the main alterations described in the Fearon and Vogelstein 
model trough CRISPR/Cas9 targeted gene modification of human intestinal organoids can 
efficiently recapitulate the phenotypic hallmarks of carcinoma progression and invasiveness 
(Drost et al. 2015; Matano et al. 2015). In particular, the concomitant loss of APC and P53 
leads to extensive aneuplody, a condition referred to as chromosome instability (CIN), 
whereas the concomitant alteration of APC, KRAS, p53, SMAD4 and PIK3CA confer 
metastatic potential to epithelial cells when those cells are injected into immunosuppressed 
mice.  In addition to this well described sequence it is estimated that about 7 to 15% of CRC 
may develop via a different morphological sequence, known as serrated pathway (Noffsinger, 
2009). The progression via this pathway shares some characteristics with the Lynch syndrome 
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(hereditary non polyposis colorectal cancer, HNPCC), which is a dominant negative condition 
associated to mismatch repair gene mutations (mostly MSH2 or MLH1) (de la Chapelle 2004). 
About 80-90% of serrated polyps are classified as benign hyperplastic lesions whereas a small 
proportion may progress to colorectal carcinoma (IJspeert et al. 2016). Tumors developing via 
this alternative pathway are highly heterogeneous in terms of molecular feature. However the 
most common initiating alteration is represented by the BRAF V600E mutation (Rad et al. 
2013). 
 
2.2. Toward a molecular classification of CRC 
The advent of in-depth wide-range genomic and transcriptomic analyses has allowed the 
comprehensive characterization of the genomic features associated with CRC heterogeneity. 
Such analyses have been used to attempt to answer to the need for a more precise 
classification of patients according to their molecular profiles and propose more accurate 
prognostic parameters (figure 14) (Müller, Ibrahim, and Arends 2016).  A major common 
feature of CRC is represented by genetic instability, and the mechanisms by which the 
accumulation of genetic lesions occurs have been successfully used to establish a 
classification with clinical relevance.   
Two main mechanisms have been classically proposed to explain genetic instability. 
Chromosome instability (CIN) represents the most common phenotype (84% of tumors) 
characterized by gross karyotypic alterations in chromosomes copy number and various 
chromosomal rearrangements such as insertion/deletion and translocations (Pino and Chung 
2011). This phenotype is detectable in most tumors that arise via the classic adenoma-
carcinoma sequence and are associated to the loss of APC. However, Dross and collaborators 
have shown that the p53 mutation dramatically enhances the rate of chromosomal aberrations 
due to an increase in the percentage of mitotic errors (Bhanot et al. 1996).  The second cluster 
of lesions is characterized by hypermutation and micro-satellite genomic instability (MSI) and 
accounts for about 13-16% of CRC (Vilar and Gruber 2010). These lesions frequently display 
a WT p53 status and a near-diploid karyotypic profile. The high mutational rate is associated 
to defective DNA mismatch repair (MMR) mechanisms mostly related with heterozygous 
dominant alteration on either MSH2 or MLH1 genes. A third phenotype is known and is 
commonly referred to as CpG islands methylation phenotype (CIMP), characterized by an 
enrichment of hypermetylated genomic regions corresponding to CpG islands within the 
promoters of genes with oncosuppressive function (Serra et al. 2014). MSI and CIMP groups 
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partially overlap, since in many cases the suppression of MLH1 activity represents the result 
of a hypermethylation of its promoter associated to transcriptional downregulation of the 
gene. Two molecular classifications have been recently proposed for CRC and are based 
either on integrated genome-wide genomic and transcriptomic profiling, or on the 
stratification of transcriptomic profiling data from multiple previous studies. The cancer 
genome atlas (TCGA) network project account for the combined analyses of whole genome 
sequencing of germline and cancer samples from patients, mRNA, miRNA and DNA 
methylation profiling (The Cancer Genome Atlas, 2012). The results revealed that patients 
can be split into two major groups by mutation rate that match well the previously described 
MSI and CIN groups. The category with high mutational rate can be further divided into 
distinct subgroups accounting for high (13%) or extremely high mutation rate (3%). The 
integrated analyses allowed establishing lists of genes that are significantly frequently altered 
in the hyper- and ultra-mutated groups. The consortium molecular subtypes (CMS) defined 
two major categories and 4 sub-categories classified by molecular attributes and expression 
signatures (Guinney et al. 2015).  
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Figure 14: schematic illustration of the molecular classification of CRC types according the cancer 
genome atlas (TCGA) and the consensus molecular subtypes proposed by Guinney and colleagues in 2015. 
The illustration shows the overlap between the different groups of each classification. (Muller et al. 2016). 
 
2.3.  Intestinal tumor initiating cells 
Cancer is commonly thought to initiate in a single cell after an initial oncogenic event and 
eventually progress through the clonal selection of additional mutations in the progeny of this 
cell. However, the identity and features of tumor initiating cells remain highly debated. 
Central to the theory of cancer initiating cells, or cancer stem cells, is the observation that not 
all tumor cells are equal (H. Clevers 2016). This suggests a hierarchical organization of the 
tumor that somehow resemble the one found in normal tissue, in which cells have different 
life span, with some that are long-lived and capable to self-renew. The first attempts to 
demonstrate the existence of cell with increased capacity to initiate the tumor consisted in 
xenotransplants of phenotypically different tumor cells into immunosuppresed mice (Lapidot 
et al. 1994; Al-Hajj et al. 2003). Only a fraction of these cells were able to efficiently give rise 
to newly formed tumors accounting for the same heterogeneity than the primary tumor. Acute 
myeloid leukemia represents a paradigmatic model in this sense: tumor initiating cells are 
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likely to represent the mutated counterpart of normal stem cell, since they share hierarchical 
maturation into progenitors and differentiated lineages.  
In 2009 Barker and colleagues showed that Lgr5+ cells acquire the capacity to establish and 
maintain intestinal tumor upon the Cre-mediated induction of Apc loss in ApcLoxp/Loxp , 
Lgr5-EGFP-ires-CreERT2
 mice (Barker et al. 2009). They also showed that the loss of Apc in 
transiently amplifying progenitor cells does not efficiently lead to tumor formation, and the 
rare lesions that arise in this model do not progress over the state of microadenoma. Cancer 
initiating cells thus represent the result of the tumor initiating mutation in the intestinal stem 
cell pool. However, as previously discussed, a certain degree of plasticity seems to exist in the 
hierarchy of the normal epithelium, and some populations are capable to reconstitute the 
Lgr5
+ compartment upon injury. Krt19+ cells were shown to be able to repopulate the 
epithelium upon irradiation and to initiate tumors upon the deletion of Apc in these cells 
(Asfaha et al. 2015). Therefore, multiple populations with differential stem potential could be 
able to initiate intestinal cancer. In 2013 Schwitalla and collaborators showed for the first time 
that under certain conditions differentiated epithelial cells may acquire a tumorigenic potential 
(Schwitalla et al. 2013). Indeed, the activation of NF-ΚB signaling reinforces the activity of 
the B-Catenin and accelerates crypt transformation but also induces differentiated cells to 
dedifferentiation and expression of bona fide stem markers. These dedifferentiated cells gain 
tumor-initiating capacity. In 2012 Nakanishi and collaborators proposed Dclk1 as a possible 
marker of tumor initiating cells (Nakanishi et al. 2013). This marker is only expressed by 
differentiated tuft cells in the healthy intestine (Gerbe et al. 2009). However, lineage-tracing 
experiments showed that Dclk1+ cells can fuel tumor growth whereas conditional ablation of 
these cells remarkably induces a regression of adenomas of ApcMin mice. Of note, how rare 
and poorly proliferative tumor Dclk1+ cells can populate the whole tumor within a couple of 
days remains difficult to understand. A contrasting work recently proposed Dclk1+ tuft cells 
as quiescent long-lived stem cells with tumor initiating ability (Westphalen et al. 2014b), in 
sharp contradiction with previously published studies (Gerbe et al. 2011). According to their 
evidences, the authors proposed that tuft cells are important for tissue regeneration and do not 
initiate tumors upon conditional deletion of Apc unless in the case of injury experimentally 
induced by administration with the proinflammatory dextran sodium sulfate (DSS). Together, 
these works seem to support the idea that upon constitutive activation of the Wnt pathway 
(which constitutes the first step to cancer initiation) only cells with stem identity are able to 
initiate tumors with different efficiency according to their position in the hierarchy, and 
additional stimuli are needed to trigger tumor initiating ability in differentiated cells.  
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Less is known about the identity of cancer initiating cells in human. CD133+ cells were first 
identified as potential human CRC initiating cells capable to efficiently renew the tumor after 
serial xenotranplants (Ricci-Vitiani et al. 2007). Later works showed that these tumor 
initiating cells probably form a heterogeneous population in which cells display distinct self-
renewal and metastatic potential (Dieter et al. 2011). The identification of the molecular 
mechanisms involved in tumor initiation, self-renewal ability and heterogeneity represent a 
major issue for the design of tool for the effective eradication of cancer.   
 
2.4. Genetic animal models of CRC 
To better identify the alterations in the homeostatic processes associated with the initiation 
and progression of CRC as well as the possible targets for prevention and treatment, a number 
of genetic and non-genetic models have been developed (Johnson and Fleet 2013). The use of 
animal models allows avoiding the mutational complexity that is typically found in cancer cell 
lines, allowing the investigation on the impact of single genetic components. In vivo models 
also allow defining the role played by the microenvironment on tumor development. To be 
suitable for the study of the pathology these models were designed to respond to some 
important criteria. First, the development of cancer is limited to the intestine, in order to avoid 
the confounding effects exerted by neoplasia in other organs. Second, the histological and 
molecular features of lesions have to mimic as closely as possible those found in human 
cancer. To study the processes that are associated to tumor initiation, a panel of genetic 
models carrying a heterozygous germline mutation on the Apc gene was developed. During 
adult age these animals spontaneously lose the WT allele trough loss of heterozygosity and 
invariably develop adenomas in the small and large intestine at variable rate, recapitulating 
the condition of FAP patients. An important discrepancy between these models and human 
cancer consists in the fact that these mouse models carrying mutations on Apc develop tumor 
in the small intestine at higher rate than they do in the large intestine whereas the greatest 
majority of human CRC is found in the colon. This discrepancy is probably due to the inverse 
trend of proliferation rate that characterize human and mouse stem cells: stem cells divide 
more rapidly in the human colon than in the small intestine, which may explain the higher 
chance of biallelic loss in the colon (Sangiorgi and Capecchi, 2015). In this case the 
workhorse in the pre-clinical studies has been represented ApcMin mouse identified from a 
mutagenesis screen in the the C57Bl6/J genetic background (Moser, Pitot, and Dove 1990). 
These mice carry a heterozygous T-to-A transversion at position 2549 which truncate the Apc 
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protein at amino acid 850. Other similar models were developed by homozygous 
recombination in the germline, as in the case of ApcΔ14 mice (obtained through the Cre 
mediated germline deletion of the exon 14) that have features similar to those of ApcMin mice 
but develop a higher number of intestinal adenomas at adulthood (Colnot et al. 2004). The 
Apc
1322T model was designed to express a 1322 amino acid Apc protein and retain one of the 
20 aminoacid repeats that bind β-catenin, and was useful to examine the “just-right” 
hypothesis according to which the presence of at least one binding repeat represents the 
condition for optimal WNT signaling driving CRC initiation and progression (Albuquerque et 
al. 2002; Pollard et al. 2009). Other models were created to express non degradable β-catenin 
or defective form of the mismatch repair genes like Msh2 (Reitmair et al. 1996). Conditional 
models are available to combine the expression of specific recombinase proteins to LoxP 
flanked sequences in order to study the immediate and/or specific effects of genetic 
alterations. The control of the temporal/spatial activity is conferred by the expression of the 
recombinase driven by a tissue or cell type related promoter. The best examples are 
constituted by the Villin-Cre mice, which allows targeting intestinal epithelial cells, the Ah-
Cre mouse in which the expression is driven by the P4501A1 promoter allowing the 
expression of the recombinase upon oral administration of mice with Β-napthoflavone and the 
Lgr5-EGFP-ires-Cre mouse in which the oncogenic hit can be specifically induced in the 
intestinal stem cell compartment and is then inherited by its progeny (el Marjou et al. 2004; 
Ireland et al. 2004; Barker et al. 2007). Additional models are available to investigate the 
feature associated with invasiveness and metastasis. The combination of ApcΔ14 allele and 
Fabl-Cre;LSL-Kras
G12D/+  or Villin-Cre;LSL-KrasG12D/+ (i.e. in which one Kras allele is 
replaced by the oncogenic variant carrying a  glycine residue replacing an aspartate on the 
chromosome 12) showed the development of more advanced tumors characterized by high-
grade hyperplasia, loss of cell polarity and complete lack of terminally differentiated cells in 
these mice (Calcagno et al. 2008). ApcMin;Pten-/- mice have larger more invasive tumors (Shao 
et al. 2007). Smad3 knockout mice on the 129/Sv background develop aggressive carcinomas 
that are often accompanied by metastasis to regional lymph nodes (Zhu et al. 1998). An 
interesting model to screen the tumor-suppressor or oncogenic identity of genes in the 
intestine is constituted by the “Sleeping Beauty” system, in which the triple combination of 
the Villin-cre, LSL-SB11 transposase and T2/Onc transposon transgenes enhances 
transposition leading to random insertional mutagenesis in the intestinal epithelium (Starr et 
al. 2011).  
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3. Epigenetic dynamics in healthy homeostasis and cancer 
According to its most popular definition, epigenetics describes the acquisition of measurable 
and stably heritable phenotypic traits that do not depend on changes in the DNA sequence. 
The genetic information contained in the DNA is packaged in the nucleus of each cell as a 
macromolecular complex, the chromatin, which is constituted by the interaction between 
DNA, proteins and RNA. Epigenetic mechanisms allow genetically identical cells to achieve 
diverse phenotypic characteristics by controlling the transcriptional availability of different 
regions of the genome through differential packaging and marking of the chromatin. Such a 
modulation of the information in the genetic sequence can be stably maintained, yet adapts to 
changing environmental or developmental needs. This dynamic adaptation is accomplished 
via the activity of different actors representing initiators, such as long non-coding RNA, 
writers, which establish the epigenetic marks, readers, which transduce the information of the 
epigenetic code modulating the availability of transcription factors and transcriptional 
machinery, remodelers, which dynamically alter the distribution of nucleosomes, and 
insulators that can form boundaries between the different domains in the chromatin (Shen and 
Laird 2013). Gene expression is modulated through a complex crosstalk between 3 main 
mechanisms: DNA methylation, histone modification and RNA interference (Dekker, Marti-
Renom, and Mirny 2013).  
Epigenetic regulation is indispensable for the control of embryonic development and adult 
homeostatic balance of tissues. During embryogenesis these mechanisms are well known to 
determine the lineage specification adopted by cells in the three germ layers. However, the 
precise involvement of the same mechanisms in post-natal homeostasis and in the stem cell 
function is less well understood in mammals and only in the recent years the development of 
pertinent in vivo models has made the information on the epigenetic control of adult stem cells 
accessible to investigators. Much more is known about the way these pathways are altered in 
cancer, since in this case the investigation benefits of the large availability of primary 
biopsies, animal and cellular models of many types of human cancer at different stages which 
can be easily compared with their non tumoral counterparts (Jones and Baylin 2002; You and 
Jones 2012).  
The application of in-depth sequencing for the epigenomic profiling of cancer cells has led the 
field to the forefront of cancer biology (Ernst et al. 2011; Adams et al. 2012; ENCODE 
Project Consortium 2012). These –omic approaches have allowed scientists to focus on the 
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clinical relevance of global epigenetic signatures and provide novel tools with diagnostic and 
prognostic value.  
 
3.1. DNA methylation 
DNA methylation is a heritable epigenetic modification consisting in the covalent transfer of a 
methyl group to the C-5 position of the cytosine ring of DNA catalyzed by DNA 
methyltransferases (DNMTs). In plants, cytosine methylation occurs in asymmetrical (CHH, 
where H is A, C or T) and symmetrical (CH or CHG) contexts (Jones 2012). In mammals, 
DNA methylation occurs in every genomic context although more than 98% of DNA 
methylation is found in a CpG dinucleotide cotext in adult somatic cells, whereas as much as 
a quarter of all methylation appears in a non-CpG context in embryonic stem cells (ESCs). 
DNA methylation plays a role in a number of processes during development including X-
chromosome inactivation, suppression of repetitive elements, regulation of transcription, 
transposition and genomic imprinting. Genomic imprinting is a mammalian specific 
epigenetic phenomenon that involves DNA methylation of precise genomic regions resulting 
in allele-specific methylation and parental-origin-dependent monoallelic expression. The 
global DNA methylation profile is erased during zygote formation and re-established in the 
embryo, except at imprinted regions. The methylation of DNA is regulated by a family of 
DNMT enzymes that use S-adenosyl-L-methionine (SAM) as a methyl donor: DNMT1, 
DNMT3A, DNMT3B and DNMT3L (Bestor 2000). DNMT1 preferentially interacts with 
hemimethylated DNA at the replication foci during the S phase of the cell cycle and is 
responsible for copying DNA methylation patterns to the nascent DNA strand (figure 15). 
DNMT1 is therefore commonly considered as a maintenance DNA methyltransferase (Probst, 
Dunleavy, and Almouzni 2009). Dnmt1 knock-out mouse models display embryonic lethality 
at E9. In contrast to DNMT1, DNMT3A and DNMT3B have higher affinity for unmethylated 
CpG and perform de novo methylation (Okano et al. 1999; M. G. Goll and Bestor 2005). Mice 
lacking Dnmt3A die at about 4 weeks of age, whereas Dnmt3B knockout mice show 
embryonic lethality at E14.5 to E18.5. DNMT3L lack the methyltransferase enzymatic 
activity but support the activity of DNMT3A and DNMT3B by increasing their capacity to 
bind S-adenosyl-L-methyonine and stimulating their activity in vivo (Kareta et al. 2006). 
Dnmt3l homozygous-null mice are viable, but its importance in maintaining the monoallelic 
expression of imprinted loci was revelead in embyos of heterozygous mice derived from 
DNMT3L-null oocytes that die at E9 (Bourc’his et al. 2001). In mammals, nearly all CG 
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dinucleotides are methylated at cytosine residues especially in areas of repetitive sequences. 
On the contrary CpG-enriched regions, defined as CpG islands, are close to the 5’ regions of 
the gene appear to be protected from this modification, in part by and guanine-cytosine strand 
asymmetry and accompanying R-loop formation and possibly also by active demethylation 
(Bird et al. 1985; Ginno et al. 2012). Methylation of CpGs in these regions occurs at variable 
extent in different cell types. Methylated cytosines are recognized and bound by methyl-CpG 
binding domain proteins (MBD) or zinc-finger protein (ZBTB) that are able to induce 
transcriptional repression by recruiting transcriptional co-repressors (Wade 2001).  DNMT3A 
and DNMT3B each consist of an NH2—terminal regulatory domain that contain a PWWP 
domain, a cystein-rich domain, and a COOH-rerminal catalytic domain (Bestor 2000). The 
PWWP domain was shown to be required for the methylation of satellite repeats in the 
genome. DNA methylation at enhancers and promoters is correlated with priming and 
activation of lineage-specific genes at the appropriate time during embryonic and post-natal 
development (Bock et al. 2012; Easwaran et al. 2012). Conversely, promoters involved in 
stem cell gene expression become more methylated as cells commit to differentiation. Indeed, 
some recent functional studies showed that DNMT3A and 3B work in a redundant fashion in 
the de novo methylation of most genomic regions during adult stem cell differentiation, as 
demonstrated by the synergistic effect of the conditional ablation of both enzymes compared 
to the (Challen et al. 2014) impact of a single knock-out on the ability of adult stem-cells to 
self-renew and differentiate. DNMT3A is required for the methylation of imprinted loci 
during gametogenesis, whereas DNMT3B is not. Conversely DNMT3B is responsible for 
methylation of pericentromeric regions of the chromosomes. To further investigate this 
functional overlap and the specific genomic targets of these two enzymes, Liao and 
colleagues recently extensively characterized the effects of their targeted or combined 
CRISPR-Cas9-mediated disruption in human embryonic stem cells (hESC) (Liao et al. 2015). 
Double ablation of DNMT3 enzymes results in a progressive and rapid global reduction of 
DNA methylation, while single knockouts only display a mild phenotype, with the exception 
of genomic satellite sequences which appear to be more sensitive to the loss of DNMT3B. 
Authors found 96% of DMRs in double knock-out cells to be redundantly targeted by both 
DNMT3 enzymes, although regions accounting for high CpG density, like certain promoters, 
are more selectively targeted by one of those. This study confirmed that de novo enzymes act 
redundantly and are both implicated in the long-term maintenance of a pluripotent state, 
although a degree of differential affinity exists for a subset of genomic features.  
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Figure 15: Schematic represantation of the involvment of the different DNMTs in mainteinance  and de 
novo methylation of the DNA.  
 
Mechanisms participating to active demethylation of the genome are way less understood. 5-
methylcytosine can be further converted into 5-hydroxymethyl-22-deoxycytidine by the 
activity of the ten-eleven-translocation (TET) enzyme family members, eventually promoting 
cytosine demethylation (Tahiliani et al. 2009). However, the precise sequence of events 
leading to demethylation and the biological relevance of this process remains unclear, 
although increasing evidences show that mutations in TET genes are associated with various 
types of cancer (Rasmussen and Helin 2016). 
Alterations in DNA methylation profiles represent a hallmark of cancer. In 1983 Feinberg and 
Vogelstein first documented that human adenocarcinoma samples are characterized by 
widespread genomic hypomethylation as they demonstrated by comparing tumor samples 
with their surrounding healthy mucosa (A. P. Feinberg and Vogelstein 1983). Several later 
works have extended this initial observation to many types of cancer, showing that the 
reduction of megabase-scale genomic domains preferentially occur in the repetitive portions 
of the genome and in regions overlapping with lamina-associated domains which interact with 
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the nuclear periphery (Berman et al. 2012). Hypomethylation of the genome is a universal 
feature shared by benign and malignant tumors and is therefore suspected to occur at the 
earliest stages of cancer development. This alteration then contributes to different aspects of 
cancer biology by leading to the overexpression of genes involved in tumorigenesis, to the 
aberrant activation to the activation of intragenic expression, genomic instability and loss of 
imprinting (LOI) (Aran et al. 2011; Aran and Hellman 2013; Aran, Sabato, and Hellman 
2013) . On the other hand, tumor development is also accompanied by the focal 
hypermethylation of selective regions that often correspond to regulatory elements associated 
with the expression of genes with tumor-suppressive function (Wu et al. 1993; Herman and 
Baylin 2003; Andrew P. Feinberg and Tycko 2004; Hegi et al. 2005). The focal 
hypermethylation in human cancers was initially extensively documented for tumor 
suppressor genes such as retinoblastoma-1 (RB1), MutL protein homolog 1 (MLH1), BRCA1, 
adenomatous polyposis coli (APC) (Greger et al. 1989). These observations were later 
extended to several other genes that are specifically affected in different malignancies. In a 
recent attempt to describe the early alterations involved in colorectal cancer development 
Grimm and collaborators analyzed the methylation profiles of intestinal adenoma from 
Apc
Min/+ mice (Grimm et al. 2013). The authors found that a large number of alterations are 
produced in early adenomas although the global alteration in gene expression profiles poorly 
correlates with the global extent of methylation of DMRs at this stage. Importantly, they 
found that hypermethylation of tumor-suppressor genes occur very rarely at this stage, 
suggesting that in the case of colorectal cancer this mechanism should be considered as a late 
mechanism in tumor progression more than as early instructive step. These results also 
suggest that this epigenetic signature arise de novo and do not represent the expansion of a 
signature associated to any given intestinal population such as the stem compartment.  Until 
recently, however, very little was known about the contribution of DNA methylation to the 
mechanisms governing the homeostatic balance of intestinal epithelium and whether the 
disruption of these mechanisms participates to colorectal cancer onset.  A recent work showed 
that some important changes occur in the methylation profiles during differentiation of 
epithelial cells (Sheaffer et al. 2014). These changes are not often associated to regions 
closely associated to gene promoters and are more frequent found in active intestinal 
enhancers of genes. Reduction in the methylation of gene enhancers associated with intestinal 
lineage specification coordinates the binding of transcription factor allowing the activation of 
expression as cells differentiate. Conversely, enhancers of genes associated with stem identity 
are methylated, which allows the repression of those genes. In accordance with these results 
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the same work shows that conditional deletion of Dnmt1 results in an expansion of intestinal 
crypts associated with an impaired differentiation of intestinal stem cells into post-mitotic 
lineages. Expression of the three DNA methyltransferases in the intestinal epithelium was 
shown to occur in a crypts-to-villus gradient, with the highest amount expressed in the stem 
fraction. This compartimentalization is coherent with the requirement of maintenance and de 
novo and methylation in actively proliferating cells that need to remodel their methylation 
profile as they commit to differentiate. Due to the embryonic lethality associated with 
mutations in these genes, there are no evidences for genetic alteration associated with 
colorectal cancer incidence in the population. However, upregulation of de novo 
methyltransferases expression has been reported as a feature of the colorectal adenoma-to-
carcinoma sequence (Lin et al. 2006). The activity of both de novo enzymes is associated with 
the rate of intestinal tumor initiation in animal models. Transgenic over-expression of one or 
the other gene in ApcMin/+ background was associated with an increase in intestinal tumor 
load. The overexpression of Dnmt3 enzymes correlate with increased methylation and 
reduced expression of precise target genes that are known to represent risk loci associated 
with colorectal cancer development, such as the oncosupressor Igf2, and the Sfrp2 and Sfrp4 
genes coding for the Wnt pathway extracellular inhibitors (Linhart et al. 2007; Samuel et al. 
2009). Analyses of the normal mucosa suggested that these few particular genes represent 
targets for aberrant de novo methylation in the pre-neoplastic tissue before the earliest 
oncogenic alteration occurs. DNA methylation was also shown to represent a prognostic 
marker for CRC. In 2011 the analysis of the transcriptomic profiling performed on cohorts of 
patients suggested that prognosis correlates with the extent of the expression of WNT target 
genes (de Sousa E Melo et al. 2011). The results described in this work confirmed the 
existence of a counterintuitive positive correlation between expression of WNT target genes 
and survival, and that reduced expression of WNT targets is associated with an increased 
chance for patients to progress more rapidly toward the malignant stages of the disease. 
Strikingly, the authors showed that the reduced expression of WNT target genes  is  
associated with focal hypermethylation of CpG islands associated with the expression of those 
genes. 
During the recent years, DNA methylation inhibitors have widely been proposed as possible 
therapeutic agents (Hatzimichael and Crook 2013). The two most frequently used DNA 
inhibitors are the azanucleosides 5-azacytidine and 5-aza-2-deoxycytidine), representing 
cytosine analogues working as demethylating agents through the covalent trapping of DNA 
methylatrasferases once they are incorporated into the DNA. Both of these agents received the 
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FDA approval for the treatment of myelodisplastic syndromes and acute leukemia (Itzykson 
and Fenaux 2011). Although these molecules have showed their efficacy in promoting the 
demethylation of tumor suppressor genes and in restoring the sensitivity to chemotherapeutics 
in various cancer models, their use in clinical trials provided less encouraging results in the 
case of solid tumors, probably due to the relatively reduced proliferative rate of these tumors. 
It should be noted that these agents are highly cytotoxic and non-specific, making the robust 
evaluation of the effectiveness of DNA methylation inhibition as a therapeutic strategy more 
complicated.  
 
3.2. Histone modification and the histone code 
The basic unit of chromatin, the nucleosome, consists in a 146-bp DNA loop wrapped around 
an octamer of core histone-proteins (two H2A/H2B dimer and H3/H4 tetramer). Histone 
proteins are decorated at their N- and C-terminal domains by different covalent modifications 
including acetylation, methylation, phopshorylation and ubiquitinylation. These post-
translational modifications determine whether chromatin domains are organized in a densely 
compact and inactive state (heterochromatin) or in a more open and active configuration 
(euchromatin). Post-translational modifications of histones are coordinated by families of 
enzymes that are responsible for adding or removing every mark, such as acetyltransferases 
(HATs) and histone deacetylases (HDACs), histone methyltransferase (HMTs) and 
demetylases (KDMs). A list of the post-translational modification and their position on 
histone tails is provided in the figure 16. 
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Figure 16: schematic representation of post-translational histone modifications. Covalent modification 
proper to each position on the histone H2A, H2B H3 and H4 are indicated. Ac: acetylation; Me: 
methylation; P: phosphorylation; Ub: ubiquitinylation. (Rodríguez-Paredes and Esteller 2011) 
 
 In animals, histone modifiers act in complex. Polcomb repressive complexes (PRC) 1 and 2, 
and the Thritorax group are guided to their targets by specific motifs in the genomic sequence 
(Tanay et al. 2007; Ku et al. 2008). The PRC2 complex act by catalyzing the trimethylation of 
the lysine 27 (H3K27me3) of the histone 3 which provide a docking site for the PRC1 
complex, whose enzymatic core RING1B monoubiquitinylates the histone H2A at lysine 119 
(H2K119ub1) thereby impeding the RNA polymerase II elongation (Mills 2010). The 
trithorax group complex, containing the MLL acetyltransferase which lays down the 
acetylation of the lysine 4 on the histone H3, and the KDM6A demethylase that removes the 
H3K27me3 mark and counteracts the repressive function of the polycomb groups (Mills 
2010). Despite the extensive literature describing the role of these complexes in regulating 
gene transcription during embryonic stem cell differentiation and embryonic development, 
their roles in the biology of adult stem cells is still largely unexplored. One interesting feature 
of embryonic and adult stem cells consists in the existence of bivalent domains on regions 
corresponding to the transcription factors responsible for differentiation of specific lineages. 
These regions are decorated with both the activating H3K4Me3 and the suppressive 
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H3K27me3 marks (Bernstein et al. 2006).  Upon differentiation the Trithorax group complex 
removes the repressive H3K27me3 allowing the transcription of specific transcription factors 
required for the specification into a particular lineage, whereas genes that are not required for 
that particular lineage lose the activating H3K4 mark and undergo spreading of the H3K27 
mark that terminally represses the transcription of those genes (Hawkins et al. 2010). Gene 
enhancers in absorptive and secretory progenitors in the intestinal epithelium were shown to 
present comparable levels of H3K4me2 and H2K27ac histone marks that define an accessible 
permissive chromatin configuration (T.-H. Kim et al. 2014). This observation may represent 
an epigenetic mechanism underlying the plasticity previously described for intestinal 
progenitors and also represent a possible explanation for the capacity of progenitors to 
undergo lateral inhibition controlling the choice between absorptive and secretory fate.  
The PRC1 complex was shown to actively ensure the maintenance of intestinal stem cell 
identity and self-renewal capacity by sustaining the activity of the Wnt pathway through the 
repression of members of the ZIC family transcription factors that interfere with the 
transcriptional activity of the β-Catenin/Tcf4 complex (Chiacchiera, Rossi, Jammula, Piunti, 
et al. 2016). Indeed, the conditional deletion of RING1B results in the overexpression of the 
Zic TF and in the displacement of β-Catenin/Tcf4 from their target promoters in intestinal 
Lgr5-positive cells, therefore altering not only the self-renewal capacity but also the β-
Catenin oncogenic activity of these cells. The same group found that the PRC2 complex is 
involved in secretory lineage commitement by regulating specific transcription factors 
(Chiacchiera, Rossi, Jammula, Zanotti, et al. 2016). It was also already known that the PRC2 
complex is involved in terminal differentiation of intestinal epithelial cells. Ideed the RNA-i 
mediated knockdown of the SUZ12 core subunit of the PRC2 complex in the Caco2/15 
intestinal cell line induces the loss of H3K27me3 mark and the activation of the enterocytic 
differentiation program (Benoit et al. 2012). A vast and increasing literature extensively 
supports the mechanistic role of genetic alterations in the modulation of the histone code in 
cancer development. As an example, aberrant translocation of the MLL gene encoding for one 
of the H3K4 methyltransferases accounts for about 80% of infant leukemia. The primary 
mechanism in this case is attributed to the inappropriate recruitment of epigenetic factors on 
the MLL target genes, resulting in the disruption of the genetic silencing (Tan et al. 2011). 
Recent studies have revealed that some important features of cancer are defined by alterations 
whose nature is purely epigenetic. In 2014, the bimodal prognostic classification of children 
affected by ependymomas was shown to be associated with a Polycomb repressive complex 
target signature corresponding to a CpG island methylator phenotype of the same loci (Mack 
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et al. 2014). Patients affected by this malignancy are indistinguishable trough genomic 
analyses, which revealed the absence of genomic alterations and zero recurrent somatic 
nucleotide variants associated with the poor- or good-prognosis groups. However, the PRC2 
binding signature and DNA methylation profiles found in the tumor samples are completely 
predictive of prognosis in these young patients.  
 
3.3. MicroRNA 
MicroRNA mediated interference represent an additional highly conserved epigenetic 
mechanism adopted throughout the animal and plant kingdoms in order to modulate the 
information contained in the genomic sequence (Hayes, Peruzzi, and Lawler 2014). These 
transcripts are encoded as single miRNA or clusters of miRNAs and processed through a 
conserved mechanism to their mature single-stranded form which can then associate to the 
RNA-induced silencing complex (RISC) (Krol, Loedige, and Filipowicz 2010). This 
interaction typically result in the reduced translation or deadenylation and degradation of 
multiple target mRNA that are recognized trough the complementarity between the mRNA 
and the 5’ “seed” region of the miRNAs (figure 17). After their discovery in 1993, an 
impressively vast literature has shown the role of miRNAs in the modulation of any biological 
process as well as their implication in the development of pathologies.  MicroRNAs 
dysregulation in cancer was first observed when genes encoding for Mir-15 and Mir-16 were 
found to be located in a genomic region that is frequently deleted in chronic lymphocytic 
leukemia (Calin et al. 2002). These microRNAs negatively regulate the expression of the 
antiapoptotic factor BCL2. Since then it has been documented that miRNAs play roles in all 
of the cancer hallmarks. Screening performed to examine the expression of miRNAs in CRC 
identified many alterations possibly implicated with cancer development as tumor suppressor 
or oncogenes. Mir143 and mir145 represent examples of tumor suppressive microRNA 
regulating cell growth and possibly stemness (Michael et al. 2003). Mir-21 has well 
characterized oncogenic function in many cancer types and its expression in CRC is well 
documented (Volinia et al. 2006; Selcuklu, Donoghue, and Spillane 2009). Several other 
miRNAs have been implicated in many features of CRC development, invasiveness and 
metastasis. However, the role of miRNAs in regulating the biology of the intestinal epithelia 
and their implication in the rupture of homeostasis is still poorly investigated. In a recent 
work a complex feedforward loop mechanism involving miR34a, Notch and the Notch 
inhibitor Numb was shown to regulate symmetric cell division and fate decision and to 
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counter excessive proliferation of intestinal stem cells under inflammatory condition (Bu et al. 
2016). The authors also showed that this mechanism can induce asymmetric cell division in 
colorectal cancer stem cells in order to limit excessive proliferation but it is subverted but the 
silencing of mi-34a at later stages of cancer progression. 
  
 
Figure 17: microRNA biogenesis and function. microRNA are produced through the transcription and 
processed by the Drosha complex before they are exported in the cytoplasm and additionally processed 
before they are included in the RISC complex. Suppression of gene expression is mediated via different 
mechanisms depending on the degree of complementarity with the target mRNAs. (Krol, Loedige, and 
Filipowicz 2010)  
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3.4. The epigenetic progenitor: a unifying model in cancer etiology 
Although cancer cells have long been represented as the best example of the phenotypic result 
of genetic alterations, genomic and epigenomic analyses are increasingly revealing the 
widespread misregulation of epigenetic mechanisms at all steps of cancer development. The 
disruption of the epigenetic regulation currently represents a major focus in the study of 
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cancer biology. In the previous sections we summarized whether genetic and epigenetic 
mechanisms can influence each other and cooperatively interfere with the factors involved in 
the maintenance of normal homeostatic balance. These evidences have prompted the 
formulation of a theory known as the epigenetic progenitor origin of cancer (Andrew P. 
Feinberg, Ohlsson, and Henikoff 2006). According to this model, epigenetic alterations may 
occur in a population of healthy progenitor cells prior to the accumulation of the tumor-
initiating genetic alteration. Such epigenetic disruption would result in an alteration of the 
balance between proliferation and differentiation or in an increased susceptibility of a 
subpopulation of cells to genetic alterations (figure 18). These epigenetic alterations are likely 
to concern genes involved in the maintenance of stemness. In this model, the stochastic or 
environmentally induced epigenetic imbalance of stem cells is followed by a cancer initiating 
mutation involving a tumor suppressor or a gatekeeper gene in the population of 
epigenetically disrupted progenitors. Such a mutation further increases the genetic and 
epigenetic plasticity of the progeny, allowing the subsequent development of distinct sub-
clones responsible for tumor evolution. Multiple lines of evidences support this model. 
Importantly, some epigenetic features such as the global hypomethylation of the genome 
represent hallmarks of oncogenic transformation, which are supposed to occur very early 
during tumor development. In addition, hypermethylation and silencing of certain loci are 
retrieved in the healthy tissue of cancer patients, suggesting that these alterations may even 
occur prior to cancer initiation. In addition, genomic instability which is commonly used to 
explain rapid clonal evolution does not apply to most solid tumor types which are 
genomically stable yet display high plasticity. At present, however, the epigenetic progenitor 
cancer model remains speculative and still awaits a formal demonstration.  
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Figure 18: the epigenetic progenitor model of cancer development. A)  Schematization of the classic view: 
upon the initiating mutation the tumor initiating cells start dividing rapidly and additional mutations 
clonally selected to give rise to the tumor heterogeneity responsible for different features of aggressive 
cancers. B) The epigenetic progenitor model: adult progenitor cells are epigenetically and become more 
prone to accumulate the oncogenic alteration driving tumor initiation. Further genetic and epigenetic 
alterations increase the plasticity of tumor cells. TSG: tumor-suppressor gene; ONC: oncogene; TPG: 
tumor-progenitor gene; GKM: gatekeeper mutation  (Andrew P. Feinberg, Ohlsson, and Henikoff 2006) 
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AIMS OF THE WORK 
 
Cancer represents nowadays one of the main concerns, if not the greatest concern, in public 
health management. The elucidation of the mechanisms implicated in cancer susceptibility, 
initiation and progression toward its latest stages has also largely contributed in promoting the 
basic understanding of their contribution to the control of the normal homeostatic balance in 
cells and tissues. The outstanding accomplishments made during the last few decades in the 
identification of the genetic changes involved in cancer development have been accompanied 
by comparable advances in the characterization of the epigenetic control of malignancies. 
These include (but are not limited to) the role of widespread epigenomic changes, such as the 
alteration of the DNA methylation profiles, the nuclear architecture and the nuclear 
compaction. For multiple experimental reasons, such as the relative ease to recover the 
biological substrate from different types of sample, DNA methylation has long represented 
the most well studied epigenetic modification in cancer (Kulis and Esteller 2010; Sandoval 
and Esteller 2012). Some alterations associated with this modification are now considered as 
hallmarks of cancer development and currently represent targets for the discovery of 
prognostic biomarkers and for the development of therapeutic strategies. General 
hypomethylation of the genome represented the first widespread alteration to be ubiquitously 
retrieved in cancer samples, independently on the stage and on the genetic pathway associated 
with cancer initiation (A. P. Feinberg and Vogelstein 1983). In the case of colorectal cancer, 
genome-wide hypomethylation is thought to occur very early, probably immediately after the 
first oncogenic mutation which is commonly represented (80% of sporadic CRC) by the loss 
of APC. Focal hypermethylation of regions controlling the expression of genes with tumor 
suppressive function also represents an interesting debated issue. Some evidences show that 
even this kind of change may occur very early, even prior to the genetic alteration driving 
oncogenic transformation, as demonstrated by the fact that hypermethylation of certain genes 
is found in the non-tumoral healthy tissue of animal models and in patients (Linhart et al. 
2007). However a recent work raised some concerns on whether these alterations actually 
represent rare stochastic events subjected to clonal selection rather than a general instructive 
mechanism associated with intestinal tumorigenesis (Grimm et al. 2013).  
In 2006 some authors speculated that epigenetic disruption of stem/progenitor cells may 
represent a possible common mechanism in cancer etiology (Andrew P. Feinberg, Ohlsson, 
and Henikoff 2006). Their model proposes that epigenetic alterations may represent the 
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earliest source of the impairment in the homeostatic balance occurring in multipotent cells, 
and that this disruption may set the stage for the subsequent accumulation of genetic 
alterations. Increasing evidences show that cells at the top of tumor hierarchy (i.e. tumor 
initiating cells and/or tumor stem cells) are reminiscent of the features describing normal stem 
cells, i.e. self-renewal ability and multipotency, and should therefore be considered as a 
mutated counterpart of these latter.  
However, one main concern can be raised on the strategy used to obtain the evidences 
presented so far, which is intrinsically summarized in the title of the landmark work 
“Hypomethylation distinguishes genes of some human cancer from their normal counterpart” 
published in 1983 (A. P. Feinberg and Vogelstein 1983). Since then, the experimental strategy 
to investigate the epigenetic features of cancer development has always consisted in the 
comparison between the tumor samples and their surrounding healthy tissue. Such a 
comparison accounts for an intrinsic heterogeneity since cell types in cancer and healthy 
tissue are differentially represented, which inevitably results in a different representation of 
the molecular signatures associated to each of these cell types.  This heterogeneity becomes 
confounding when we consider that each tumor arises from a single cell belonging to one 
precise population. In other words, the comparison of healthy and tumor samples, even in the 
case of very early lesions, cannot allow formulating conclusions about the timing at which 
epigenetic alterations actually occur and what their role is in promoting the earliest phases of 
cancer.  
The present work aims at tackling two main questions about the epigenetic contribution to 
cancer initiation and to the modulation of cancer susceptibility: 
1) How early do the epigenetic alterations occur upon the earliest genetic events in the 
sequence driving oncogenic transformation, and how do these changes functionally 
contribute to the phenotypic traits acquired by tumor cells?  
To answer this question we examined the genomic methylation and gene expression profiles 
of intestinal epithelial cells in vivo early after the loss of one or both Apc alleles, which 
represents the most common alteration associated to human CRC initiation. To do so, we 
made use of conditional mouse models in which the recombination of Apc is specifically 
targeted to epithelial cells, since the expression of the recombinase Cre is under the control of 
epithelial promoters. The initial characterization was performed on the genomic DNA and 
coding RNA recovered from Lgr5+ intestinal stem cells, whose isolation was allowed by the 
use of an Lgr5-EGFP-ires-CreERT2 transgenic model in which none, one or both alleles of Apc 
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contain LoxP sites flanking the exon 14 of the gene (Apc+/+; Lgr5-EGFP-ires-CreERT2, 
Apc
LoxP/+
; Lgr5-EGFP-ires-Cre
ERT2
, Apc
LoxP/LoxP
; Lgr5-EGFP-ires-Cre
ERT2). It should be 
noted that, at least in the context of constitutive Wnt activation as the tumor initiating event, 
intestinal stem cells are so far considered as the population most likely involved in tumor 
initiation.  
The DNA methylation profiles presented in this work were obtained in collaboration with the 
team of Michael Weber (École Supérieure de Biotechnologie de Strasbourg) by using a 
reduced representation bisulfite sequencing (RRBS) approach (Meissner et al. 2005). This 
high-throughput analysis allows the investigation of DNA methylation profiles on a single 
nucleotide level. RRBS combines restriction enzyme mediated digestion and sequencing of 
the DNA in order to restrict the analysis on the genomic regions that have high CpG content 
(CpG islands, representing about 1% of the genome). These regions include the majority of 
promoters and repeated sequences.  
Epigenetic modifications are, by definition, reversible. To challenge the possible biological 
impact of the signature we tried to modulate the activity of the machinery responsible for de 
novo DNA methylation and evaluate its contribution to the acquisition of the tumorigenic 
phenotype of intestinal epithelial cells upon the loss of Apc. This functional validation was 
performed by using in vitro organotypic models, which recapitulate in many ways the 
physiology of the intestinal epithelium. Organoids were obtained by culturing intestinal 
epithelial cells from a transgenic conditional model in which the expression of the 
recombinase Cre is driven by the epithelial Villin promoter (Apc+/+; Villin-CreERT2;. 
Apc
LoxPLoxP+
; Villin-Cre
ERT2
). 
2) How does the epigenetic variability existing within a population account for the 
heterogeneous relative risk to develop cancer independently on the genetic 
heterogeneity? 
Epigenetic mechanisms modulating the extent of gene expression are of course key mediators 
of the biological variability. Many efforts have been spent to characterize the genomic 
features of patients affected by different types of cancer in order to identify genetic loci 
associated with increased relative risk (The Cancer Genome Atlas, 2012). However the 
epigenetic control may provide a supplemental layer of complexity. A work published in 2011 
showed that cohorts of isogenic animals (i.e. genetically identical) display a large degree of 
heterogeneity in terms of the extent of DNA methylation at multiple regions of the genomes 
resulting in heterogeneous expression of associated genes (Andrew P. Feinberg and Irizarry 
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2010). The analysis of differentially methylated regions revealed that these are often 
associated with the expression of genes implicated in key developmental processes. These 
results confirm that the heterogeneity existing within a population is, at least in part, 
modulated by the epigenetic variability. We therefore decided to investigate the existence of a 
molecular signature in the healthy intestine associated with differential susceptibility to 
develop intestinal cancer. To do so, we made use of a constitutive inbred model consisting in 
isogenic mice carrying a germline heterozygous mutation on Apc (ApcΔ14/+). These mice 
invariably develop multiple adenomas during their adult life, although the severity of the 
phenotype (i.e. the number of adenomas developed at a given age) is largely variable. Since 
these mice are genetically identical, the source of such a phenotypic heterogeneity is to be 
researched elsewhere. We therefore examined the molecular profiles (RRBS and 
transcriptomic analyses) found in the healthy (tumor-free) intestine of isogenic mice with 
variable degree of susceptibility, which we quantified according to the number of tumors 
found at the age of sixteen weeks. In order to test the capacity of these signatures to be 
predictive of the relative risk to develop multiple adenomas before the pathology initiate, we 
designed and validated in collaboration with the team of Michael Helmrath (MD, MS, director 
of the surgical intestinal rehabilitation research program at the Cincinnati Children Hospital) a 
surgical strategy according to which intestinal samples are collected in young mice before 
tumors have time to develop and variability becomes extensive. Animals were then let age 
and develop tumors in order to correlate the severity of the pathology with the molecular 
signature found in the previously collected tumor-free intestinal biopsies from the same 
individuals. However, the development of an effective surgical protocol required us a very 
long set-up. At the same time, we therefore decided to investigate the correlation between the 
molecular profiles found in the tumor-free portion of the intestine of adult mice (sixteen 
weeks) and their individual susceptibility (numbers of adenomas developed at sacrifice when 
intestinal samples are collected). This double approach allowed us to test whether the 
molecular signatures in the healthy intestine are informative of individual risk to develop 
tumors at two different stages: before tumor initiation, and after the heterogeneous 
development of multiple adenomas has occurred. 
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RESULTS 
 
 
SECTION I: ALTERATIONS IN THE DNA METHYLATION AND GENE 
EXPRESSION PROFILES UPON THE ONCOGENIC ACTIVATION OF THE WNT 
PATHWAY AND THEIR FUNCTIONAL IMPACT ON EPITHELIAL 
HOMEOSTASIS 
 
1. Epithelial response to the loss of Apc 
Inactivation of Apc in intestinal epithelial cells results in the rapid translocation of the β-
catenin and constitutive activation of the Wnt pathway, whose immediate effects consist in 
the impairment of cell differentiation and migration (Sansom et al. 2004). This alteration 
induces distinct biological responses in the proliferative and differentiated compartments, 
governed by the different molecular programs activated in immature and post-mitotic cells 
(Andreu et al. 2005). 
Apc
LoxP/Loxp
; VillinCre
ERT2 animals become visibly ill and have to be sacrificed at day 6 after 
the injection with tamoxifen. At this time point the intestinal epithelium displays the expected 
“crypt-like” phenotype, in which proliferating cells exceed the crypt-villus boundary and 
occupy the majority of the axis (figure 19). However, at day 1 post-injection the morphology 
of crypts appears normal or slightly hyperproliferative, and the phenotype is then acquired 
gradually, as shown by the progressive increase in the number of Ki-67 positive cells in the 
crypt compartment. The opposite trend is observed for the alkaline-phosphatase staining, 
indicating a progressive elimination of terminally differentiated cells in the crypt-villus axis. 
These observations indicate that, as expected, the loss of Apc does not induce a 
dedifferentiation of mature cells, and the crypt-like phenotype is rather associated to the 
renewal of the epithelium in which terminally differentiated cells are gradually replaced by 
actively proliferating ones.   
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Figure 19: Apc loss results in increased proliferation and de novo differentiation but not in de-
differentiation of intestinal epithelial cells of Apc
LoxP/LoxP
; VillinCre
ERT2
 mice. Ki-67 immunostaining (left 
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panels) indicates actively proliferating cells at different time points after injection with tamoxifen (40X 
magnification). Alkaline phosphatase staining (right panels) highlights the terminally differentiated 
compartment at the same time points (20x magnification). 
 
The crypt-like phenotype is associated with a shift in the expression of some markers in the 
epithelium of ApcLoxp/Loxp mice that were selected among target genes of Wnt signaling 
activation (Lgr5, Myc), DNA methyltransferas (Dnmt1, Dnmt3b), and factors belonging to 
histone modifier complexes (Eed, Ezh2, Bmi1, Hdac2). All of these genes are up-regulated in 
the Apc-deficient epithelium. The immunostaining of Dnmt1 confirmed that six days post-
injection its expression co-localizes with markers of active cell division (PCNA) and exceeds 
the crypt-villus junction, further demonstrating that a distinct program is maintained in the 
immature compartment and propagated in hypertrophic crypts (figure 20).  
 
 
Figure 20: the hypertrophic proliferative compartment upon the deletion of Apc in the intestinal 
epithelium. A) Relative gene expression of Wnt targets (Lgr5, Myc), DNA methyltrasferases (Dnmt1, 
Dnmt3b) and components of the Polycomb repressive complex in the Apc
+/+
, Apc
LoxP/+ 
, Apc
LoxP/LoxP
; Villin-
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Cre
ERT2
 epithelium 6 days after the administration with tamoxifen. Results represent the average of 4 
biological replicates and are normalized on the expression of the Gapdh and Hprt housekeeping genes.  
Error bars represent S.E.M. * represents a P-value <0.05, ** P-value<0.01 as calculated by the Mann-
Whitney U-test. B) immunostaining showing the pattern of expression of Dnmt1 (red) and PCNA (green) 
in the intestinal Apc
LoxP/Loxp 
epithelium 6 days after the administration of tamoxifen. Hoechst (blue) is used 
to stain the nuclei; 40x magnification 
 
2. The loss of Apc induces an expansion of the CBC compartment and alters the cell 
cycle dynamics of Lgr5
+
 cells 
Given the epithelial morphologic and molecular changes associated with the loss of Apc in the 
Villin-Cre
ERT2 model, we reasoned that any comparison between the ApcWT, ApcHet and ApcKO 
epithelium in this model would rather reflect the impairment in the epithelial architecture and 
ratio of proliferating versus differentiated cells. We therefore decided to better focus the 
attention on the immediate outcome associated with the constitutive activation of the Wnt 
pathway in Lgr5+ CBC cells by making use of the Lgr5+-EGFP-ires-CreERT2 model. This 
model provided us with multiple advantages: 
1) The variegated expression of the transgenic locus (about 1 out of 4 crypts express the 
recombinase, figure 21), results in a less sever phenotype, which allows the 
characterization of the effects of inactivation of Apc at later time points than in the 
case of the Villin-CreERT2 model, in which the duration of the experiment is limited by 
the short survival of the animals (sacrifice at day 6 days upon the first injection). We 
reasoned that fifteen days might represent a reasonable lapse of time for the de novo 
establishment and propagation of DNA methylation patterns within the crypt 
compartment. 
2) The recombinase is specifically expressed by Lgr5+ cells, which allows us to 
determine the impact exerted by the constitutive activation of the Wnt pathway on the 
intestinal stem cells and their immediate progeny. 
3) The locus contains a reporter gene (coding for enhanced GFP), allowing us to isolate 
the Lgr5+ cell population, representing the main tumor cell-of-origin population, and 
monitor the progressive outcome of the recombination in this specific cell 
compartment.  
As expected, fifteen days after the administration with tamoxifen nearly 100% of GFP-
positive cells display the translocation of the β-Catenin (hallmark of the activation of the Wnt 
signaling) and transgenic crypts become hypertrophic (figure 20).  In our experimental set-up, 
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however, this model may have one limitation related to the stability of the GFP. The Lgr5 
locus represents a transcriptional target of the Wnt pathway. Indeed, the GFP is expressed and 
accumulates more abundantly in Lgr5+ cells upon the deletion of Apc than it does in Apc+/+ 
Lgr5
+ cells. At day 15 post-injection this accumulation results in an expanded population of 
GFP-labelled progeny that is no longer confined to the bottom of the crypt. This implicates 
the possibility that, at this time point, some early differentiating cells in the crypt might have 
inherited some “leaking” GFP from their progenitors.  
 
 
Figure 21: Wnt activation in Lgr5
+
 stem cells leads to the formation of a hypertrophic GFP-positive 
compartment. The GFP (green) staining in the crypts expressing the transgene exceeds the normal 
localization of Lgr5
+
 cell compartment 15 days after the activation of the Lgr5-Cre recombinase. All GFP
+
 
cells show the translocation of the β-Catenin (white) within the cytoplasm and the nucleus. GFP is absent 
in post-mitotic Paneth cells within the same crypts. 
 
However, when we examined the expression of markers of terminally differentiated secretory 
populations most commonly found at the bottom of the crypt such as tuft cells cells (Dclk1), 
Paneth cells (Lyzozyme) and enteroendocrine cells (Chromogranin A) we observed minimal 
or no co-localization with the GFP staining, suggesting that both in Apc+/+ and ApcLoxP/LoxP 
crypts, GFP positive cells are very likely to only consist in Lgr5+ cells and their immediate 
undifferentiated progeny fifteen days post-injection (figure 22). 
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Figure 22: The GFP rarely co-localizes with markers of the post-mitotic cell populations typically found at 
the bottom of the crypt. A) Dclk1 (red) identifying differentiated tuft cells. B) Lyzozyme marks Paneth 
cells within the crypt. C) Example of the rare colocalization of the GFP with Chromogranin A expressed 
by enteroendocrine cells. 40x magnification. D) Quantification of the co-expression of these makers with 
the GFP. Results represent the average quantification of > 20 transgenic crypts found in two biological 
replicates of each genotype (Apc
+/+
; Lgr5-EGFP-ires-Cre or Apc
LoxP/LoxP
; Lgr5-EGFP-ires-Cre). Error bars 
represent S.E.M. Statistical significance was evaluated by two-tailed Student t-test. 
 
To better characterize the increase of the proliferative compartment occurring upon the 
deletion of Apc in Lgr5-positive stem cells we decided to quantify the size of the stem cell 
compartment in the transgenic crypts. As mentioned, however, the stability of the GFP makes 
the reporter alone uncertain to this aim, since Lgr5+ cells transfer part of their GFP content to 
their non-stem progeny at cell division. We therefore decided to perform a double 
quantification by using an anatomical criterion, the position between two Paneth cells, as well 
as the expression of a supplemental bona fide marker, Olfactomedin 4 (Olfm4), both 
associated with the CBC identity (van der Flier, Haegebarth, et al. 2009, 4) (figure 23 A). 
Apc
LoxP/LoxP 
Lgr5-EGFP-ires-Cre
ERT2 crypts display a slight but statistically significant 
increase in the number of Olfm4-expressing cells that we revealed by in situ hybridization of 
the Olfm4 mRNA, as well as a slight significant increase in the number of GFP-positive cells 
intermingled between two Paneth cells fifteen days after the initial injection of mice with 
tamoxifen (Figure 23 B).  Both strategies converged to reveal a relative increase in the 
number of CBC close to 15%. The increase in the number of stem cells is accompanied by a 
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similar raise in the number of Paneth cells in the transgenic crypts (figure 23 C).  As 
previously described, the constitutive activation of Wnt signaling perturbs the homing of 
Paneth cells (Batlle et al. 2002). Indeed, we frequently observed Paneth cells aberrantly 
located outside their normal position.  Therefore, the inactivation of Apc in Lgr5+ cells leads 
to an increase in the size of the stem cell compartment including its own epithelial niche. 
 
 
Figure 23: Expansion of the CBC stem compartment 15 days after the deletion of Apc in Lgr5
+
 cells. 
Quantification of Olfm4-positive cells within the GFP-positive crypts. B) Representative Olfm4 staining 
obtained by in situ hybridization. C) Average number of GFP
+ 
cells intermingled between two Paneth cells 
per crypt. D) Average number of Paneth cells in the GFP
+
 crypts. All the results represent the average 
value of > than 20 crypts in two biological replicates of each genotype (Apc
+/+
; Lgr5-EGFP-ires-Cre or 
Apc
LoxP/LoxP
; Lgr5-EGFP-ires-Cre.). Error bars represent S.E.M. * represents a P-value<0.05 as calculated 
by the Mann-Whitney U-test. 
 
The activation of the Wnt pathway makes intestinal stem cell independent on the secretion of 
Wnt stimuli provided by the niche, especially those provided by surrounding Paneth cells. 
However, active Wnt signaling alone is not sufficient to explain the increase in the size of the 
stem compartment. We reasoned that the accumulation of intestinal stem cell consequent to 
the deletion of Apc could be explained by either an alteration in the dynamics of ISC or by a 
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reduced responsiveness of ApcKO ISC to the pro-differentiation stimuli exerted by the 
microenvironment outside the normal stem-permissive location.   
The sequential loss of Apc alleles was previously shown to confer a selective advantage to 
ISCs, which are more likely to replace their WT counterparts (Vermeulen et al. 2013). We 
therefore decided to better investigate the cell cycle dynamics of GFP-positive cells 15 days 
after the initial injection with tamoxifen. Unexpectedly, the analyses by mean of flow 
cytometry on the cell cycle distribution of isolated GFP-positive cells showed a significant 
reduction in the number of cells in the S phase, associated with an accumulation of cells in the 
G0/G1 phase (Figure 24 A). This result may indicate a surprising reduction in the proliferative 
rate of ApcKO cells, or the presence of post-mitotic cells in the GFP-positive population. As 
previously shown in the figure 22, we rarely observed the co-localization of the GFP with 
markers of terminally differentiated populations in the crypt.  To ensure that the increase in 
proportion of G0/G1 cells does not represent the result of a bias introduced in the fluorescent-
activated cells sorting of the different genotypes, we quantified the co-localization of the GFP 
with Siglec-F, a surface marker of post-mitotic tuft cells that are frequently found in the 
mouse intestinal crypts (Gerbe et al. 2016). The result of the staining shows a weak and 
comparable co-expression of the two markers (less than 1% of GFP-positive cells for all 
genotypes), making the possibility of bias due to a differential contamination with post-
mitotic cells very unlikely (Figure 24 C). Together, these observations suggest an unexpected 
reduction in the rate of cell division of GFP+ cell compartment after the loss of function of a 
key tumor suppressor gene.  
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Figure 24:  Alteration in the cell cycle dynamics of GFP
+
 cells 15 days after the deletion of Apc in Lgr5+ 
cells. A) Mean percentage of cells in the different phases of the cell cycle is quantified by flow cytometry 
according to their DNA content after staining. Results represent the average  of 3 Apc
+/+
; Lgr5-EGFP-ires-
Cre,  4 Apc
LoxP-/+
; Lgr5-EGFP-ires-Cre and 4 Apc
LoxP/LoxP
; Lgr5-EGFP-ires-Cre mice in which at least 7000 
GFP
+
 cells were analyzed. Error bars represent S.E.M. * represents a p-value <0.05, ** p-value<0.01 as 
calculated by two-tailed Student t-test. B) Example of the flow cytometry strategy to evaluate the 
proportion of cells expressing Siglec-F and/or the GFP. C) Representative percentage of GFP cells co-
expressing the Siglec-F tuft cell marker in one individual per genotype. Records above each bar represent 
the real number of positive events. 
 
3. In vivo molecular profiling of Lgr5
+
 cells and their immediate progeny 
 
3.1. Fluorescent-activated cell sorting strategy  
To characterize the earliest impact of the sequential loss of Apc alleles we decided to analyze 
the DNA methylation and gene expression profiles found in Lgr5+ cells and their immediate 
progeny (progenitors/transit amplifying cells) in ApcWT, ApcHet and ApcKO GFP+ cells that we 
isolated fifteen days after the first injection with tamoxifen. Several studies have shown that 
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GFP-positive cells actually account for functionally distinct populations (Barker et al., 2007; 
Barker et al., 2009; Munoz et al., 2012). It was shown that due to the stability of the eGFP 
reporter (inherited at cell division by the early Lgr5-negative progeny), the epithelium of 
these mice actually consists in 3 main populations that are distinguishable according to their 
brightness: the GFPhigh (brightest fluorescence) population accounts for cells with high 
clonogenic capacity, whereas the GFPlow population accounts for actively proliferating non 
clonogenic cells. The GFPneg population is constituted by late TA and differentiated cells 
(Barker et al. 2007; Sato et al. 2011; Muñoz et al. 2012).  
Although the highly clonogenic population would appear as the most interesting to be 
examined, our in vivo experimental design does not allow to easily discriminate the different 
functional populations according to the brightness of cells in the Apc-deficient context as in 
the case of WT cells. Coherently with the previously mentioned increase in the size of the 
GFP+ compartment, the ApcLoxP/LoxP dissociated epithelium shows a remarkable rise (6-fold) in 
the percentage of the GFP+ cell fraction as well as a shift in the brightness of cells when they 
are excited by a 488nm laser (figure 25 B). We reasoned that any attempt to functionally 
classify Apc-/- cells according to their brightness would be over-simplistic and we therefore 
decided to include in the analysis all the GFP+ cells whose brightness exceeds a severe 
threshold that we defined in order to minimize the risk of contamination with post-mitotic or 
false-positive GFP+ cells (gates are shown in the figure 24A).  Overall, this strategy allows us 
to focus the subsequent analyses on Lgr5+ cells and their most immediate progeny, the 
compartment accounting for the highest plasticity and most likely involved in tumor initiation, 
by providing the cells with a reasonable lapse of time for epigenetic changes to be produced 
and propagated within the proliferative compartment.  
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Figure 25: Fluorescent-activated cell sorting of GFP-positive cells from Lgr5-EGFP-ires-Cre epithelia. A) 
Illustration of the gating strategy. The positive gate established above the threshold of autofluorescence 
(orange gate) quantified in the Lgr5
+/+
 control epithelium is then applied to isolate GFP-positive single live 
(7-AAD negative) cells from all of the three genotypes (Apc
+/+
; Lgr5-EGFP-ires-Cre, Apc
LoxP-/+
; Lgr5-
EGFP-ires-Cre and Apc
LoxP/LoxP
; Lgr5-EGFP-ires-Cre. B) Quantification of GFP
+
 cells in the three 
genotypes represented as the average percentage of single live cells from 5 Apc
+/+
; Lgr5-EGFP-ires-Cre,  5 
Apc
LoxP/+
; Lgr5-EGFP-ires-Cre and 8 Apc
LoxP/LoxP
; Lgr5-EGFP-ires-Cre mice. Error bars represent S.E.M.  
* represents a p-value <0.05 as calculated by the Mann-Whitney U-test.  
 
3.2. The sequential loss of Apc alleles progressively alters the transcriptomic profiles 
of the self-renewal compartment 
According to the Knudson model, the oncogenic inactivation of a gene with tumor 
suppressive function occurs upon the sequential alteration of both alleles (Knudson, 1971). In 
the case of colorectal cancer, the loss of the first Apc allele can either occur in the germline 
(as in the case of FAP patients) or somatically (sporadic CRC). The second hit occurs during 
the adult life, via either the disruption of the second allele or its epigenetic silencing. To 
investigate the molecular changes associated with this progressive sequence we performed a 
transcriptomic analysis on the polyadenylated transcripts (mRNA) of Lgr5-positive cells and 
their immediate progeny isolated from Apc+/+, ApcLoxP/- and ApcLoxP/LoxP small intestines. The 
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comparison between KO and WT cells shows that the biallelic loss of Apc dramatically 
impacts on the global gene expression profiles of these cells and we found significant 
differential expression of 5112 out of 25797 analyzed transcripts (figure 26). Similar effects 
are observed by comparing the gene expression profiles of heterozygous (HET) cells with 
those of KO cells, confirming that most of changes occur after the abrogation of Apc function 
upon the inactivation of the second allele (complete loss of function) that in turn allows the 
constitutive activation of the Wtn signaling. Nevertheless, 478 transcripts were found to be 
differentially expressed upon the earliest genetic alteration (loss of the first allele) suggesting 
that the reduction in the Apc gene dosage impacts on the molecular phenotype of Lgr5+ cells, 
although the heterozygous epithelium appears macroscopically normal and does not show any 
major alteration in the features considered so far in both Villin-CreERT2 and Lgr5-CreERT2 
mice.  
 
 
Figure 26: progressive alteration of the gene expression profile in GFP
+
 cells. Volcano plots illustrating the 
relative change for all the transcripts analyzed in the comparison between Apc
+/+
 (WT), Apc
+/- 
(HET) and 
Apc
 -/-
 (KO) Lgr5-positive cells and their progeny. Red dots represent transcripts whose expression is 
significantly altered. Gene expression analyses are performed on cohorts of 4 animals per genotype. X-axis 
represent the log2 relative fold change, Y-axis represents the P-value associated to each transcript. 
 
Gene ontology (G.O.) analyses performed on the list of genes differentially expressed upon 
the loss of one allele show the significant overrepresentation of a number of KEGG pathways 
(figure 27). Interestingly, G.O. functional classes of genes associated with “xenobiotic 
metabolism” and “drug metabolism” are highly represented among differentially expressed 
genes.  
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Figure 27: Altered gene expression in response to the loss of one Apc allele in Lgr5
+
 cells and their 
immediate progeny. A) Heatmap representing the differential expression profiles of Apc
+/+
 and Apc
+/-
 
sorted cells. B) List of the 15 most represented KEGG pathways obtained by G.O. analysis performed by 
using David public resource (david.ncifcrfgov). The associated P-value corrected for multiple testes is 
shown for each class.   
 
The trancriptomic profiles obtained from ApcKO GFP+ cells provided us with the opportunity 
to further investigate the molecular features associated with the accumulation of intestinal 
stem cells and the changes in their proliferative dynamics previously described. To this aim 
we decided to interrogate the gene expression profiles via gene set enrichment analyses 
(GSEA) (Subramanian et al. 2005). This bioinformatic tool consists in a computational 
method that determines whether an a priori defined set of genes associated with a given 
biological or molecular function, cell identity, developmental process or disease shows 
statistically significant concordant differences between two biological states (in our case 
represented by the presence or deletion of Apc). The primary result provided by the GSEA is 
an enrichment score (ES), which defines the extent of the positive or negative correlation of a 
given biological state with the specific set of genes considered. We therefore selected sets of 
genes representing the transcriptomic signature previously found to be up-regulated in 
intestinal stem cells (Muñoz et al. 2012), transit-amplifying cells (Merlos-Suárez et al. 2011) 
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and differentiated epithelial cells (Merlos-Suárez et al. 2011). The results show that the 
transcriptomic profile associated with the loss Apc correlates with the expression of the gene 
set associated to the stem identity (figure 28). Conversely, the gene set associated with 
intestinal differentiation show a positive correlation with the profile of expression in WT 
cells. None of the two states showed significant correlation with the signature associated to 
transit-amplifying progenitors.  
 
 
Figure 12: Altered gene expression in response to the loss of function of Apc in Lgr5
+
 cells and their 
progeny. A) Heatmap representing the differential expression profiles of Apc
+/+
 and Apc
-/-
 sorted cells. B) 
GSEA analyses performed by evaluating the enrichment of signatures with associated with stemness 
(Munoz et al., 2012), transit amplifying cells (Merlos-Sauarez et al., 2011) and differentiated cells (Merlos-
Suarez et al., 2011). NES represents the normalized enrichment score corrected for multiple tests 
calculated with 1000 permutations (Subramanian et al. 2005), and indicates the extent of the correlation 
with the transcriptomic profile associated with the ApcWT phenotype.  
 
Indeed, when we manually inspected the list of differentially expressed genes we found that 
the expression of several markers commonly associated with ISC identity is up-regulated in 
knock-out cells, with the exception of Olfm4, whereas key regulators and markers of epithelial 
commitment toward the different mature lineages (enterocytes, enterendocrine, goblet, tuft 
and M-cells) are down-regulated in these cells. The Paneth cell lineage, the differentiation of 
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which relies on Wnt activity (van Es et al. 2005), represents the only exception in this altered 
fate program. We concluded that this is coherent with the proportional increase of the stem 
and Paneth compartment found in ApcKO crypts and with previous findings on the effect of 
Apc loss on the Paneth cell compartment (Andreu et al. 2005). Table 1 provides some 
examples of differentially expressed genes associated with stemness and differentiation of 
intestinal epithelial cells. 
 
 
Table 1:  Relative change in the expression of genes associated with stemness and commitment of the 
intestinal epithelium. “Stem” genes represent part of the signature associated with Lgr5
high  
cells proposed 
by Munoz and collaborators (Munoz et al., 2012). Atoh1 is the master regulator of the secretory cell fate in 
the intestinal epithelium.  The list also contains transcription factors responsible for commitment and 
markers of terminal differentiation of all the intestinal cell types: enterocytes (Alpi, Lct, Krt20), goblet cells 
(Spdef, Agr2, Muc2), Paneth cells (Sox9, Mmp7), enteroendocrine cells (Insm1, Neurog3), tuft cells (Pou2f3, 
Dclk1) and M-cells (SpiB).  Corrected P-value for multiple tests is shown for each gene. 
 
Overall, these results confirm the key role exerted by Apc in controlling the balance between 
proliferation and differentiation via the modulation of Wnt signaling and support the observed 
increase of the stem compartment occurring as a result of the accumulation of stem cells at the 
expense of differentiation. Moreover, the raise of the transcriptional signature associated with 
stemness occurs in absence of any significant change in the representation of TA cell markers 
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in the population constituted by Lgr5+ cells and their progeny, thus supporting the idea that 
commitment of intestinal stem cells toward differentiation occurs very early in the crypt.  
 
3.3. Biallelilc loss of Apc alters the DNA methylation profiles of the self-renewal 
compartment 
Genomic DNA samples collected from the same samples were used to examine the DNA 
methylation profiles associated with the sequential deletion of Apc copies, via reduced-
representation bisulfite sequencing. We considered as differentially methylated all of the 
CpGs displaying a significant relative variation over a threshold of 10%.  
Overall, the comparison between ApcWT and ApcHet cells revealed very few changes (58 
DMR) associated with the first genetic hit. The cross-comparison with transcriptomic data 
shows a poor correlation between the methylation and gene expression, with most of the 
significantly differentially methylated genes being equally expressed in the GFP-positive 
compartment of wild type and heterozygous animals (data not shown).  
The biallelic Apc loss, however, produced a more consistent impact, since 790 CpGs were 
found to be differentially methylated in ApcKO cells (figure 29). We found 595 (75%) of these 
CpGs to be hypomethylated in Apc-deficient cells. Importantly, hierarchical clustering shows 
a high degree of similarity in the profiles of the biological replicates in the two groups, 
indicating that the loss of Apc produces well defined concordant changes in DNA 
methylation. The G.O. analysis performed on the genes associated with differentially 
methylated regions shows the significant overrepresentation of some KEGG pathways terms. 
Notably, this analysis revealed an overrepresentation of genes associated with Wnt and TGF-
beta/BMP signaling, among the others.  
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Figure 29: Differentially methylated regions in WT and KO Lgr5
+
 cells and their immediate progeny. A) 
Heatmap representing the hierarchical clustering of differential methylation profiles of Apc
+/+
 and Apc
-/-
 
sorted cells. B) List of the 15 most represented KEGG pathways obtained by the G.O. analysis performed 
by using David public resource. The associated corrected P-value is shown for each class.   
 
RRBS results do not allow us to attempt any speculation on the general extent of genomic 
methylation, since this method only takes into account 1% of the genome consisting in CpG-
rich regions. However, when we examined more closely the intracisternal A particle mobile 
elements (IAP), which are transposable regions severely methylated in normal cells, we did 
not find any significant decrease in their DNA methylation patterns on a single nucleotide 
scale (figure 30). This result was validated by McrBC enzymatic genomic digestion followed 
by region-specific qPCR analysis (for further details see material and methods), which 
confirmed that the high extent of CpG methylation is maintained at IAP genomic regions in 
Apc
KO cells. This observation suggests that hypomethylation does not necessarily occur at 
genome-wide scale at this initial stage of cancer development and may involve only some 
specific genomic features of intestinal stem cells.  
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Figure 30: methylation of a representative IAP region in Apc
+/+
 and Apc
-/-
 Lgr5
+
 cells and their immediate 
progeny. A) Integrative genomic viewer (IGV) snapshot focusing the genomic region associated to IAP 
element showing methylated sites. Bars represent the extent of methylation (0 to 1) in 4 biological 
replicates of Apc
WT
 (blue) and Apc
KO
 (red) FACS-isolated cells. B) Verification of DNA methylation extent 
by qPCR performed on McrBC digested genomic DNA on 4 biological replicates. The strategy used for 
the normalization is detailed in the material and methods. 
 
4. Constitutive activation of the Wnt pathway in ISC is associated with reduced 
responsiveness to the BMP/TGF-β signaling pathway via altered DNA methylation 
and expression of its components 
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We decided to investigate whether the impairment in the cells fate associated with the 
constitutive activation of the Wnt signaling in ISC might correlate with the remodeling in the 
methylation patterns observed upon the loss of Apc in these cells.  
As previously mentioned, the G.O. analysis on the list of differentially methylated regions 
revealed a significant number of genes belonging to the TGF-β/BMP signaling pathway.  
BMP signaling plays a crucial role in sustaining cell differentiation, and its activity is 
regulated in a crypt-to-villus gradient by the variable secretion of BMP ligands and their 
antagonists by epithelial and mesenchymal cells (Vanuytsel et al., 2013). We found that a 
region associated with transcription of the BMP inhibitor Smad6 is hypomethylated in Apc-
deficient cells (mean methylation difference of -46%), whereas the promoter of the activin 
receptor 1 (Acvr1) and the BMP2-associated kinase (Bmp2k) are hypermethylated 
(respectively 14% and 12%  gain of methylation). RNAseq data show a three-fold increase in 
the expression of Smad6 and Smad7 BMP inhibitors, and a two-fold downregulation of 
BMP2k. McrBC enzymatic digestion followed by region-specific qPCR analysis confirmed 
the hypomethylation of the Smad6 associated region in GFP+ cells, and RT-PCR 
semiquantitative was used to validate its transcriptional upregulation in an independent 
biological cohort of GFP+ cells (figure 31). We concluded that the constitutive activation of 
Wnt signaling provokes an alteration in the extent of DNA methylation and expression of key 
factors involved in the Bmp/TGF-β signaling.  
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Figure 31: methylation and expression of Smad6 in Apc
+/+
 and Apc
-/-
 Lgr5
+
 cells and their immediate 
progeny. A) IGV snapshot focusing the genomic region associated to the Smad6 promoter showing 3 
differentially methylated sites. Bars represent the extent of methylation (0 to 1) in 4 biological replicates of 
WT (blue) and KO (red) sorted cells as quantified by RRBS. B) Verification of DNA methylation extent by 
qPCR performed on McrBC digested genomic DNA on 4 biological replicates. The strategy used for the 
normalization is detailed in the material and methods. * represents a P-value <0.05 as calculated by 
Mann-Whitney U-test C) RT-PCR showing the expression of Smad6 in 3 Apc
+/+
 and 4 Apc
-/-
 biological 
replicates. ActinB is showed as an internal housekeeping control. 
 
Since an increasing literature shows that opposite gradients of BMP and Wnt activity 
cooperates in the maintenance of well-defined stem, proliferative and differentiated 
compartments in the intestine, we reasoned that these changes could indicate a reduced 
responsiveness of Lgr5+ cells and their progeny to the pro-differentiation BMP stimuli.  
To test this hypothesis we analyzed the localization of the intracellular effectors of this 
signaling cascade in the epithelium of the small intestine of Apc+/+; Villin-CreERT2 and 
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Apc
Flox/Flox
; Villin-Cre
ERT2 mice six days after their administration with tamoxifen. As 
expected, in the WT epithelium we observed the phosphorylation and translocation of the 
Smad 1/5/8 effectors into the nuclei of differentiated cells in the villus, and in post-mitotic 
Paneth cells at the bottom of the crypts, whereas the proliferative crypts show a weak 
cytoplasmatic staining (figure 32). Strikingly, this pattern of translocation is abrogated or 
severely altered in the epithelium upon the deletion of Apc. Nuclear staining could only be 
observed at the tip of villi in part of the epithelium, suggesting that the progressive loss of 
phosphorylation/translocation occurs in the epithelium in a crypt-to-villus direction as a result 
of the cellular turnover after the deletion of Apc. The same alteration was found when we 
examined the patterns of translocation of the BMP2/3, which are described as effectors of the 
canonical TGF-β singaling in the small intestine (not shown).  Together, these results indicate 
that the loss of Apc leads to an altered expression of some components of the Bmp/TGF-β 
signaling pathway, in part associated with the alteration in the DNA methylation profiles of 
these same genes. In turn, this likely results in an impaired responsiveness of the self-renewal 
compartment to the pro-differentiation stimuli exerted by the microenvironment.  
 
 
Figure 32: translocation patterns of phospho-Smad 1/5/8 effectors in the Apc
+/+
 and Apc
LoxP/LoxP 
; Villin-
Cre
ERT2 
at day 6 post-tamoxifen injection. p-Smad (white), Lyzozyme (Paneth cells marker) and β-catenin 
(green) are immunostained. 40X magnification. 
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5. Inhibition of the Dnmt3b de novo methyltransferase activity reduces the proliferative 
rate of Apc
KO
 organoids and restores the responsiveness to exogenous Bmp stimuli 
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The RRBS profiling shows that the loss of function of Apc and the subsequent constitutive 
activation of the Wnt pathway are accompanied by the establishment of DNA methylation 
patterns in the stem cell compartment that affects the activity of pathways related with 
stemness and fate determination of those cells. Patterns of DNA methylation are generally 
established de novo by Dnmt3a and Dnmt3b methyltransferases, and maintained at cell 
division by the activity of Dnmt1. Enzymatic activity of the Tet family enzymes participates 
in promoting demethylation. This multiplicity makes the design of a biological validation 
challenging, since each of these modifiers and erasers is likely to contribute in the 
establishment of these patterns. We reasoned that by modulating the activity of the de novo 
methyltransferases we would, at least in part, affect the capacity of stem cells to remodel their 
DNA methylation profile upon the loss of Apc. Several inhibitors of Dnmt enzymes are used 
to test the role of DNA methylation in tumor growth and cancer progression. However, these 
molecules do not show selective affinity with respect to the three enzymes participating to de 
novo and maintenance methylation, and their effectiveness is based on the progressive 
demethylation of the genome leading to the demethylation of hypermethylated tumor 
suppressors. In 2010, Kuck and collaborators showed that Nanaomycin A, an antibiotic 
belonging to the quinone class extracted from Streptomyces, presents selective binding 
affinity to the catalytic domain of human Dnmt3b (Kuck et al. 2010). This affinity was 
confirmed by molecular docking and in vitro assays. They also found that the treatment of 
human cell lines with this molecule reduces the general extent of DNA methylation and re-
activates the expression of some genes without affecting the activity of Dnmt1. At the best of 
our knowledge, this was the first and only known de novo methyltrasferase-specific inhibitor. 
We therefore decided to functionally test the role of de novo methylation in the achievement 
of the tumorigenic phenotype by treating organotypic cultures prepared from the epithelium 
of ApcLoxP/LoxP;Villin-CreERT2 mice with Nanaomycin A. These cells received Nanaomycin A 
in their medium at the same time as the pulse with 4-hydroxy-tamoxifen. The treatment was 
maintained all along the duration of the experiment and fresh medium was replaced every 3 
days. As a control, we included wells that we treated with 5-Azacytidine, a nucleoside 
inhibitor that functions through unspecific enzyme covalent trapping to the DNA. Although 
the formation of different epithelial compartments is well recapitulated in intestinal 
organotypic cultures, these are, overall, fast-dividing. When we examined the proliferative 
rate, we found that about 60% of Apc+/+;Villin-CreERT2 cells were Ki-67-positive, and the 
treatment with either Nanaomycin A or 5-azacytidine did not disturb the proliferation of live 
WT cells, although 5-azacytidine treatment induces extensive cell death (not shown). 
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Macroscopically, we did not observe any change in cell death associated with Nanaomycin A 
administration. Upon the administration with 4-hydroxi-tamoxifen, cells from 
Apc
LoxP/LoxP
;Villin-Cre
ERT2
 organoids displayed, as expected, an alteration in the morphology 
of the structures that became cystic (epithelial spheroids), which was accompanied by an 
increase in their proliferative rate (78% +/- SEM of KI-67 positive cells) (figure 33 C). 
Strikingly, both Nanaomycin-A and 5-azacytidine significantly reduced the proliferation of 
knock-out organoids to extents comparable to those found in treated and untreated WT 
cultures (figure 33 C). Although we did not examine the DNA methylation profiles, it seems 
unlikely that these results could depend on cell pathways other than DNA methylation (off-
target effects), since Nanaomycin A and 5-azacytidine are molecules belonging to different 
classes (a nucleoside and an antibiotic), which both inhibit DNA methylation via different 
mechanisms (substrate-catalytic domain interaction and enzyme covalent trapping 
respectively).  
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Figure 33: morphologic changes upon Apc deletion in intestinal organotypic cultures and effects of 
Dnmt3b inhibition. A) Brightfield image of Apc
+/+
 and Apc
LoxP/LoxP
;Villin-Cre
ERT2 
organoids 3 days after the 
addition of 4-hydroxy-tamoxifen to the medium: the deletion of Apc induces the formation of spheroids. B) 
Ki-67 proliferative marker in Apc
+/+
 and Apc
LoxP/LoxP
; Villin-Cre
ERT2
 organoids showing the loss of the 
distinct compartments after the deletion of Apc. C) Quantification of Ki-67-positive cells indicating the 
proliferation in Apc
+/+
 and Apc
-/-
; Villin-Cre
ERT2 
organoids in response to the addition of 5-Azacytidine or 
Nanaomycin A. Results represent the average of >40 structures in two biological replicates per condition. 
Error bars represent S.E.M. ** indicates p-value < 0.01 as calculated by Student t-test.  
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We then decided to test whether the inhibition of de novo methylation could reverse the 
immediate effects of Apc loss impacting on cell fate determination by monitoring the 
responsiveness to the BMP stimuli. One main advantage provided by organotypic cultures 
consists in the absence of mesenchymal cells, which allows culturing the cells in the defined 
presence of morphogenetic factors in the medium. The BMP inhibitor Noggin is usually 
added to the medium in the absence of exogenous BMP ligands, which favors the 
maintenance of the self-renewal ability by preventing precocious differentiation. We therefore 
tested the effects of the depletion of recombinant Noggin and the subsequent addition of 
recombinant Bmp2 in presence or absence of Nanaomycin A. Even in this case, Nanaomycin 
A was added to the medium at the same time of the administration with 4-hydroxi-tamoxifen. 
After 6 replatings (24 days) the medium of WT and KO cultures was depleted of Noggin. This 
did not produce consistent changes in the morphology of WT organoids, although we noticed 
a progressive reduction in re-plating efficiency, which is consistent with the role of Noggin in 
preventing precocious differentiation. In the case of ApcKO cultures, the absence of Noggin 
induced the onset of a “dimpling” morphology in spheroids that was severely accentuated in 
the presence of Nanaomycin A (figure 34). When we further increased the BMP stimulation 
by addition of recombinant Bmp2, this result was exacerbated and we observed the 
progressive formation of several crypt-like structures in ApcKO cultures in the presence of 
Nanaomycin A. We interpreted these morphological observations as an attempt of Apc knock-
out cells to recover the formation of a differentiated compartment in the presence of Bmp 
signals, which is favored by the inhibitory activity of the Nanaomycin A. This result 
functionally confirms the implication of de novo methyltransferase activity in the impaired 
responsiveness to BMP stimuli. 
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Figure 34: Dnmt3b inhibition increases the epithelial responsiveness to differentiation stimuli. 
Representative fields (10x magnification) show the effects of the Bmp stimulation through deprivation of 
recombinant Noggin and addition of recombinant Bmp2 in presence or absence of Nanaomycin A in 
Apc
Lox/LoxP
; villinCre
ERT2
 cells treated with 4-hydroxytamoxifen to induce the recombination. Bars indicate 
100 µM. 
 
6. shRNA mediated knock-down as a stable model for the repression of de novo 
methylation in intestinal organotypic cultures 
The use of a specific inhibitor seems to support our initial hypothesis concerning the 
functional requirement of de novo methylation for the establishment of the phenotype 
associated with the loss of Apc in intestinal stem cells. This approach has the clear advantage 
of inhibiting the methyltransferase activity of Dnmt3b without affecting its expression and its 
interactions within the nucleus. However it also has some limitations. First, the lack of other 
specific inhibitors limits the possibility to extend the investigation to Dnmt3a, whose activity 
and targets are not necessarily redundant with those of Dnmt3b. Second, although de novo 
DNA methylation is very likely to be the main target of this treatment, we cannot exclude that 
off-target effects might cooperate in modulating the stemness of primary cultures. Indeed, a 
recent work has shown that antibiotics may impact on the stemness of cancer cell lines, 
probably by differentially modulating the activity of the ribosome and translation (Relier et 
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al., 2016). Third, this approach makes the design of an in vivo pre-clinical study challenging, 
due to the lack of knowledge on the bioavailability of this molecule upon the administration to 
animals and to its possible systemic effects that may impact tumor formation and growth.    
To get further insight into the contribution of de novo methylation to the tumorigenic potential 
of ApcKO intestinal stem cells, we decided to establish stable models of Dnmts knockdown via 
the lentiviral transduction of transgenic organotypic cultures with shRNA targeting the Dnmts 
transcripts. Immunohistochemical staining shows that the knock-down occur at variable 
extent in different structures within the WT cultures, with heterogeneous expression of 
Dnmt3a and Dnmt3b (intensity of the nuclear staining ranging from absent or very weak to 
comparable with the intensity found in lentiviral transduced non-target control cells) (figure 
35). We reasoned that such heterogeneity is probably due to the variable location and 
multiplicity of lentiviral integration in the stem cell genome. Indeed, since the primary cell 
cultures are polyclonal and form from multiple stem cells, the insertion of a single copy of the 
lentiviral genome can be sufficient for a given cell to acquire the resistance to the antibiotic 
selection without efficiently impacting the target mRNA expression, whereas multiple 
genomic insertions may result in more abundant expression of the shRNA and more effective 
knockdown.  
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Figure 35: lentiviral-mediated tranduction of Dnmt3a and Dnmt3b specific sh-RNA results in 
heterogeneous knock-down in intestinal Villin-Cre
ERT2
 organoids. Left panels show the patterns of 
expression in control cells transduced with non-target lentivirus. Right panels show the patterns of 
expression in cells transduced with the specific shRNA or combination of both. DNA methyltrasferases are 
immunostained (white) and nuclei are stained with Hoechst (blue). 40X magnification.  
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Despite this heterogeneity, we found that upon the treatment with 4-hydroxy-tamoxifen, the 
general rate of cell-division was significantly reduced in ApcKO cultures expressing the 
Dnmt3b specific shRNA, whereas the stable expression of the Dnmt3a specific shRNA did 
not significantly impact the proliferation (figure 36). Interestingly, the combination of both 
shRNA provokes a reduction in the Ki-67 expression and BrdU incorporation comparable to 
that found in the case of Dnmt3b knock-down.  Together, these observations suggest that 
Dnmt3a does not critically sustain the proliferation of ApcKO cells, although other important 
features (e.g. cell death) may be regulated by its activity, and that Dnmt3a does not takes on 
the role of Dnmt3b when this latter is depleted. On the other hand, Dnmt3b knock-down can 
phenocopy the effect obtained by treating cells with a Dnmt3b-specific inhibitor (Nanaomycin 
A), or a general Dnmts inhibitor (5-Azacytidine), supporting its prominent role in sustaining 
cell growth upon the deletion of Apc. 
 
 
Figure 36: proliferative rate in response to Dnmt3a/Dnmt3b knockdown in organotypic Apc
LoxP/LoxP
,Villin-
Cre
ERT2
 cultures treated with 4-hydroxy-tamoxifen. Figures show the average % of Ki-67 expressing cells 
and BrdU incorporation in the different conditions. Results represent the average of at least 25 individual 
structures.  * indicates a P-value <0.05, *** indicates a P-value <0.001 as calculated by Mann-Whitney U-
test. 
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SECTION II: DNA METHYLATION AND TRANSCRIPTOMIC PROFILES 
ASSOCIATED WITH DIFFERENTIAL SUSCEPTIBILITY TO TUMOR INITATION 
IN Apc
Δ14 
MICE 
 
1. Genetic and non-genetic heterogeneity governing the variable tumor initiation rate 
in Apc
Δ14 
mice 
Apc
Δ14/+ mice constitute a valuable model to investigate the genetic and environmental 
modifiers modulating the rate of tumor initiation in the gut. These mice spontaneously 
develop multiple intestinal adenomas with complete penetrance during their adult life as a 
consequence of the stochastic loss of heterozygosity (LOH) in intestinal stem cells leading to 
the constitutive activation of the Wnt signaling in those cells (Colnot et al., 2004). We can 
therefore consider the number of tumors developed at a given age as proportional to the 
relative susceptibility of any individual to develop intestinal neoplasia. Our team recently 
found that ApcΔ14/+ mice in our inbred colony develop intestinal adenoma at highly variable 
rate. The highest heterogeneity in the tumor count is found at the age of sixteen weeks, when 
the number of intestinal adenomas varies between one and more than one hundred and twenty. 
This heterogeneity is remarkably more pronounced than the one originally described in 
Apc
Δ14/+ mice raised in specific pathogen free (SPF) conditions by Colnot and collaborators. 
Surprisingly, the team also found that these mice develop adenoma in a bimodal manner, and 
Apc
Δ14/+ individuals can be assigned to two distinct phenotypic groups according to the 
number of adenomas that are found in the small intestine at the age of sixteen weeks (Quesada 
et al., unpublished data).  As shown in the figure 37, the number of visible adenomas at this 
age is either between one and twenty (ApcΔ14/+ “FEW” animals) or higher than forty (ApcΔ14/+ 
“MANY” animals).  Mice belonging to the “MANY” group begin to die at the age of sixteen 
weeks with signs of rectal bleeding, anemia and splenomegaly. The formation of rectal 
prolapses also frequently occurs in mice developing severe polyposis in the colon. Mice 
belonging to the “FEW” group do not show any of these signs at sixteen weeks, and nearly 
100% of those mice are alive at five months. Overall, the onset of the systemic effects 
associated with severe polyposis is delayed in this group (Quesada et al., unpublished).  
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Figure 37: intestinal tumor burden in 16 weeks-old co-isogenic mice. A) Individual tumor count in a 
representative cohort of 57 animals. B) Genetic-dependent differential tumor burden.  n= 39 Apc
Δ14/+ 
“FEW” + 18 Apc
Δ14/+ 
MANY”). Error bars represent standard deviation, *** indicates a P-value <0.001 as 
calculated by two-tailed Student t-test.  
 
As expected, the progeny of any ApcΔ14/+ parents accounts for a mendelian proportion of 50% 
Apc
+/+ and 50% ApcΔ14/+. However, by examining the breeding schemes used to maintain the 
colony, we observed that the ApcΔ14/+ progeny of any parent having developed less than 
twenty adenomas accounts for 73% of ApcΔ14/+ belonging to the same group and 27% of mice 
with a tumor count >40. On the other hand, the ApcΔ14/+ progeny of any parent having 
developed >40 tumors at the age of 16 weeks only consists in mice with >40 adenomas at this 
same age, and we never observed any reversion in this mode of segregation across several 
generations (figure 38). Together, these evidences suggested the existence of a genetic 
polymorphism in an independent locus located on the chromosome 18 (where Apc is located) 
approximatively 27 centiMorgan away from the Apc locus (the genetic distance between two 
loci represents the frequency of crossing-over occurring between these two). This 
polymorphism exerts tumor suppressive function in the genetic substrain accounting for mice 
developing less than twenty tumors by sixteen weeks, while its disruption as a consequence of 
meiotic recombination occurring in 27% of the progeny of parents carrying the suppressive 
allele reverts the Apc phenotype to the a “MANY” status. The littermates represent therefore 
two co-isogenic substrains (i.e. they are genetically identical at all but one loci). This finding 
does not represent a unique case: genetic polymorphisms known as modifiers of Min (Mom) 
exert comparable tumor suppressive functions in the ApcMin model.  
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Figure 38: schematic representation of the breeding outputs showing the non-random segregation of the 
unknown genetic polymorphism.  
 
When we analyzed cohorts of younger individuals we found that ApcΔ14/+ mice belonging to 
the “FEW” substrain invariably develop less than three visible lesions at the age of six weeks, 
whereas ApcΔ14/+ mice in the “MANY” substrain invariably display more than twelve visible 
intestinal adenomas (figure 39). This confirms that this unprecedented polymorphism delays 
the tumor initiation in the gut of ApcΔ14/+ mice rather than inducing a regression of pre-formed 
adenomas.   
 
 
Figure 39: intestinal tumor burden in 6 week-old co-isogenic mice. A) Individual tumor count in a 
representative cohort of 34 animals. Blue and red boxes highlight the individuals belonging to “FEW” and 
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“MANY” genetic sustrain respectively. B) Genetic-dependent differential tumor burden.  n= 12 Apc
Δ14/+ 
“FEW” + 22 Apc
Δ14/+ 
MANY”). Error bars represent standard deviation. *** indicates a P-value <0.001 as 
calculated by two-tailed Mann-Whiney U-test.  
 
The formal identification of this modifier and its functional role in intestinal homeostasis and 
tumorigenesis does not represent the aim of the work presented here. However, it provides a 
valuable example of the dramatic role played by the genetic variability in modulating the 
individual susceptibility to develop intestinal neoplasia. Nonetheless, both genetic substrains 
of ApcΔ14/+ animals display a remarkable intra-group heterogeneity in terms of tumor initiation 
rate (i.e. susceptibility to develop multiple adenomas), which cannot be associated to any 
other major genetic change present in the ApcΔ14/+ colony.     
 
2. Molecular profiles associated with variable tumor initiation rate in sixteen week-old 
isogenic Apc
Δ14/+ 
mice 
Epigenetic mechanisms control the expressivity of a given genotype. Furthermore, the 
epigenetic landscape was shown to be highly variable in cohorts of isogenic animals 
(Feinberg and Izarry, 2010). Both ApcΔ14/+ substrains display an extensive variability in terms 
of the relative risk to develop multiple adenomas, which we consider as a surrogate of 
individual susceptibility.  
We decided to investigate whether the heterogeneous susceptibility could be associated with 
distinct molecular signatures in the sixteen week-old healthy (tumor-free) intestine of mice 
belonging to the same genetic substrain (ApcΔ14/+ “FEW”), in order to exclude the influence of 
the unknown genetic modifier on the heterogeneity in our colony. We therefore established 
arbitrary windows of poor or high susceptibility within this group of isogenic individuals, and 
we considered as poorly susceptible all the individuals having developed less than 6 
adenomas at sixteen weeks, whereas co-aged mice having developed more than 10 adenomas 
were classified as highly susceptible (figure 40). Adult mice belonging to the “MANY” 
subtrain were not analyzed. These animals begin to develop severe polyposis very early, 
which in turn leads to the rapid onset of various types of systemic failure. This severity 
represented the main argument prompting us to select the “FEW” substrain for the subsequent 
analyses, in order to minimize the local and systemic effects exerted by adenomas on the 
surrounding non-tumoral intestinal environment. 
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Figure 40: Non-genetic variable relative risk. The individual tumor burden is shown in a cohort of 39 16 
weeks-old Apc
Δ14/+ 
“FEW” animals. Individuals with poor and high tumor initiation rate were selected for 
the comparison of the molecular profiles in their non-tumoral intestinal tissues. Light and dark blue boxes 
highlight the arbitrary poor and high susceptibility classes.  
 
We eventually selected two groups of four individuals with either poor or high tumor 
initiation rate. At sacrifice, intestinal and colonic adenomas were counted and accurately 
removed, and the tumor-free epithelial and mesenchymal (stroma + muscle) fractions from 
the distal intestine of those mice were individually collected. We decided to focus the 
analyses on the tumor-free distal small intestine, since this is the prevalent anatomical 
location of adenoma development in ApcΔ14/+ mice. We then verified the absence of any 
contamination with tumor cells by quantifying the expression of both wild-type and Δexon14 
truncated alleles in the epithelial fraction. Epithelial cells forming intestinal adenomas are 
Apc
KO as a result of loss of heterozygosity (LOH). Any contamination of the tumor-free tissue 
with tumoral cells would alter the relative ratio of expression, which is expected to be close to 
1 in the tumor-free epithelium of ApcΔ14/+ mice.  The results show a weak heterogeneity in the 
expression of both isoforms, with a ratio close to 1 for all the biological replicates in the two 
groups (figure 41). Furthermore, we detected similar extent in the activity of the Wnt pathway 
that we monitored by analyzing the expression of the Wnt target gene Myc. Overall, these 
results robustly support the absence of contamination with tumor ApcKO cells in the 8 samples 
selected for –omic profiling. 
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Figure 41: verification of the tumor-free samples selected for –omic profiling. qPCR results show 
comparable expression of the WT and truncated forms of Apc and Myc in Apc
Δ14/+ 
mice. Individual and 
average values in each of the two groups normalized on the expression of housekeeping Gapdh and Hprt 
genes are shown. P-value was verified to be >0.05 by Mann-Whitney U-test 
Since the small intestine includes a myriad of non-epithelial cell types accounting for different 
molecular signatures, we also evaluated the enrichment of the two different fractions obtained 
by scraping the intestinal epithelium after incubation in 30 mM EDTA (see material and 
methods) to avoid any bias due to heterogeneity in the collection of the biological samples. 
This verification confirmed the purity of the epithelial fraction demonstrated by the reduced 
expression of the stromal marker Vimentin associated with a strong enrichment in the 
expression of the epithelial marker Epcam (figure 42). The combination of these markers also 
demonstrates the relative enrichment of the mesenchymal fraction. Although the results seem 
to suggest some contamination of this fraction with epithelial cells, the extent is comparable 
in all the samples.  
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Figure 42: relative enrichment of epithelial and mesenchymal fractions. A) qPCR results showing the 
expression of the stromal cell marker Vimentin in the epithelial and mesenchymal fractions collected by 
scraping. B) qPCR results showing the expression of the epithelial marker Epcam. Individual and mean 
values in each of the two groups normalized on the expression of Gapdh and Hprt housekeeping genes are 
shown.    
 
The RRBS profiling performed on the epithelium of poorly and highly susceptible mice 
revealed a limited number of significant DMR distinguishing the two groups and, overall, 
clustering analyses of the signatures obtained did not show increased similarity between the 
individuals assigned to the same class of susceptibility. Some of those 53 differentially 
methylated regions are associated with the promoters of interesting candidates with potential 
biological relevance such as the phospholipase A2 group IIA (Pla2g2a, also known as the 
first discovered modifier of Min gene), the vascular endothelial growth factor A (VegfA), and 
the transcription factor Gata4. For most of these regions, however, the difference in the extent 
of methylation is relatively poor and the two groups show an overlap. We therefore decided to 
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test the impact on the transcription of genes showing a consensus in their methylation profiles 
(i.e. no overlap between the extents of methylation of the individuals in the two groups). The 
differential methylation does not seem to significantly impact on the transcription of those 
genes, although a tendency toward down-regulation seems to exist in response to the 
hypermethylation in one group as in the case of Rps5 and Gse (DNA methylation and gene 
expression are showed in figure 43  
 
 
Figure 43: CpG methylation extent as quantified by RRBS (left) in regions showing a consensus (no 
overalp between the two groups) and qPCR quantification of the transcription of the genes in close 
proximity to the DMRs: A) Rps5 and B) Gse. *** indicates a Q-value <0.001; qPCR results show the 
individual and average relative expression obtained in 6 poorly susceptible and 3 highly susceptible 
biological replicates normalized on the expression of Gapd and Hprt housekeeping genes, together with the 
associated P-value as calculated by Mann-Whitney U-test.   
 
The gene expression profiles obtained in the same cohort of 4 poorly susceptible and 4 highly 
susceptible mice provided us with more interesting results. By applying a fold change cut-off 
of log1.1 we found 73 differentially expressed genes in the epithelial fraction (figure 44) and 
780 differentially expressed genes in the mesenchymal fractions of mice belonging to the two 
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classes of susceptibility. Importantly, hierarchical clustering of the epithelial profiles of 
expression showed similarity in the biological replicates belonging to each of these classes. 
The same was true for mesenchymal profiles (data not shown). In other words, the analysis on 
the expression of coding transcripts is able to correctly determine whether any of the 8 
individuals belongs to one or the other class of susceptibility.   
 
 
Figure 44: Heatmap and hierarchical clustering analysis of 73 differentially expressed genes in the 
epithelial fraction of poorly and highly susceptible adult individuals. Mann-Whitney unpaired corrected 
P-values cut-off=0.05 
 
3. Evaluation of the predictive value of intestinal signatures in six weeks-old Apc
Δ14/+ 
isogenic mice 
We also tested whether the molecular signatures found in tumor-free intestine of young 
individuals could be informative on the relative risk to develop multiple adenomas (i.e. the 
severity of the pathology) during their adult life. To do so, we collected biopsies of the distal 
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intestine from six weeks-old ApcΔ14/ + isogenic mice belonging to the “FEW” genetic substrain 
(mice developing 1-20 by the age of 16 weeks). Six weeks looked to us as the reasonable age 
for mice to undergo intestinal anastomosis, consisting in the resection of a portion of the small 
intestine followed by the surgical restoration of its integrity in order for mice to survive. As 
previously showed in the figure 39, due to the delay associated with the presence of the 
unknown genetic polymorphism, mice belonging to the “FEW” group present a very limited 
number (0 to 2) of adenomas when they are of six week-old, whereas mice belonging to the 
“MANY” substrain already display an extensive variability in tumor initiation. However, the 
progeny of mice carrying the unknown polymorphism that determine the FEW status 
inevitably accounts for 27% of mice with a “MANY” status. As a result, since the observation 
of ApcΔ14/+ mice at the age of six weeks does not provide any indication regarding their 
“FEW” or “MANY” status, we expected 27% of the mice undergoing to surgery to be of no 
use for this part of the work. 
The surgical strategy and procedure were developed in collaboration with the team of Michael 
Helmrath (MD, MS).  Out of 60 ApcΔ14/+ that underwent to surgery, 48 survived until the end 
of the study (80% survival rate) and, according to their tumor count, 38 were found to belong 
to the “FEW” substrain. It took on average 16 days post-surgery for ApcΔ14/+ “FEW” mice to 
recover their initial weight (figure 45). Their weight evolution was comparable to what we 
observed for control WT mice that underwent to surgery, whereas the recovery was delayed in 
Apc
Δ14/+ “MANY” mice, certainly due to increased severity of their pathology and extensive 
tumor development.  
 
 
Figure 45: weight evolution after the intestinal resection. The % of the initial weight is shown at different 
time points post-resection performed on day 0. Results represent the average of 12 Apc
+/+
, 12 Apc
Δ14/+ 
“FEW” and 12 Apc
Δ14/+ 
“MANY” mice. Error bars represent S.E.M. 
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The tumor burden of operated mice at 120 days spanned from 0 to 19 and from 40 to 109. 
Importantly, when we compared the distribution of adenomas along the small intestinal axis 
in a representative cohort of four operated females belonging to the “MANY” substrain with 
the distribution in non-operated females, we didn’t observe any significant shift tumor 
initiation (figure 46). We therefore concluded that our surgical strategy did not majorly alter 
the phenotype of our ApcΔ14/+ models, and any subtle variations presented in terms of tumor 
burden are to be attributed to the resection of two-three centimeters of the anatomical portion 
(the distal small intestine) in which adenomas generally initiate at elevated rate in the ApcΔ14/+ 
model. 
 
 
Figure 46: tumor development along the small intestine of operated and control Apc
Δ14/+ 
mice. Results 
represent the average % tumors found in of 4 Apc
Δ14/+ 
“MANY” females per group. The analysis was 
performed on the “MANY” substrain to evaluate a larger n of adenomas and obtain more informative 
statistics. Error bars represent SEM. P-value were calculated by the Mann-Whitney U-test.  
 
We eventually assigned five individuals to each class of poor (tumor burden was 0, 1, 2, 3 and 4 
respectively) and high susceptibility (15, 15, 17, 18 and 19 adenomas). To avoid any possible bias 
associated to epithelial scraping, we decided to analyze the methylation and gene expression profiles 
of the intact intestinal biopsy.  
RRBS analysis of the intestinal biopsies provided us with a list of 292 differentially methylated 
regions. Even in this case, hierarchical clustering did not reveal preferential similarity between 
biological replicates belonging to the same arbitrary class of susceptibility and for most of the regions 
we did not find a consensus trend in the extent of methylation with an overlap between the two 
classes. Furthermore, differential methylation does not significantly alter the expression of genes 
associated with those DMRs, as we found in the case of Arid1B and ApoD (figure 47).   
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Figure 47: CpG methylation extent as quantified by RRBS (left) in regions showing a consensus (no 
overalp between the two groups) and qPCR quantification of the transcription of the genes in close 
proximity to the DMRs: A) ApoD and B) Arid1B. *** indicates a Q-value <0.001. qPCR results show the 
individual and average relative expression obtained in 5 poorly susceptible and 5 highly susceptible 
biological replicates normalized on the expression of Gapd and Hprt housekeeping genes, together with 
the associated P-value as calculated by Mann-Whitney U-test.   
 
Once again, the analysis of the transcriptomic profiles shows that the global gene expression 
at six weeks correlates with the severity of the phenotype quantified as the number of visible 
intestinal adenomas developed by the same individuals at the age of four months (120 days) 
(figure 48). Indeed, isogenic individuals assigned to a particular class of susceptibility 
according to their tumor burden display similarity in the transcriptional profiles even before 
multiple adenomas had time to initiate in the intestine of those individuals. Even in this case, 
however, the differential expression does not depend on the extent of methylation of the 
promoters of those genes in the healthy intestine of the two groups of mice.  
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Figure 48: Heatmap of differentially expressed genes in the intestinal biopsies of six-week old poorly and 
highly susceptible individuals. The individual tumor load at sacrifice (120 days) is shown. Mann-Whitney 
unpaired corrected p-values cut-off=0.05 
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DISCUSSION AND PERSPECTIVES 
 
In this work we tried to unravel the dynamics and the biological impact of the molecular 
signatures associated to the most precocious phases of intestinal tumorigenesis, with 
particular attention to the role exerted by DNA methylation and its effects on gene expression. 
Overall, these characterizations have allowed us to identify some novel insights into the 
biology of the intestinal stem cell compartment, including the perturbation of specific 
mechanisms controlling the balance between self-renewal and differentiation immediately 
after the earliest genetic alterations associated to the development of colorectal cancer. We 
also provided evidences suggesting the existence of a non-genetic heterogeneity associated to 
the variability in a complex phenotypic trait such as the relative individual risk to develop 
cancer. 
 
SECTION I: ALTERATIONS IN THE DNA METHYLATION AND GENE 
EXPRESSION PROFILES UPON THE ONCOGENIC CONSTITUTIVE 
ACTIVATION OF THE WNT PATHWAY AND THEIR FUNCTIONAL IMPACT ON 
EPITHELIAL HOMEOSTASIS 
The comparison between tumors and their surrounding healthy environment, which has long 
represented the common strategy for the detection of epigenetic alterations associated with 
cancer development, does not provide relevant information about the precise timing at which 
any of these alterations are produced. Moreover, the results of such comparison are somehow 
biased by the differential heterogeneity of the two samples (tumor and healthy tissue) in terms 
of representation of different cell types.  
We therefore decided to focus the molecular analyses on the compartment responsible for the 
renewal of the intestinal epithelium, which also represents the compartment-of-origin of 
intestinal neoplasia. For this part of the work we took advantage of inducible transgenic 
models allowing us to monitor at precise timing the immediate outcomes of the loss of one or 
both Apc alleles at –omic and macroscopic scale. The characterization performed on the 
isolated Lgr5+ intestinal stem cells and their immediate progeny shows that very few 
modifications in the methylation of CpG-rich genomic regions are associated with the earliest 
genetic event in cancer development, represented by the loss of one allele of Apc. 
Nonetheless, a number of changes occur in the transcriptomic profile of heterozygous 
intestinal stem cells involving a significant number of genes associated with mechanisms of 
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cellular detoxification.  Although these alterations cannot to be attributed to differential DNA 
methylation, they might exert a relevant biological impact. We could imagine that the loss of 
a single copy of Apc may render the actively proliferating stem cells more prone to 
accumulate further genetic alterations due to a deficit in the detoxification of the xenobiotics 
that are commonly present in the environment. This hypothesis will of course require a 
functional validation. To this aim, we will challenge intestinal cells with common xenobiotics 
and we will then monitor in vivo or ex vivo the accumulation of genotoxic agents immediately 
after the loss of one allele and quantify the rate of accumulation of genomic damage in these 
cells, compared to ApcWT cells. Organotypic cultures will represent a valuable model to 
mechanistically dissect these aspects. 
We found that the most dramatic impact on the molecular phenotype is produced upon the 
complete loss of function of Apc in the self-renewal compartment of the small intestine. The 
transcriptomic profiling of Lgr5+ cells and their immediate progeny indicates a deficit in the 
capacity to commit toward differentiation, which is accompanied by an increase in the 
expression of markers associated with stemness. These evidences are consistent with the role 
of the Wnt signaling in the modulation of the balance between stemness and differentiation 
(Sansom et al. 2004; Andreu et al. 2005). We also showed that a number of alterations are 
produced in the DNA methylation profiles of these cells. The RRBS analyses do not allow 
investigating the general extent of genomic methylation at this particular stage. However the 
fact that transposable IAP regions remain severely methylated upon the deletion of Apc may 
suggest that the general hypomethylation of the genome, described as a hallmark of oncogenic 
transformation, may not necessarily apply to the early phase consequent to the loss of Apc in 
the stem cell population. To validate this hypothesis we are now considering the whole-
genome bisulfite sequencing (WGBS) of these cells that would provide us with more 
comprehensive information on regions with reduced representation of CpG (CpG shores). 
However, our approach allowed us to focus our attention to the regions of the genome 
associated with the gene promoters, and to monitor the functional impact of these alterations 
on gene expression. Among the most represented biological functions in our list of DMR we 
found the BMP/TGF-β signaling pathway, whose implication in the cell fate determination of 
intestinal stem cells is well documented (Vanuytsel et al. 2013). Interestingly we found that 
differential methylation correlates with the differential expression of some regulators of this 
pathway, which in turn induces an altered pattern of activation of the BMP signaling upon the 
loss of Apc in vivo. This observation by itself represents a novelty in the biology of intestinal 
stem cells. Although these two signaling pathways are known to cooperate in the cell fate 
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determination (Vanuytsel et al., 2013), we previously ignored the existence of a “cross-talk” 
by which the activation of the Wnt pathway would reduce the responsiveness of epithelial 
stem cells to the BMP stimuli. Although we did not examine any possible key factor at which 
these pathways can converge, we provided evidences that this reduced responsiveness is in 
part mediated through the differential methylation of positive and negative regulators of the 
BMP signaling. The characterization of the ApcKO stem cell compartment confirms the 
reduced potential of Apc-deficient ISC to undergo differentiation, and indeed these cells 
accumulate in hypertrophic crypts (figure 49).  
 
 
Figure 49: Schematic representation of the early effect produced by the loss of Apc in intestinal stem cells. 
The constitutive activation of the Wnt signaling makes intestinal stem cells and their immediate progeny 
less responsive to the gradient of BMP stimuli produced by the surrounding niche (Noggin and Grem1 
represent the BMP inhibitors secreted by the mesenchyme nearby the crypt bottom). This impaired 
responsiveness results in an expansion of the stem and Paneth cell compartment at the expense of cell 
differentiation.  
 
However, when we considered the proliferative dynamics of ISCs, we unexpectedly found 
that ApcKO cells in the self-renewal compartment divide more slowly that their wild-type 
counterpart. This reduced proliferation rate may represent a mechanism adopted by Apc-
deficient stem cells to avoid an excessive accumulation (due to the deficit in their 
commitment and elimination) that would probably expose them to hypoxia or other types of 
cellular stress. 
Strikingly, we showed that the reduced responsiveness to pro-differentiation stimuli can be 
partially rescued by inhibiting the function of de novo methyltransferases. Indeed, by treating 
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cells with an inhibitor of Dnmt3b, we observed an increased responsiveness of ApcKO 
organotypic cultures to extrinsic pro-differentiation Bmp stimuli (figure 50). This functional 
verification represents a proof of principle of the fact that the biological outcome of a critical 
genetic alteration is in part mediated by reversible epigenetic mechanisms. Aside from its 
importance in the basic understanding of stem cell biology, this finding may become relevant 
for the future design of therapeutic strategies. A recent work showed that constitutively active 
Wnt signaling upon Apc inactivation represents a conditio sine qua non for the establishment 
and maintenance of colorectal cancer (Dow et al., 2015). Indeed, this work shows that the 
restoration of Apc expression in conditional in vivo models is associated with tumor 
regression and re-establishment of the normal crypts-villus homeostatic balance via the 
promotion of differentiation even at late stages of the adenoma-to-carcinoma progression. We 
could realistically imagine that the modulation of the activity of the epigenetic mechanisms 
functioning downstream the loss of Apc would recapitulate the biological outcome obtained 
through its genetic restoration.  This perspective is further supported by our data showing that 
the inhibition of the Dnmt3b enzymatic activity via the administration of Nanaomycin A as 
well as the shRNA-mediated knock-down of its expression both result in a drop of the 
proliferative rate of ApcKO cells to extents comparable to those of wild-type cells. In order to 
complete this functional characterization we will soon evaluate the “stemness” of ApcKOcells 
upon the inhibition of de novo methylation activity. In brief, this experiment will consist in 
treating ApcKO organoids with BMP ligands in presence or absence of Nanaomycin A or upon 
the stable knockdown of de novo DNMTs expression. The organotypic structures obtained in 
the two conditions will be then dissociated, single cells will be seeded and their self-renewal 
ability will be tested by measuring their capacity to re-form new structures (clonogenicity 
assay). Since the inhibition of de novo methylation seems to promote the differentiation of 
Apc
KO cells, we would expect a reduced capacity to self-renew and form spheroids as a read-
out of the de novo Dnmts inhibition. 
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Figure 50: schematic representation of the effects of the inhibition of de novo methyltrasferases activity on 
epithelial organotypic structures in which Apc is deleted. Constitutive activation of Wnt signaling is 
accompanied by a remodeling of the methylation profiles resulting in hyperproliferation and reduced 
responsiveness to the pro-differentiation BMP stimuli. When the activity of the de novo methyltrasferases 
is inhibited at the same time of Apc inactivation via the treatment with a Dnmt3b inhibitor or via shRNA-
mediated knockdown, the proliferative rate of knock-out cells is reduced (red nuclei represent actively 
dividing cells). Moreover, when those cells are stimulated with BMP morphogens, organoids display an 
increased ability to form a differentiated compartment.  
 
The establishment of a genetic stable model of de novo Dnmts knockdown has also allowed 
us to design a pre-clinical strategy to further investigate in vivo the impact of the de novo 
methylation on the capacity of ApcKO  epithelial cells to initiate a tumor. To this aim, the 
shRNA and control lentiviral-transduced cells will be soon injected into the flank of Nude 
mice in order to monitor the establishment and outgrowth of adenomas. We recently tested the 
capacity of ApcLoxP/LoxP ; VillinCreERT2 treated with 4-hydroxy-tamoxifen to initiate tumors 
after the allo-transplant in these mice, and we  found that these cells form tumors at elevated 
rate, whereas, as expected, Apc+/+; VillinCreERT2 control cells do not display any tumorigenic 
potential. This strategy will provide us with the outstanding possibility to compare the in vivo 
read-out with the molecular profiling obtained from the same cell-cultures. However, the 
heterogeneous effectiveness of shRNA transduction found in our cultures have so far 
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represented a limitation, since cells accounting for the most effective knock-down are likely 
to undergo a negative selection. To overcome this limitation we recently established clonal 
cultures in order to select clones accounting for the most effective knock-down and avoid any 
negative selection during in vitro expansion and tumor formation. Together with the 
establishment of a shRNA-mediated knock-down model, we are also currently establishing 
organotypic models of de novo Dnmts abrogation by mean of CRISPR-Cas9 gene editing. 
Supplemental pre-clinical read-out will be obtained by using the existing conditional in vivo 
models (Dnmt3aLoxP/LoxP; Dnmt3bLoxP/LoxP) that are not currently available in the team. The 
conditional deletion of these genes in the intestinal epithelium will be used to further 
investigate their impact on the rate of spontaneous tumor initiation in ApcΔ14 mice, focusing 
the analysis to the self-renewal compartment by using the Lgr5-EGFP-ires-CreERT2 reporter 
transgenic model. 
The characterization we initiated does not take in account any epigenetic modification other 
than DNA methylation. It should be noted that it is still unclear whether DNA methylation 
represents a superior instructive mechanism serving as a template for other epigenetic 
modifications (e.g. histone marks) or a subordinate mark in the regulation of the chromatin 
status. Therefore, a better comprehension of the epigenetic mechanisms regulating the 
acquisition of the tumorigenic potential in intestinal stem cell would certainly benefit of an 
extensive investigation on the dynamics of histone modifications. 
 
SECTION II: DNA METHYLATION AND TRANSCRIPTOMIC PROFILES 
ASSOCIATED WITH DIFFERENTIAL SUSCEPTIBILITY TO TUMOR INITATION 
IN Apc
Δ14 
MICE 
Unraveling the mechanisms modulating the relative susceptibility to develop cancer probably 
represented the most conceptual and technically challenging part of the work. The results 
provided us with some interesting information. Indeed, although genetic polymorphisms play 
a major role in determining the severity of the pathology, we showed that an extensive degree 
of variability exists in two genetic substrains of ApcΔ14 mice. Isogenic mice belonging to each 
substrain are challenged by identical housing conditions and fed with the same diet. As full 
inbreeding is impossible, minimal residual segregation should be taken into account. 
However, the genetic heterogeneity due to novel mutations corresponds to 8-12 single-
nucleotide polymorphisms across the entire genome (Bailey, 1982). Inbred mice can also vary 
with respect to variable number of tandem repeats and transposon insertion (Julier et al. 1990; 
Lathe 2004). Some other sources of initial individuality should be considered, such as 
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intrauterine position, imprinting errors, maternal stress, and post-natal handling. However, the 
heterogeneity in complex phenotypic traits in inbred mice is already documented in the 
literature. Recently, Freund and collaborators showed that genetically identical mice develop 
heterogeneous exploratory behavior correlating with individual difference in adult 
hippocampal neurogenesis (Julia Freund et al. 2013; J. Freund et al. 2015). Furthermore, 
several studies in the medical literature describe the concept of epigenetic individuality of 
human homozygotic twins (Bell and Spector 2011). 
Here we examined the possible correlation between differential individual risk and 
heterogeneous molecular states, by analyzing DNA methylation and gene expression of 
isogenic mice belonging to the same genetic strain. Our characterization via reduced-
representation bisulfite sequencing can only partially tackle the question regarding the 
involvement on DNA methylation, and a more comprehensive investigation by WGBS would 
be required. However, our data suggest that the methylation of CpG-rich sequences 
(accounting for promoter regions involved in the regulation of gene expression) in the pre-
tumoral healthy tissue does not significantly correlate with the relative susceptibility to 
initiate intestinal tumors. We cannot exclude the possibility that the differential methylation of 
other genomic features (e.g. gene bodies and CpG shores) could impact on this trait. It should 
also be mentioned that the analysis of tissues made up of several cells types represents a 
limitation in this part of the work, since the remodeling of the epigenetic profiles is likely to 
occur in the most plastic compartments like the self-renewal epithelial stem/progenitor 
compartment. However, the use of transgenic reporter models (e.g. the Lgr5-EGFP-ires-
CRE
ERT2) would introduce a source of genetic heterogeneity, since mice are not in a pure 
genetic background.  
On the other hand, gene expression profiles in the healthy tissue of differentially susceptible 
mice revealed an interesting correlation with the tumor initiation rate. Importantly, this result 
was confirmed in intestinal biopsies of young mice before they had time to develop multiple 
adenomas, suggesting that global transcriptomic profiles may have a predictive value in the 
evaluation of the individual risk. In the immediate future these results will require an attentive 
validation that was so far impeded by the limited size of our biological cohorts especially in 
the case of surgical biopsies, in order to identify a minimal core signature associated with 
increased susceptibility to tumor initiation. Such signature could be then compared by mean 
of bioinformatic analysis with the data obtained in cohorts of patients in order to evaluate 
whether this may be predictive on the severity and the recurrence of the human pathology.  To 
test the biological relevance of the differential gene expression, the most significant 
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candidates could be chosen to evaluate the influence of their dosage on the rate of tumor 
initiation. In 2010 Alimonti and colleagues showed that gene dosage impacts tumor 
development and tumor growth by using a hypomorphic model of expression of Pten, which 
revealed an increased susceptibility to CRC consequent to the downregulation of this gene 
(Alimonti et al. 2010). We could imagine adopting the same strategy and testing whether the 
downregulation or overexpression of certain genes in our signatures may modify the average 
tumor burden in cohorts of ApcΔ14 mice. However, we suspect that the combinatorial effect of 
the signature rather than single candidates can influence the susceptibility at the population 
scale.   
Epigenetic signatures other than DNA methylation (e.g. the polycomb repressive complex 
binding landscape) could constitute an instructive mechanism and the investigation on these 
epigenetic signatures may therefore provide an interesting tool to decipher and evaluate the 
individual risk. To this aim, the transcriptomic profiles will be examined via gene set 
enrichment analyses, in order to evaluate in silico the enrichment of pre-established epigenetic 
signatures that would be then further investigated by molecular biology and in-depth 
sequencing in the already existing cohorts of biological samples. 
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METHODS 
 
1. Animal models in this work 
Apc
LoxP/+
; Villin-Cre
ERT2  mice were generated by crossing ApcLoxP/LoxP (Colnot et al., 2004) 
mice with Villin-CreERT2 mice (El Marjou et al., 2004), and siblings were then bred to 
maintain the colony constituted by ApcLoxP/LoxP, ApcLoxP/+ or Apc+/+; Villin-CreERT2  animals. 
For the conditional deletion of the exon 14 (inducing a frameshit mutation at AA580 
position), all mice (including Apc+/+; Villin-CreERT2 controls) were injected at day 0 with 1 
milligram of Tamoxifen (Sigma-Aldrich) reconstituted in a solution of 9 volumes of 
sunflower oil and 1 volume of 70% Ethanol, and fed with tamoxifen-rich diet (Harlan) for no 
longer than five consecutive days before sacrifice at different time-points (2h-24h-72h and 6 
days post-injection).  
The same breeding strategy was used to generate and maintain the colony of Lgr5-EGFP-ires-
Cre
ERT2 (Barker et al., 2007) containing the conditional LoxP sites flanking the exon 14 of 
one, both or none Apc alleles. Even in this case, activation of the Cre recombinase was 
obtained by a single injection with Tamoxifen followed by five consecutive day of tamoxifen-
rich diet. Mice were generally sacrificed at day 15 post injection.  
The ApcΔ14/+ model was generated by Colnot and collaborators (Colnot et al. 2004). Briefly, 
Apc
LoxP/+ males were crossed with Meu3Cre40 (germline Cre) females to obtain the 
constitutive heterozygous deletion of the exon 14. The ApcΔ14/+ colony (“FEW” and “MANY” 
substrains) was maintained by breeding ApcΔ14/+ males with C57BL6/J females (Charles 
Rivers laboratories). 
All mice were housed at the Institut de Génomique Humaine animal facility in specific 
pathogen free (SPF) conditions. Experimental procedures were performed in accordance with 
the French government regulation for animal experimentation (Ministère de l’agriculture, de 
l’agroalimentaire et de la forêt).  
The genotype of all mice was analyzed by PCR on tail-tip genomic DNA, using the primers 
listed in the table below. 
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Primer 
(Forward-Reverse) 
Sequence Amplicon size 
Apc.Int13S CTAGTACTTTTCAGACGTTCATG 
Apc.Int14a CAATATAATGAGCTCTGGGCC 
ApcΔ14 = 240 bp 
   
ApcFlox F CTGTTCTGCAGTATGTTATCA 
ApcFlox R CTATGAGTCAACACAGGATTA 
WT = 180 bp 
KO = 250 bp 
   
Villin-Cre F CAAGCCTGGCTCGACGGCC 
Villin-Cre R CGCGAACATCTTCAGGTTCT 
Tg = 280 bp 
   
Lgr5-EGFP-ires-Cre F GCAGAAGAACGGCATCAAG 
Lgr5-EGFP-ires-Cre R GCTCAGGTAGTGGTTGTCG 
Tg = 138 
 
Table 2: list of primers used for animal genotyping. The expected amplicon size is provided. In the 
Apc
Δ14/+
, Villin-CreERT2 and Lgr5-EGFP-ires-CreERT2, the presence of PCR product indicates the 
deletion (Apc
Δ14/+
) or the presence of the transgene, whereas WT genotypes do not produce any amplicon.  
 
2. Epithelial and mesenchymal samples preparation.  
After sacrifice, ApcΔ14 intestines were everted and washed with 1x PBS. The selected 
intestinal portion (indicated in the results) was then opened longitudinally on an ice-cold 
plate. Tumors in this portion were counted under a stereomicroscope (Nikon SMZ1000, 
Nikon Instruments), carefully removed, collected and snap-frozen in liquid nitrogen. The 
surrounding tumor-free environment was then incubated in 30mM EDTA (Sigma-Aldrich) in 
HBSS pH 7.4 (Gibco) on ice and the epithelium was scraped by mean of two thin needles, 
collected and snapfrozen in liquid nitrogen. The remaining portion (muscle + submucosa) was 
further checked under to eliminate any remaining epithelium, collected and snapfrozen. 
Representative images of the two isolated fractions are shown in figure 51.  
Epithelial samples from Apc+/+, ApcLoxP/+ and ApcLoxP/LoxP; Villin-CreERT2 mice injected with 
tamoxifen were scraped as described above, snap-frozen and stored at -80°C.  
All frozen intestinal samples were subsequently submerged in liquid-nitrogen and underwent 
to mechanical dry pulverization. Powder samples were then aliquoted and stored at -80°C 
until subsequent gDNA and RNA extraction.   
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Figure 51: Example of epithelial and mesenchymal fractions obtained by epithelial scraping after 30mM 
EDTA incubation. 
 
3. Intestinal biopsy collection by ileo-ileal resection 
A trained operator performed intestinal microsurgery on six week-old ApcΔ14 mice. 48 hours 
prior to surgery mice were switched to liquid isotonic diet (Jevity 1 Cal, Abbot Nutrition) and 
provided with water ad libitum. Mice were anesthetized with 1.5-2.5% isoflurane (IsoFlo, 
Axience) administered by aerosol. Surgery was performed on a warm plate (37°C) using a 
stereomicroscope (Nikon SMZ1000, Nikon Instruments) equipped with a camera (Nikon 
Instruments). The peritoneal cavity was irrigated with Zosyn (Tazocilline) antibiotic solution 
(200 mg/ml Piperacillin, 25mg/ml Tazobactam). The 2-3 cm long ileal portion to be collected 
was selected according to the anatomical vascular organization in order to avoid the resection 
of arteries and vessels and maintain the normal intestinal blood supply. After the resection, 
the integrity of the gut was surgically restored using a non-absorbable 9-0 ethilon suture 
(Ethicon). The peritoneal cavity was sutured with a 4-0 absorbable ethilon suture (ethicon). 
After completion of the surgery, mice were maintained in a recovery room at 32°C until 
awakening, when they were injected with 0.05 mg/kg Buprenorphine solution (Vetergesic 
multidose) and returned to their cages, where they were fed with liquid isotonic diet during 
seven days post-surgery. They were then switched to standard solid diet, housed in a 12-hour 
light/dark cycle, and weight evolution was monitored twice a week until sacrifice.  
 
4. Tumors count in the  Apc
Δ14/+
 intestine 
After sacrifice, intestines were everted and washed with 1X PBS before they were fixed 
with 10% buffered formalin during 4 hours at room temperature or over-night at 4°C. 
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Intestines were then washed twice with 1X PBS, opened longitudinally and tumors were 
counted using a stereomicroscope (Nikon SMZ1000, Nikon Instruments) and registered. 
Intestines were then processed as “swiss-rolls” as described in the section “histology and 
immunohistochemistry”.  
 
5. Epithelial dissociation, fluorescent activated cell sorting and flow cytometry analysis 
of the cell cycle. 
Freshly isolated small intestines mice were opened along their length and washed with 
PBS. Tissue from the most proximal third of the intestinal length was then incubated for 
15’ in 30mM EDTA (Sigma) in HBSS pH 7.4 (Gibco) on ice, 10’ in the same solution at 
37°C and transferred in DMEM (Life Technologies) supplemented with 10% FBS 
(Sigma-Aldrich).  Vigorous shaking yelded the epithelial fraction that was then 
resuspended and incubated in 100ul of Dispase (Becton Dickinson) in 10 ml of HBSS, 
supplemented with 100 ul of DNAse (Sigma-Aldrich). To investigate the co-localization 
of GFP with markers of mature tuft cells, single cell preparation obtained by filtration on a 
30 µM mesh was incubated with a Phycoerythrin Rat anti-mouse Siglec-F antibody (BD 
pharmigen 552126) for 30 minutes at 4°C, washed with HBSS and resuspendend in an 
appropriate volume of HBSS pH 7.4 supplemented with 5% FBS. To exclude dead cells 
from the analysis and sorting, 7-Amino-Actinomycin D (7-AAD, Life Technologies) was 
added to the mix at a concentration of 2µl/ml, 30’ prior to the analysis. GFP+/Siglec-F-/7-
AAD- cells were sorted directly in RLT+ lysis buffer (Qiagen) supplemented with β-
mercaptoethanol (Sigma-Aldrich) for subsequent gDNA/RNA extraction using a 
FACSAria (Becton Dickinson) at the IRMB imaging platform of Montpellier. An Lgr5+/+ 
(GFPneg) epithelial sample was systematically used as a control to establish the 
autofluorescence threshold and create a positive GFP-positive gate.  
 In the case of cell cycle analysis, after cell sorting GFP+ cells were incubated for 20’ at 
4°C in a solution containing 50 µg/ml propidium iodide (PI, Interchim), 2,4 mg/ml bovine 
pancreas RNAse (to avoid intracellular RNA staining, Sigma Aldrich), 0,5% W/V sodium 
citrate dehydrate (Sigma), 0,5% triton (Sigma-Aldrich) in distilled water. DNA content 
was then analyzed by mean of a GALLIOS cytometer (Beckman Coulter) at the IRMB 
imaging facility of Montpellier. Data analysis was performed using FlowJo flow-
cytometry software.   
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6. Crypt isolation, organotypic culture and lentiviral-mediated transduction 
For organotypic cultures, the most proximal third of the small intestine of Apc+/+ or 
Apc
LoxP/LoxP ; Villin-CreERT2 mice is everted, opened longitudinally and washed with a 1% mix 
solution of antibiotics (Ampicillin, Streptomycin) in 1X PBS, and then incubated in the same 
solution for 15’ at 4°C, twice. Intestine is then cut in small pieces (0.5 cm) and incubated in 
2mM EDTA (Sigma) in HBSS pH 7.4 (Gibco) for 30’ on ice. After vigorous pipetting, crypts 
are isolated by filtration on a 70 µM mesh and resuspended in DMEM/F12  (Gibco) 
supplemented with 1% antibiotics mix, 10mM Hepes and 2mM L-Glutamyne.  Crypts are 
then counted 2000 crypts are mixed with an equivalent volume of Matrigel (Corning), and 
plated in presence of DMEM supplemented with N-2 supplement (Gibco), B-27 supplement 
(Gibco), 1,25mM N-acetylcystein, 50 ng/ml EGF (Peprotech), 100 ng/ml Noggin (R&D 
system), 500 ng/ml R-spondin (R&D system) and 10 µM Y-27632 (Sigma Aldrich).  Cultures 
were replated every five days. Briefly, cells are resuspended in 500ul of DMEM/F12, 
mechanically dissociated by mean of a 27G needle, and approximatively ¼ of cells are 
resuspended in DMEM/F12 and mixed with a volume of Matrigel, and plated in presence of 
DMEM/F12 supplemented with growth factors.  
To induce the Cre-mediated recombination of Apc in vitro, cells are cultured in a medium 
supplemented with 200 ng/ml of 4-hydroxytamoxifen resuspended in absolute ethanol during 
3 days. The deletion of Apc knock-out organoids is then selected by removing R-Spondin 
from the medium. To inhibit the Dnmt3b activity, 5µM Nanaomycin A reconstituted in 
DMSO is added at the same time than 4-hydroxytamoxifen treatment and maintained all along 
the culture. Alternatively, medium is supplemented with 200 nM 5-Azacytidine in aqueous 
solution.  
To test the Bmp responsiveness, after 4-hydroxytamoxifen and Nanaomycin A administration, 
organoids were seeded in absence of recombinant Noggin in the medium and recombinant 
Bmp2 (RD systems) reconstituted in 4mM HCl was added at the following re-plating at 200 
ng/ml 
For lentiviral-mediated transduction, we slightly modified the protocol described by Onuma 
and collaborators (Onuma et al., 2012). Briefly, organoids are single-cell dissociated with 
Tryple reagent (Gibco) supplemented with 10mM Y-27632 (Sigma-Aldrich). Single cells are 
diluted in DMEM/F12, counted and infected with Dnmt3a (clone TRCN0000039035), 
Dnmt3b (clone TRCN0000071068) or equivalent non-target shRNA-containing lentivirus 
(MISSION shRNA, Sigma-Aldrich) at M.O.I.=10 and single cells are seeded on a layer of a 
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solidified mix of one volume DMEM/F12 and one volume Matrigel in presence of 
DMEM/F12 supplemented with 2,5 uM CHIR99021 (Sigma-Aldrich) and growth factors, in 
which however R-Spondin is added at 1 ug/ml (instead of 500ng/ml). Virus-containing 
medium is removed 18 hours later and a supplemental layer of DMEMF12/matrigel is added 
over the cells in presence of the standard medium supplemented with growth factors. 
Antibiotic selection was performed 48 hours post-infection by adding puromycin at 1ug/ml or 
G418 400 ug/ml, and stopped one week later.  Double infection with both Dnmt3a/Dnmt3b or 
non-target/non-target shRNA-containing lentivirus and antibiotic selection were performed 
sequentially. 
To evaluate the rate of cell division, BrdU is added to the medium at 10 µM two hours prior 
to cells harvesting. Part of the cells were harvested in RLT+ lysis buffer (Qiagen) 
supplemented with β-mercaptoethanol and stored -80°C for further gDNA and RNA 
extraction. 
 
7. Immunofluorescence, immunohistochemistry and in-situ hybridization 
After sacrifice, intestines were everted and washed with 1X PBS before they were fixed in 
10% neutral buffered formalin during 4 hours at room temperature or over-night at 4°C. 
Intestines were then washed twice with 1X PBS, opened longitudinally and histological 
samples were prepared as “swiss-rolls”, dehydrated through successive baths of ethanol at 
increasing concentration (70-100%) and xylene and embedded in paraffine. 3-5 µM-thin 
sections were cut using a microtome (Leica) and rehydrated through successive baths of 
xylene and alcohol at decreasing concentration (100-70%). Organotypic cultures were fixed in 
1neutral buffered formalin over night at 4°C, embedded in histogel (Thermo scientist) and 
further processed in the same manner. Epitope unmasking was systematically performed in a 
boiling solution of 10 mM sodium citrate dehydrate (Sigma-Aldrich) pH 6.4 for 20’, and 
sections were let cool-down for 40’ before blocking buffer solution (5% milk or 3% Donkey 
serum in 0,1% TBS triton) was applied for one hour at room-temperature. Primary antibodies 
were appropriately diluted in blocking buffer and incubation with primary antibody was 
performed over-night at 4°C. The list of primary antibodies used in this work is provided in 
table 2. Sections were then washed with two serial baths of TBS or PBS 0.1% Tween (Sigma-
Aldrich). Fluorescent signal was developed by incubating with secondary antibodies coupled 
with AlexaFluor 488, cyanine3 or cyanine 5.5 dyes (Jackson immunology) for one hour at 
room temperature in the dark, and Hoechst was added at 1g/ml to stain the nuclei. Sections 
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were then washed twice with TBS or PBS 0,1% Tween and mounted with fluoromount 
aqueous mounting medium (Sigma-Aldrich). Anti-mouse/rabbit universal immuno-peroxidase 
polymer (N-histofine) was used for bright-field imaging. In this case, signal development was 
obtained by applying the SIGMAFAST 3,3’-diamino-benzidine  substrate (Sigma-Aldrich). 
Nuclei were then stained with hematoxylin, sections were dehydrated through successive 
baths of ethanol and xylene, and samples were mounted with PERTEX (Histolab).  
In situ hybridization was performed to detect Olfm4-expressing cells in transgenic (GFP+) 
crypts. Briefly, GFP+ crypts were identified by conventional immunohistochemistry and in-
situ hybridization was performed on adjacent sections. Olfm4+ cells were only counted in 
GFP+ crypts found on adjacent sections. Sections were rehydrated and permeabilization was 
performed by applying 0,2N HCl during 15’, which was followed by treatment with 3 µg/ml 
proteinase-K solution for 20’ at 37°C. Sections were then fixed 10’ with 10% neutral buffered 
formalin, and acetylation was performed applying a fresh a 0,1 M  triethanolamine, 0,02 N 
HCl,  0,25% (v/v) acetic anhydre solution in sterile water during 5’ at 58°C. Pre-hybridization 
solution (20X SSL, 500nM EDTA pH8, Dehart buffer, tRNA) was applied 2 hours at 58°C. 
Hybridization with 2 µg/ml Olfm4 RNA digoxygenin-coupled probes was then performed 
over-night at 58°C. Sections were then washed and incubated with anti-digoxigenin alkaline-
phosphatase coupled antibody (Roche) for 2 hours at room temperature. Signal was developed 
using SIGMAFAST FastRed TR/Naphthol (Sigma-Aldrich) for 2 hours at room temperature.   
All fluorescent pictures were acquired at room temperature on a Axioimager Z1 microscope 
(Carl Zeiss, Inc.) equipped with a camera (AxioCam MRm; Carl Zeiss, Inc.). Bright-field 
immunohistochemistry pictures were taken at room temperature on an Eclipse 80i microscope 
(Nikon) equipped with a digital camera (Q-imaging Retiga2000R with a Q-imaging RGB 
slider).  
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Antibody Reference Host Concentration 
α-Β-Catenin BD biosciences 610154 Mouse 1:800 
α-BrdU Hybridoma bank G3GA Mouse 1:600 
α-Chromogranin A SantaCruz 1488 Goat 1:800 
α-Dclk1 Abcam 31704 Rabbit 1:1000 
α-Digoxigenin-AP Fab Sigma-Aldrich 
11093274910 
  
α-Dnmt1 Abcam 19905 Rabbit 1:400 
α-Dnmt3a Abcam 23565 Rabbit 1:400 
α-Dnmt3b Abcam 2851 Rabbit 1:400 
α-Lyzozyme Santa Cruz 27958 Goat 1:400 
α-GFP Life Technologies A6455 Rabbit 1:1000 
α-Ki-67 Abcam 16667 Mouse 1:1000 
α-PhosphoSmad 1/5/8 Cell signalling 9511S Rabbit 1 :200 
α-PhosphoSmad 2/3 Cell signalling 8828S Rabbit 1 :200 
 
Table 3: primary antibodies used for immunofluorescence and immuhistochemistry in this work.  
 
8. gDNA and RNA extraction 
For nucleic acid extraction from intestinal fractions, dry powder samples were homogenized 
in RLT+ buffer (Qiagen) supplemented with β-mercaptoethanol. gDNA and total RNA 
extraction was then performed by using the AllPrep DNA/RNA/miRNA universal kit 
(Qiagen) following the manufacturer instructions. The integrity of RNA samples used for 
RNA-sequencing and qPCR analyses presented in this work was evaluated with a Bioanalyzer 
and the RNA integrity number was confirmed to be higher than 6 for all selected samples. 
Extraction of gDNA and RNA from FACS-isolated GFP-positive cells was performed by 
using the AllPrep DNA/RNA micro KIT following manufacturer instructions with the only 
exception that 80% ethanol was replaced by 70% ethanol to increase the RNA yeld. The 
integrity of RNA samples used for RNA-sequencing was evaluated with a Bioanalyzer and 
the RNA integrity number was confirmed to be higher than 6 for all of the twelve selected 
samples.  
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9. RT-PCR, semi-quantitative RT-PCR, RT-qPCR and DNA methylation 
quantification by qPCR on McrBC-digested genomic DNA. 
Reverse transcription of RNA samples was performed by using the Transcriptor First 
strand cDNA synthesis KIT (Roche) following manufacturer instructions. Both random 
hexamer and oligodT primers were used for reverse transcription. 
In the case of semi-quantitative PCR, 10 ng of cDNA prepared from GFP+ cells RNA 
template were used for amplification with a thermocycler (Eppendorf). Primers used for 
semi-quantitative PCR are listed below. 
 
Gene 
symbol 
Gene name Forward primer Reverse primer 
Amplicon 
size 
Smad6 
Mothers against 
decapentaplegic 6 
AAGCCACTGGATCTGTCCGA GGGAGTTGACGAAGATGGGG 379 
Actb Actin beta AGCTCAGTAACAGTCCGCCT CCAGCCTTCCTTCTTGGGTATG 360 
 
Tableau 4: Primers for semiquantitative PCR performed on cDNA samples from FACS-isolated GFP
+
 
cells. 
 
Real-time PCR quantification of gene expression was systematically performed in 
triplicate on 5 ng of cDNA by using the LightCycler 480 SYBR Green I Master (Roche) 
on a LightCycler 480 detection system (Roche). The efficiency of the primers used for 
real-time quantification (listed in the table below) was evaluated relatively to the slope 
obtained by the quantification of a standard curve, and the presence of a single amplicon 
at the expected size was checked on an 2% agarose gel. Results were normalized on the 
average of the expression of Gapdh and Hprt housekeeping genes and the relative 
quantification was obtained by applying the -ΔΔCt method described by Pfaffl (Pfaffl 
2001): 
Relative expression = Efficiency-ΔΔCp 
! *"+!
 
Table 5: Primers used for real-time PCR mRNA expression quantification. Expected size of the amplicon 
and efficiency calculated on a standard curve are indicated. 
!
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qPCR quantification of DNA methylation of selected genomic regions was performed on 
genomic DNA samples after digestion (16 hours at 37°C) with methylation sensitive McrBC 
restriction enzyme (New England Biolabs) performed by adding 400 ng of gDNA to a mix of 
4 µl of NEB buffer, 0,4 µl of BSA, µl of GTP, 2 µl of McrBC enzyme and water to a final 
volume of 37 µl. Undigested controls are obtained by replacing the enzyme with an equivalent 
volume of water. Reaction was stopped by incubating the samples for 20’ at 65°C. Real-time 
PCR quantification was then performed in triplicate on 1.39 ng of the digestion product, using 
specific primers designed to flank target genomic regions. Results were normalized on the 
average Cp of three unmethylated control regions (Col1A2, Col3a1 and Col9A2) and the 2-
ΔΔCt value was calculated. The extent of methylation is then calculated by using the formula: 
 
 
 
The primers used for real-time PCR quantification of the DNA methylation extent are 
listed in the table below. 
 
Genomic 
locus name 
Forward primer Reverse primer 
Col1A2 
AAAGAGAAGGATTGGTCAGAGCAGT 
 
GCCAAGGGAGGAGACTTAGTTG 
 
Col3a1 
TTGCTGTTTCAACCACCCAATA 
 
CATTGAGACATTTTGAAGTTGGAATT 
 
Col9A2 
CTCTGGACTTATTTTTATTGGGTATCTTTT 
 
CAGGGAAGATGGATGTTTAAATACTG 
 
Iap 
TATGCCGAGGGTGGTTCTCTA 
 
TGCGGCAAAACTTTATTGCTT 
 
Smad6 GGCAAGCTTCTCCATGTACC TTCTAGAGAGTCCAACAGTTGGC 
 
Table 6: Primers used for real-time PCR quantification of DNA methylation in genomic samples digested 
with McrBC restriction enzyme. 
 
10. Tanscriptomic analyses by Next Generation Sequencing  
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The transcriptomic profiling presented in this work were performed by Next Generation 
Sequencing on two different platforms. The RNA-seq data from Lgr5+ cells were collected by 
GATC-biotech (European Genome and Diagnostic Centre, Konstanz-Germany) on an 
Illumina HiSeq 2500 (Illumina). After poly-A selection, strand specific DNA libraries were 
built for sequencing performed on 125 bp paired-end reads with sequencing depth of 30 
million read pairs. The RNA-seq reads were aligned to the reference genome (mm10) using 
Bowtie alignment. TopHat identified the potential exon-exon splice junctions of the initial 
alignment. Then Cufflinks identified and quantified the transcripts from the pre-processed 
RNA-seq alignment. After this, Cuffmerge merged the identified transcript pieces to full 
length transcripts and annotates the transcripts based on the given annotations. Finally, 
merged transcripts from samples/conditions were compared using Cuffdiff to determine the 
expression levels (quantified as fragment per kilobase per million mapped reads, FPKM) at 
transcript level including in each biological sample. Combined expression data were 
generated by merging all the sample of each condition into one table, the differential 
expression values are expressed as fold-change and a measure of significance (P-value) 
between conditions is provided.  
The RNA-seq data from ApcΔ14/+ intestinal samples and biopsies were collected by Cincinnati 
Children’s Hospital Medical Center NGS platform (European Cicinnati, USA) on an Illumina 
HiSeq 2500 (Illumina). In this case, after poly-A selection, strand specific DNA libraries were 
built for sequencing performed on 75 bp paired-end reads with sequencing depth of 20 million 
read pairs. Gene expression analyses were performed as described above. 
 
11. Reduced representation bisulfite sequencing 
RRBS were performed on gDNA samples extracted from ApcΔ14 intestinal surgical biopsies, 
tumor-free epithelial fraction from sixteen week-old ApcΔ14 mice and Apc+/+, Apc+/- and Apc-/- 
GFP+ FACS-isolated cells. RRBS libraries were produced as previously described (Auclair et 
al. 2014). Briefly, we digested 100 ng of genomic DNA 5 hours with MspI (Thermo 
Scientific), performed end-repair and A-tailing (with 5 U Klenow-fragment, Thermo 
Scientific), and ligated to methylated adapters (with 30 U T4 DNA ligase, Thermo Scientific) 
in Tango 1× buffer. Fragments between 150 and 400 bp were excised from a 3%agarose 0.5× 
TBE gel with the MinElute gel extraction kit (Qiagen) and bisulfite-converted with the 
EpiTect bisulfite kit (Qiagen) with two consecutive rounds of conversion. Final RRBS 
ibraries were amplified by PCR with the PfUTurbo Cx hotstart DNA polymerase (Agilent) 
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using the following PCR  conditions: 2 min at 95°C; 16 cycles of 30 sec at 95°C, 30 sec at 
65°C, and 45 sec at 72°C; and 7 min at 72°C. We purified the libraries with AMPure 
magnetic beads (Beckman Coulter) and performed pairedend sequencing (0032 × 75 bp) on 
an Illumina HiSeq 2500 at Integragen SA. RRBS was performed with 100 ng starting DNA 
and 14 cycles for the final PCR. We cleaned the sequencing reads with Trim Galore (v0.2.1, 
parameters –rrbs –paired -r1 30 -r2 30 -q 20 –length 20 –retain_unpaired,  
http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) and aligned to the 
mm10genome with BSMAP (v2.74, parameters -v 2 -w 100 –r 1 -x 400 -m 30 -D C-CGG -n 
1) (Xi and Li 2009). Percentage of methylation values were calculated as the ratio of the 
number of Cs over the total number of Cs and Ts with methratio.py in BSMAP (parameters -z 
-u -g). The bisulfite conversion efficiency was estimated by calculating the C-to-T conversion 
in non-CpG sites. For all data analysis, we filtered CpGs to have a minimum sequencing 
depth of 8× and visualized methylation values with the IGV browser (Robinson et al. 2011). 
 
 
12. Statistical analysis  
The Prism software was used for descriptive statistical analyses. As normal distribution was 
not met, a two-tailed Mann-Whitney U-test was used to calculate the P-value. For histological 
data quantification, sample (n) was defined as the number of cell per crypt or crypt-villus unit. 
Unless otherwise stated, 20 cypts, crypt-villus axes or organotypic structures were counted 
per histological per histological section of each genotype and condition. According to the 
central limit theorem, in the case of n>30, data comparison was achieved with a two-tailed 
Student’s t-test. Results shown as histograms represent means, and error values are 
represented as SEM or standard deviation as indicated in each figure. 
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mainteinance and de novo methylation of the DNA. 
16. Schematic representation of post-translational histone modifications. 
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17. MicroRNA biogenesis and function. 
18. The epigenetic progenitor model of cancer development. 
19. Apc loss results in increased proliferation and de novo differentiation but not in 
de-differentiation of intestinal epithelial cells of Apc
LoxP/LoxP
; VillinCre
ERT2
 mice. 
20. The hypertrophic proliferative compartment upon the deletion of Apc in the 
intestinal epithelium. 
21. Wnt activation in Lgr5
+
 stem cells leads to the formation of a hypertrophic GFP-
positive compartment. 
22. The GFP rarely co-localizes with markers of the post-mitotic cell populations 
typically found at the bottom of the crypt. 
23. Expansion of the CBC stem compartment 15 days after the deletion of Apc in 
Lgr5
+
 cells. 
24. Alteration in the cell cycle dynamics of GFP
+
 cells 15 days after the deletion of 
Apc in Lgr5+ cells. 
25. Fluorescent-activated cell sorting of GFP-positive cells from Lgr5-EGFP-ires-Cre 
epithelia. 
26. Progressive alteration of the gene expression profiles in GFP
+
 cells. 
27. Altered gene expression in response to the loss of one Apc allele in Lgr5
+
 cells and 
their immediate progeny. 
28. Differentially methylated regions in WT and KO Lgr5
+
 cells and their immediate 
progeny. 
29. Altered gene expression in response to the loss of function of Apc in Lgr5
+
 cells 
and their progeny. 
30. Methylation of a representative IAP region in Apc
+/+
 and Apc
-/-
 Lgr5
+
 cells and 
their immediate progeny. 
31. Methylation and expression of Smad6 in Apc
+/+
 and Apc
-/-
 Lgr5
+
 cells and their 
immediate progeny. 
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32. Translocation patterns of phospho-Smad 1/5/8 effectors in the Apc
+/+
 and 
Apc
LoxP/LoxP 
; Villin-Cre
ERT2 
at day 6 post-tamoxifen injection. 
33. morphologic changes upon Apc deletion in intestinal organotypic cultures and 
effects of Dnmt3b inhibition. 
34. Dnmt3b inhibition increases the epithelial responsiveness to differentiation 
stimuli. 
35. Lentiviral-mediated tranduction of Dnmt3a and Dnmt3b specific sh-RNA results 
in heterogeneous knock-down in intestinal Villin-Cre
ERT2
 organoids. 
36. Proliferative rate in response to Dnmt3a/Dnmt3b knockdown in organotypic 
Apc
LoxP/LoxP
,Villin-Cre
ERT2
 cultures treated with 4-hydroxy-tamoxifen. 
37. Intestinal tumor burden in 16 weeks-old co-isogenic mice. 
38. Schematic representation of the breeding outputs showing the non-random 
segregation of the unknown genetic polymorphism. 
39. Intestinal tumor burden in 6 week-old co-isogenic mice. 
40. Non-genetic variable relative risk. 
41. verification of the tumor-free samples selected for –omic profiling. qPCR results 
show comparable expression of the WT and truncated forms of Apc and Myc in 
Apc
Δ14/+ 
mice. 
42. Relative enrichment of epithelial and mesenchymal fractions. 
43. CpG methylation extent as quantified by RRBS (left) in regions showing a 
consensus (no overalp between the two groups) and qPCR quantification of the 
transcription of the genes in close proximity to the DMRs (16 weeks). 
44. Heatmap and hierarchical clustering analysis of 73 differentially expressed genes 
in the epithelial fraction of poorly and highly susceptible adult individuals. 
45. Weight evolution after the intestinal resection. The % of the initial weight is 
shown at different time points post-resection performed on day 0. 
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46. Tumor development along the small intestine of operated and control Apc
Δ14/+ 
mice. 
47. CpG methylation extent as quantified by RRBS (left) in regions showing a 
consensus (no overalp between the two groups) and qPCR quantification of the 
transcription of the genes in close proximity to the DMRs (6 weeks). 
48. Heatmap of differentially expressed genes in the intestinal biopsies of six-weeks 
old poorly and highly susceptible individuals. 
49. Schematic representation of the early effect produced by the loss of Apc in 
intestinal stem cells. 
50. Schematic representation of the effects of the inhibition of de novo 
methyltrasferases activity on epithelial organotypic structures in which Apc is 
deleted. 
51. Example of epithelial and mesenchymal fractions obtained by epithelial scraping 
after 30mM EDTA incubation. 
TABLES: 
1. Relative change in the expression of genes associated with stemness and 
commitment of the intestinal epithelium. 
2. List of primers used for animal genotyping. 
3. Primary antibodies used for immunofluorescence and immuhistochemistry in 
this work.  
4. Primers for semiquantitative PCR performed on cDNA samples from FACS-
isolated GFP
+
 cells. 
5. Primers used for real-time PCR mRNA expression quantification. Expected size 
of the amplicon and efficiency calculated on a standard curve are indicated. 
6. Primers used for real-time PCR quantification of DNA methylation in genomic 
samples digested with McrBC restriction enzyme. 
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LIST OF ABBREVIATIONS 
 
 
5-Aza: 5-azacytidine 
7-AAD: 7-Amino-Actinomycin.!
BMP: bone morphogenetic factor. 
bp: base pair.!
BrdU: Bromodeoxyuridine.!
CBC: crypt base columnar cells.!
CIMP: CpG island methylator phenotype. 
CIN: chromosome instability. 
CMS: consortium molecular subtypes. 
CpG: CpG dinucleotide. 
CRC: colorectal cancer. 
DMEM: Dulbecco’s modified eagle medium. 
DNA: deoxyribonucleic acid. 
DNMT: DNA methyltransferase 
EGF: epidermal growth factor. 
EDTA: Ethylenediaminetetraacetic acid. 
FDA: food and drugs administration. 
GFP: green fluorescent protein. 
GLP: glucagon-like peptide. 
GIP: gastric-inhibitory peptide. 
GO: gene ontology. 
GSEA: gene set enrichment analysis. 
HAT: histone acetylase transferase. 
HBSS: Hank’s balanced salt solution. 
HCl: hydrochloric acid. 
HDAC: histone acetyltransferase. 
HET: heterozygous. 
HNPCC: hereditary non polyposis colorectal cancer 
ISC: intestinal stem cell.  
Kb: kilobase. 
KI: knock-in. 
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KO: knock-out. 
LOH: loss of heterozygosity. 
LOI: loss of imprinting. 
lncRNA: long non-coding RNA 
mRNA: messanger RNA 
miRNA: micro-RNA 
MMR: mismatch repair. 
MSI: micro-satellite instability. 
NGS: next generation sequencing. 
NICD: Notch intracellular domain. 
NLRs: NOD-like receptors. 
PAMPs: pathogen-associated molecular patterns. 
PBS: phosphate buffered saline. 
PCR: polymerase chain reaction 
PE: phycoerythrin. 
PRRs: pattern recognition receptors. 
PI: propidium iodide. 
RELM: Resistin-like molecule. 
RNA: ribonucleic acid. 
RNA-i: RNA interference 
RNA-seq: RNA sequencening.  
RRBS: reduced representation bisulfite sequencing. 
RT: reverse transcription 
SEM: standard error of the mean. 
shRNA: short-hairpin RNA. 
TF: transcription factor. 
TG: transgenic. 
TGF-β: transforming growth factor beta 
TCGA: the cancer genome atlas. 
TLRs: toll-like receptors. 
WNT: Wingless-related integration site. 
WGBS: whole genome bisulfite sequencing. 
WT: wild-type. 
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